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Summary and Main Trends and Developments 
The basic indicators of the situation in the field of drug use and its consequences in the Czech 
Republic do not differ from the average or standard state of affairs in the EU (see Table below).  
The Czech drug policy did not change significantly in 2002. Drug policy coordination is gradually 
responding to the new regional arrangement. There has been no significant change in the legislation 
in the field of drugs. It is a positive matter that judicial practice is to make increasing use of alternative 
sentences for drug users.  
The data about drug use are characterized by, on the one hand, a diverging development in the field 
of experimental and recreational drug use and, on the other, problem use. While there is an 
increasing trend towards experimental and recreational use, problem use has stabilized and some 
indicators even suggest that it has decreased.  
There is a favourable trend in the occurrence of health consequences of drug use, especially with 
regard to deaths and infectious diseases. There has been a decrease in the number of deaths, and 
the rate of infections among drug users has stabilized. The proportion of problem users who are in 
contact with treatment centres has been growing; problem drug users are getting older, and this 
represents a favourable trend.  
In the Czech Republic, there is a solid network of different types of help and treatment facilities. There 
is a lack of substitution (methadone) centres and other substitution treatment providers in comparison 
with the EU states.  
The number of offenders of drug-related crimes prosecuted, accused, and convicted has increased; 
most cases involve offences related to pervitin and cannabis. The prices of drugs have remained 
stable, heroin purity is decreasing.  
Comparison between selected indicators in the Czech Republic and in the European Union 
Source (EMCDDA, 2002) and the data collected by the Czech National Focal Point for preparation of the Annual Report  
  
Note: * range of values in most countries  
 
 
 
 
 
Indicator  Czech 
Republic  
Range of 
values / 
Average in EU 
states  
Lifetime prevalence of cannabinoids in the general population (%) 16 – 20 20 – 25 
Number of problem drug users (per 1,000 inhabitants aged 15 – 64) 5 2 – 9  
Number of injecting drug users (per 1,000 inhabitants aged 15 – 64) 4 2 - 7 
Proportion of heroin users in treatment demands (%) 25 50 - 70 
Proportion of cannabinoid users in treatment demands (%) 16 3 - 24 
Proportion of opiate users in substitution treatment (%) 7 20 – 60* 
HIV rate among injecting drug users (%) < 1  1 – 34 
HBV rate among injecting drug users (%) 10 - 50 20 - 60 
HCV rate among injecting drug users (%) 35 - 60 40 – 90 
Fatal drug overdoses (per 100,000 inhabitants) 1 2 
Proportion of marijuana in prosecuted drug-related criminal offences (%) 37 37 – 85 
Proportion of possession of drugs for personal use in all prosecuted drug-
related criminal offences (%) 
10 55 – 90 
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Organizational Background  
The year 2002 was the second year of the implementation of the 2001 – 2004 National Drug Policy 
Strategy. The Secretariat of the National Drug Commission drew up an Evaluation Report about  the 
fulfilment of the targets of this strategy. It claimed a failure to meet 14 short-term targets.  
On the basis of the Government Resolution, the Czech National Focal Point for Drugs and Drug 
Addiction was set up within the framework of the Secretariat of the National Drug Commission on 
June 19, 2002. It is responsible for the collection, analysis, distribution, and coordination of collection 
of data about drugs at a national level. Since January 1, 2003, it has been fully equipped in terms of 
staff and material equipment.  
On the basis of the Government Resolution No. 1177/2001, the Ministry of Health categorized drugs 
according to their levels of health risks. The Ministry of Health submitted the final draft of the 
categorization to the Minister of Justice and the Executive Vice-Chairman of the National Drug 
Commission. It is intended that the categorization should be reflected in the Penal Code and therefore 
allow the law-enforcement bodies to focus primarily on the organized drugs trafficking. At the same 
time, it is hoped that the black markets for cannabis and more dangerous drugs will be separated. 
The government has not discussed this intention yet, and nor have individual members of the 
government taken a uniform approach to this issue.  
As 2002 became 2003, the House of Commons of the Parliament of the Czech Republic received a 
government bill about measures for protection against damage caused by tobacco products, alcohol, 
and other narcotic and psychotropic substances (NPS). It should replace the existing legal regulations 
included in Act 37/1989 Coll. On Protection against Alcoholism and Other Drug Abuse. The 
Secretariat of the National Drug Commission believes that the final draft of the government bill is not 
satisfactory – especially because it does not clearly and sufficiently define the relations between the 
state and the regions during drug policy implementation.  
After two years of the existence of higher self-governing territorial units (regions), all 14 of them have 
established the position of a drug coordinator. Interdepartmental and interdisciplinary regional drug 
commissions have been set up in 11 regions; 9 regions have developed their own drug strategy.  
In September 2002, the newly elected House of Commons of the Parliament of the Czech Republic 
set up a subcommittee for drugs and drug abuse issues. 
An essential part of the project Phare Twinning 2000 “Strengthening National Drug Policy” was 
carried out in 2002. The project focused on three fields that correspond with the main components of 
the National Strategy: (1) the establishment, and facilitating the operations of the Czech National 
Focal Point for Drugs and Drug Addiction and the assurance of data collection in compliance with the 
EU requirements; (2) the improvement of horizontal and vertical cooperation in the field of 
coordination of drug policy, and (3) the education of staff in the field of drug supply and drug demand 
reduction.  
As far as the criminal law (drug-related criminal offences) is concerned, the factual basis of a crime of 
the promotion of drug use was extended in 2002, according to the provision of Section 188a of Act 
140/1961 Coll., the Penal Code, on Promotion in “print, film, radio, television, public computer 
networks, or in another similarly effective manner”; however, police statistics record a decline in the 
prosecution of this type of criminal activity.  
It is positive that the judicial practice is to make increasing use of alternative sentences even for drug 
users; this involves both the prosecution of drug-related criminal offences and/or related petty crime 
against property. There is no doubt that this is strongly supported by the higher level of awareness 
about drug issues on the part of judges; in addition, the work of Probation and Mediation Service 
officers who have been in place since January 1, 2001 has also made a significant contribution.  
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Nearly CZK 205 million (€ 6.5 million1) was earmarked from the state budget for the purposes of the 
implementation of drug policy programmes; approximately CZK 92 million (€ 2.9 million) thereof were 
subsidies of the National Drug Commission. There were again problems with the delayed forwarding 
of funds to NGOs.  
Drug Use 
While the number of experimental and recreational drug users (especially of cannabis and ecstasy) 
has been increasing in the Czech Republic, the number of problem drug users (i.e. heroin and pervitin 
users) has stabilized.  
16-20% of the adult population (i.e. approximately 1.4 – 1.7 million people) have tried an illicit drug. 
Most frequently, this involves marijuana and hashish (the relative and the absolute numbers of lifetime 
experience with cannabis are practically identical with the figures on general experience with illicit 
drugs). Then there follows ecstasy, a typical dance drug - 4% of the population (i.e. 350,000 people). 
In the last 12 months, approximately 11% of the population (i.e. approximately 950 thousand people) 
have used an illicit drug (especially cannabis drugs again), and 2.5% have used ecstasy (i.e. 
approximately 200,000 people). The use of heroin, pervitin, cocaine, or LSD is relatively rare among 
the Czech population; approximately 2% report experience with at least one of these drugs (i.e. 
approximately 170,000 people). 
Data about drug use in the secondary school population are not available for 2002. According to the 
latest nationwide survey carried out in 2000, approximately 50% of secondary school students (age 
15 – 19) have tried an illicit drug, and approximately 15% of them use drugs regularly (recreationally); 
again, this mainly involves marijuana and ecstasy.  
31% of adolescents in the final grades of primary schools (age 14 – 15) have tried a drug (the share 
of experience with marijuana is again practically identical; 5% report experience with ecstasy). The 
steadiness of the rate of experience with solvents is disturbing – 7% of pupils in the final grades of 
primary schools report using/having used them. A comparison of the current surveys from primary 
schools with the previous surveys carried out in secondary schools shows that there is an increasing 
trend towards the experimental and recreational use of cannabis drugs; at the same time, pervitin and 
heroin use in the school-aged population is still very rare. The results of the ESPAD survey, carried 
out in 2003, will provide a picture of the current state of drug use among the secondary school 
population.  
Drug use is more common in the population of recreational users – this especially involves cannabis 
drugs, ecstasy, hallucinogens, and pervitin.  
The number of problem drug users (i.e. injecting users and/or regular or long-term users of pervitin 
and heroin) is stable, and has reached 35,000 – 37,000 people, of whom 30,000 – 32,000 are 
injecting users. Problem drug users are growing older, and this represents a favourable trend that 
suggests a decline in new problem users.  
Czech society is increasingly tolerant towards so-called soft drugs (i.e. mainly cannabis drugs), 
according to public opinion polls. To a great extent, society perceives the issues related to so-called 
hard drugs as a criminal issue; however, it does not have a strongly negative attitude towards 
individual users.  
Consequences of Drug Use  
In 2002, 9,237 drug-related treatment demands were recorded; 4,719 cases thereof involved first 
treatment demands. The primary drugs involved are most frequently pervitin, heroin, and 
cannabinoids. As far as treatment demands in 2002 are concerned, the most marked trend involved a 
rapid drop in the number of heroin users and a sharp rise in the number of pervitin users. Possible 
causes may involve an outflow of heroin users to substitution treatment with methadone and 
                                                           
1 at the rate CZK 31.6 = 1 € (2002, December 31) 
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buprenorphine treatment (the Register of Treatment Demands does not cover substitution treatment), 
heroin market instability in the geopolitical context, and, last but not least, a decrease in the number of 
new heroin users. It is likely that the rise in the number of pervitin users is mostly caused by the 
increasing coverage of the Register of Treatment Demands (pervitin users are not clients of 
substitution treatment). 
Despite the unquestionable qualities of the Register of Treatment Demands, it does not cover all drug 
users who are in contact with help and treatment centres. 7,441 problem users were entered in the 
Register of Treatment Demands in 2002 (i.e. 21% of the estimated number of all problem users). 
Approximately 21,000 problem users are in contact with low-threshold centres (i.e. 60% of all problem 
users); active files of out-patient health facilities record approximately 13,500 (i.e. 40% of all problem 
users). Psychiatric hospitals registered 2,510 hospitalizations due to disorders caused by drug use in 
2002 (i.e. 7% of all problem users). 391 clients underwent therapy in therapeutic communities (i.e. 1% 
of all problem users). Only 463 were registered at substitution centres (i.e. 3% of all problem opiate 
users); it is estimated that approximately 1,000 people undergo legal substitution with methadone or 
buprenorphine (including treatment provided outside substitution centres (i.e. 6% of all problem opiate 
users).  
There is a trend for the proportion of problem users who are in contact with helping and treatment 
facilities (especially with low-threshold facilities) to increase. 
There were 115 fatal overdoses on narcotic and psychotropic substances in the Czech Republic in 
2002; medicaments were involved in 72 cases (48 cases thereof involved benzodiazepines). Drugs 
were involved in 43 cases (21 cases of opiates, 14 cases of solvents, and 8 cases of pervitin). The 
number of drug-related deaths has decreased with regard to all drugs except pervitin in comparison 
with 2001. Even in the context of the overall decrease in the number of toxicological examinations of 
the dissected, this picture is in accordance with trends and their possible causes that were mentioned 
above in the section about treatment demands.  
In comparison with alcohol, the influence of illicit drugs on fatal traffic accidents is low (less than 1% of 
dead drivers tested positively for illicit drugs, approximately 40% were positive for alcohol). 
The rate of infections (especially HIV/AIDS, HBV and HCV) among drug users has remained stable. 
The HIV rate among injecting drug users is still under 1%. The HBV rate in the population of clients of 
low-threshold facilities is around 10%, and that in the population of long-term and intensive opiate 
users in substitution treatment 40 – 50%. The HCV rate among the clients of low-threshold facilities is 
around 35%, and among opiate users in substitution around 60%. This favourable picture has been 
partly influenced by the dense network of needle and syringe exchange programmes; approximately 
one half of injecting users are in contact with these programmes. 
Prevention and Treatment  
Primary Prevention  
Primary prevention activities are implemented by many different organizations (schools, ministries, 
regions, municipalities, and NGOs). Because of this it is practically impossible to gain an insight into 
the volume, content, and costs of the implementation of these activities.  
In the Czech Republic, school-based prevention represents the most common form of primary 
prevention activity. It is carried out within the framework of two basic types of programmes, namely 
the Minimum Preventive Programme in schools and educational facilities and the Programme of the 
Prevention of Socially Pathological Phenomena within the sphere of competence of the Ministry of 
Education, Youth, and Sports. The Minimum Preventive Programme is implemented by schools; 
school prevention workers who operate in all Czech schools play a key role in the implementation of 
this programme. The programmes of the prevention of socially pathological phenomena within the 
sphere of competence of the Ministry of Education, Youth, and Sports are implemented by NGOs, 
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subsidized organizations set up by the Ministry of Education, Youth, and Sports, and other 
organizations outside this Ministry. Even the Police of the Czech Republic implements primary 
prevention projects in schools; they are carried out within the framework of crime prevention 
programmes. Specific extracurricular primary prevention programmes are implemented especially by 
NGOs and pedagogical-psychological counselling centres. Community programmes and Internet-
based prevention are under development.  
Harm reduction 
There is a network of 93 low-threshold projects (drop-in centres and outreach programmes) in the 
Czech Republic. The services generally offered include needle and syringe exchange, the mediation 
of contact with treatment facilities, infectious disease testing, and health and social services for drug 
users; most low-threshold centres provide hygiene and food services. Some facilities operate a 
programme of secondary exchange of injecting materials. 15 projects provide an information service 
accompanied by benchmark drug quality testing for recreational drug users of ecstasy directly at 
dance events. Three low-threshold facilities provide services especially for Roma drug users. Four 
facilities provide services in prisons. There is a trend for the number of needles and syringes issued to 
increase. Approximately 1.5 million of them were handed out in 2002.  
Treatment and After-care 
The network of abstinence-oriented programmes for drug addicts has achieved a relatively good level. 
The drug addicts’ treatment system consists of public health care facilities (out-patient care, AT 
(alcohol and toxicology) clinics, residential treatment, and detoxification) and NGOs that provide 
treatment in day-care centres, therapeutic communities, and after-care programmes). 342 out-patient 
psychiatric surgeries provided outpatient care in 2002. There were 19 psychiatric hospitals in the 
Czech Republic (of which 15 were hospitals for adults, with 1,194 beds for drug and alcohol addiction 
treatment). Residential care was provided in 16 communities with 215 beds. There are 19 
detoxification units in the Czech Republic.  
8 substitution centres provided opiate agonist treatment in 2002. There is absolutely no coverage in 
the Zlín, Pardubice, Vysočina, South Bohemia, Pilsen, and Karlovy Vary regions. The number of out-
patient health care centres that prescribe buprenorphine is not known.  
Currently, there are 12 specialized after-care facilities in the Czech Republic. Approximately 398 
clients used their services in 2002. 7 facilities provide sheltered housing, and 7 facilities provide 
sheltered work. Two programmes in Prague are adapted for mothers with children within the 
framework of after-care.  
The capacity of treatment programmes in the prison system increased in 2002. Two prison hospitals 
(Prague - Pankrác and Brno) provided detoxification. There was a further increase in the number of 
drug-free zones in prisons (22 out of 35 prisons, with a capacity of 1,114 beds). Specialized 
departments in prisons in Rýnovice, Opava (department for females) and, newly, also in Znojmo (with 
a capacity of 62 beds) provide residential compulsory treatment. The possibility of serving a 
differentiated  sentence in treatment departments was offered  in three prisons (with a capacity of 188 
beds). Substitution treatment or harm reduction programmes are not implemented in the Czech 
prisons.  
The Sixth Revision of the Standards of the Quality of Drug Services was drawn up in 2002, and 
organizational and administrative steps were taken towards the implementation of the system of 
certification of the quality of drug services in 2003 so that it could be implemented in 2004.  
Law Enforcement  
4,330 drug-related criminal offences were detected in 2002 (i.e. criminal offences according to the 
provision of Section 187 to 188a of the Penal Code). 2,204 offenders were prosecuted for these 
crimes. There were 122 children (5.5%) (in these cases, the sentence is waived due to their young 
age), 329 (15%) juveniles (i.e. persons that are 15 – 18 years old) and 633 (29%) repeat offenders. 
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There is a trend towards an increase in the number of offenders of drug-related crime prosecuted; the 
only decrease took place under the provision of Section 188a (promotion of drug abuse). The cases 
related to amphetamines, especially pervitin (40%), and cannabinoids (37%), represent the highest 
share of drug-related criminal offences; the shares of heroin- and ecstasy-related cases are 8% and 
7% respectively.  
The cases related to cannabinoids (40%), followed by pervitin (35%), represent the highest share of 
criminal offences according to Section § 187a (possession of drugs for personal use). The relatively 
low numbers of those prosecuted according to Section 187a of the Penal Code (possession of drugs 
for personal use), in comparison with the number of people who use drugs recreationally or 
problematically, indicate that the law is enforced selectively in practice; in addition, regional 
differences in how the police and the judiciary judge individual cases persist. 
The Police of the Czech Republic prosecuted 2,204 persons in connection with drug-related criminal 
offences in 2002; Public Prosecutors’ Offices brought charges against 2,247 persons. In summary, 
more people were formally accused of these criminal offences (according to the data of the Public 
Prosecutors’ Offices) than were prosecuted (according to police data); this also indicates 
inconsistencies in the statistics of the police and the Public Prosecutors’ Offices. 1,216 persons were 
convicted for drug-related criminal offences. Even the numbers of those accused and convicted show 
an upward trend.  
As of December 31, 2002, 615 offenders were undergoing punishment in prison for drug-related 
criminal offences. This means a decrease in comparison with 2001. This was especially caused by 
the favourable growth in alternative sentences. In addition, there was a significant decrease in the 
number of offenders in custody; this was especially caused by the amendment to the Penal Code that 
arranged the conditions for imposing custody.  
716 offences involving the possession of drugs in a greater than small quantity were recorded in 
2002; there was a slight increase in comparison with 2001. 
So far, data about secondary drug-related crime committed by drug users are not available in the 
Czech Republic.  
Police and customs officers seized 157 kg of illicit drugs and precursors in 2002; these seizures are 
lower than in 2001. It is estimated that 0.25% of the annual consumption of drugs in the Czech 
Republic was seized.  
The price of drugs has remained stable. The purity (concentration) of heroin has been decreasing due 
to the relatively insufficient and instable market supply in the geopolitical context (the war in 
Afghanistan). The quantity and concentration of MDMA and its analogues is fluctuating.  
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Part I: National Strategy – Institutional and Legal Framework  
1 Drug Policy 
1.1 Political Framework in the Drug Field 
Parliamentary elections took place and a new government was constituted in the summer of 2002. 
The change of government has not had any impact on the framework, principles, and direction of the 
drugs policy. This is documented by the balance and rational basis for the preparation of the 2001 – 
2004 National Drugs Policy Strategy adopted by the Government by means of Government 
Resolution No. 1045.  
The 2001 – 2004 National Drugs Policy Strategy follows from an analysis of the strengths, 
weaknesses, opportunities, and threats2 of the drug policy system that was carried out in 2000. On 
the basis of the findings, the basic underpinning principles, priorities, objectives, and targets were 
defined for four basic (prevention, treatment and resocialization, harm reduction, and law 
enforcement) and four supporting (international cooperation, training, funding, and coordination) fields 
of the drugs policy. The National Strategy assigned 84 targets and aims to accountable ministries and 
local and regulation administrative bodies; at the same time, it serves as a basis for the forming and 
implementing of their own drug strategies.  
In 2002, the Secretariat of the National Drug Commission prepared a Evaluation Report on the 
Fulfilment of Targets from the 2001 – 2004 National Drugs Policy Strategy. The Evaluation Report 
(adopted by the Government Resolution No. 1110/2002 of November 13, 2002) focused especially on 
the evaluation of the fulfilment of targets specified in the 2001 - 2004 National Drugs Policy Strategy 
(Sekretariát Rady vlády pro koordinaci protidrogové politiky, 2002). The report states that 14 short-
term targets have not been fulfilled - 6 of them were previously assigned to the Ministry of Education, 
Youth, and Sports, 4 to the Executive Vice-Chairman of the National Drug Commission, 2 to the 
Ministry of Health, 1 to the Ministry of the Interior, and 1 to the Ministry of Labour and Social Affairs. 
The failure of the Ministry of Education, Youth, and Sports to draw up minimum standards of primary 
prevention probably represents the most important target that was not complied with. The deadline for 
this target was postponed to the end of 2003.  
One of the tasks was to set up an appropriate institutional framework for the evaluation of drugs policy 
measures in order to ensure that the measures already implemented and prepared were based on 
scientific and verified information. Therefore, the Government Resolution No. 643 of June 19, 2002 
provided for the establishment of the Czech National Focal Point for Drugs and Drug Addiction within 
the Secretariat of the National Drug Commission. The Focal Point is responsible for the collection, 
analysis, distribution, and coordination of drug data collection at national level (since January 1, 2003, 
it has been fully equipped in terms of staff and material equipment).  
On the basis of the Government Resolution No. 1177/2001, the Ministry of Health categorized drugs 
according to their health risks. The Government Resolution No. 1177/01 was adopted by the 
government as a result of the PAD study  (Zábranský et al.  2001b). Its objective was to increase the 
efficiency of activities and procedures, especially in the field of drug use. The Ministry of Health 
submitted the final draft of the categorization to the Executive Vice-Chairman of the National Drug 
Commission and the Ministry of Justice. The National Drug Commission assigned these two bodies to 
negotiate the reflection of the drug classification in the prepared re-codification of the Penal Code. It is 
the intent of the categorization and its reflection in the Penal Code to allow bodies acting in criminal 
proceedings to focus primarily on the supervision and prosecution of the activities of organized 
criminal groups that produce, traffic in, and distribute illicit drugs (especially Category C drugs – i.e. 
heroin, pervitin, and cocaine). At the same time, it is hoped that the markets for Category A drugs 
                                                           
2 The SWOT analysis. 
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(cannabis drugs), Category B drugs (ecstasy, hallucinogens), and Category C drugs will be separated 
and, therefore, there will also be a lower risk of cannabis users being offered other drugs. The 
government has not discussed this intention yet; the individual members of the government have not 
taken a uniform approach to this issue.  
At the turn of 2002 and 2003, the House of Commons of the Parliament of the Czech Republic 
received a government bill about measures for protection against damage caused by tobacco 
products, alcohol, and other NPSs. It should replace the existing legal regulations included in Act 
37/1989 Coll. on Protection against Alcoholism and Other Drug Abuse. The Secretariat of the National 
Drug Commission believes that the final draft of the government bill is not satisfactory – especially 
because it does not clearly and sufficiently specify the relations between the state and the regions 
drugs policy implementation.  
After two years of the existence of higher self-governing territorial units (regions), it is possible to claim 
that all regions have established the position of a drug coordinator. The position of a regional drug 
coordinator is of key importance for the transfer of information and implementation of measures in 
compliance with the 2001 - 2004 National Drugs Policy Strategy in any given region. In addition to 
these obligations, the drug coordinator also fulfils tasks that were assigned to him/her by the self-
government. Interdepartmental and interdisciplinary regional drug commissions have been set up in 
11 regions and they involve local experts in these issues. The regional drug commissions serve as 
advisory bodies to the Board of Representatives of the region (or the President of the region) in drug-
related issues. For activities at the local/municipal level, regional drug coordinators cooperate with the 
so-called contact persons in municipalities with extended competence (in some municipalities, this 
function is performed by former district coordinators who were transferred from the cancelled district 
authorities).  
1.2 Legal Framework 
1.2.1 Extension of the Facts of the Case of a Criminal Offence according to Section 188a of the 
Penal Code 
In the field of the criminal law’s treatment of drug-related criminal offences, the factual basis of a 
criminal offence of the promotion of drug addiction according to the provision of Section 188a of Act 
140/1961 Coll., the Penal Code, was extended within the framework of an amendment to the Penal 
Code implemented by Act 134/1962 Coll. With effect from July 1, 2002, according to the amended 
provision of Section 188a Article 2 letter b), the criminal offence of the promotion of drug use3 also 
takes place when it is committed “in the press, film, radio, television, public computer network, or 
another similarly efficient manner”; the penalty ranges from one to five years. This involves a so-called 
harmonization amendment that reflected the obligations imposed on the Czech Republic’s legal 
system in connection with the harmonization of the laws and practice of EU Member States regarding 
the prevention of, and the fight against the illicit drugs trafficking; from the point of view of the Czech 
penal law, this rather involves clarification of the manner of commission of the criminal offence of 
promotion of drug use, namely in the increase of penalties in Article 2. The amendment stirred up 
negative responses among several activists and journalists; on the contrary, penal statistics for 2002 
report a slight decrease in this criminal activity that may have taken place due to this amendment; see 
the chapter on Drug Offences .  
1.2.2 Amendments to the Code of Criminal Procedure 
On January 1, 2002, an extensive amendment to Act 141/1961 carried out by Act 265/2001 Coll. 
became effective; this was of primary importance for the whole field of the criminal law (and therefore 
also for the prosecution of primary and secondary criminality). At the same time, this is one of the 
                                                           
3 The Criminal Code provides this definition of the factual basis of a criminal offence of the promotion of drug use: “He/she who 
encourages another person to use an NPS other than alcohol or supports him/her in this, or he/she who instigates or spreads the 
use of such a substance in a different manner, will be sentenced to.…” 
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harmonization rules in connection with the accession of the Czech Republic to the EU. This 
amendment heralds the upcoming re-codification of the criminal law. This process is very complex, 
and so it was necessary to adopt several substantial changes by means of this amendment. The 
main objective was to make penal proceedings in the Czech Republic easier and faster in order to 
ensure that the detection, conviction, and penalization of an offender will take place as soon as 
possible after the commission of the crime. A substantial part of penal proceedings should take place 
in front of the court; in this respect, the amendment has had a marked impact on the previous legal 
arrangement of all stages of penal proceedings.  
Within the framework of the amendment, the position of the public prosecutor during supervision and 
decision-making in the preparatory proceedings (the pre-trial stage, investigation of the crime by the 
police, and the preparation of documentation for prosecution) was reinforced. This means that 
investigating offices were scrapped; their existence used to mean that it was necessary to carry out 
double police operations in the pre-trial stage. It is no longer important in penal proceedings which 
police body carried out a particular operation. It is only important now whether the content of this 
operation will stand up in the evidence procedure. The possibility of the so-called shortened 
preparatory proceedings represents another significant change with regard to the length of the penal 
proceedings; it allows solving the least serious forms of crime in informal proceedings that should be 
completed within two weeks; at the same time, this term can be prolonged by a maximum of 10 days. 
In the field of evidence, the use of expert opinions has been limited to use of the so-called expert 
statements. Even custody proceedings have changed significantly. As a matter of principle, the 
highest admissible term of custody follows from the degree of seriousness of the offence for which the 
accused is prosecuted and from the cause for custody. The court that conducts the custody 
proceedings is obliged to decide upon the legitimacy of the further continuation of the custody within 
prescribed terms. This should lead to (and it already did in 2002 - see the chapter on Drug Offences ) 
a significant decline in the number of persons in custody who had to wait there pointlessly due to long 
and inflexible penal proceedings. Together with the above-mentioned modifications, other changes in 
the Code of Criminal Procedure should shift the operations from the police to the court  (Ministerstvo 
spravedlnosti ČR, 2000; Šámal et al.  2002a; Šámal et al.  2002b).  
1.2.3 Amendment to the Penal Code 
The amendment of the Penal Code follows on from the amendment of the Code of Criminal 
Procedure. It is a direct reflection of the changes that were suggested to be included in the material 
law in the course of the process arrangement. Therefore, the amendment of the Penal Code changes 
the general provisions of the Penal Code so that they have become consistent with the modification of 
the Code of Criminal Procedure. As far as this amendment is concerned, the new definition of the 
term “criminal damage” represents a significant change. This provision has major significance for 
defining the limit of a criminal offence against property (or other) and a corresponding violation. 
Therefore, the original minimum amount of criminal damage increased from CZK 2,000 to CZK 5,000 
(€ 63 – 158). This change may especially affect hard drug users who procure the means for drugs 
through petty criminal activities.  
1.2.4 Act on Narcotic and Psychotropic Substances  
Act No. 167/1998 on Narcotic and Psychotropic Substances did not change at all in 2002. The text 
was subject to many modifications in the past, and so the full text was published under No. 55/2002 
Coll. However, there have been modifications in the continuation and the implementing regulations to 
this act. In the field of the handling of narcotic drugs and psychotropic substances, Ordinance 
304/1998 Coll. was amended through Ordinance 82/2002 of the Ministry of Health. This ordinance 
specifies the cases when a license for the export of assistant materials is not required; it specifies 
details about the registration of narcotic drugs and psychotropic substances, preparations, and 
precursors and the documentation of substances. In addition, the ordinance of the Ministry of Health 
specified a list of legal and physical entities whose operations do not require a license for them to be 
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able to handle narcotic drugs and psychotropic substances, preparations containing them, and with 
precursors.  
1.2.5 Other Laws 
It is necessary to mention the adoption of Act 198/2002 Coll. on Volunteer Service and the adoption of 
Act 109/2002 Coll. on the Execution of Residential Care or Protective (Compulsory) Care in School 
Facilities and Preventive Educational Care in School Facilities and Change of Several Laws with 
regard to other laws that may affect drug users or have an influence on the operations of facilities 
where even children and juveniles that use drugs may be treated, and the operations of non-
governmental organizations dealing with the treatment and prevention of drug use. The President of 
the Republic returned the second of these acts to the House of Commons of the Parliament of the 
Czech Republic; however, it did not modify it at all and passed it.  
1.3 Laws Implementation 
Since January 1, 1999, the Czech Penal Code has included the provision of Section 187a that 
sanction the possession of narcotic and psychotropic substances for personal use “in a greater than 
small quantity”. The application practice has experienced difficulties in connection with the existence 
of this provision; it related to the unclear definition of the term “greater than small quantity”. At the level 
of police bodies and Public Prosecutors’ Offices, these hardships were overcome by means of the 
instructions of the Police President and the Supreme Prosecutor; at court level, the judicature of the 
Supreme Court of the Czech Republic was used. The number of criminal offences prosecuted 
according to this provision continues to increase, as does the number of persons prosecuted; 
however, the proportion of those prosecuted among the total number of users is very low (see the 
chapters on Problem Drug Use and Drug Offences ). Most of the offenders were given a suspended 
sentence (60) or community service (17) or another sentence in 2002. Some of the offenders were 
given an unsuspended sentence of imprisonment (18); 8 offenders thereof were given an 
unsuspended sentence of imprisonment for more than one year. It is not possible to read from the 
existing data which specific cases were involved in these sentences, and especially which type or 
quantity of drugs were involved. The type and length of imprisonment may also be influenced by the 
previous criminal activities of the offender and other facts regarding his/her person.  
The relatively low number of people prosecuted for an offence according to Section 187a of the Penal 
Code in comparison with the number of drug users suggests that the law has been applied selectively 
in practice. In 2002, this provision mostly affected the users of cannabis and amphetamines (see the 
chapter on Drug Offences ). Cannabis drugs users are also often prosecuted according to the 
provision of Section 187 or Section 188 of the Penal Code. In these cases, this often involves persons 
who grow cannabis for personal use.  
There are still practical problems regarding the interpretation of the term “in a large extent” because 
growing cannabis “on a large scale” is prosecuted, according to the provision of Section 187 article 2 
of the Penal Code, with a sentence of 2 to 10 years. Application in practice again varies according to 
the region concerned; for instance, growing 10 cannabis plants was prosecuted according to Section 
187 article 1 of the Penal Code in the Ústí nad Labem region, while an offender who grew the same 
quantity of cannabis in the Southern Bohemia region was formally accused according to Section 187 
article 2 of the Penal Code. In both cases, this involved otherwise irreproachable persons who had 
never had any conflict with the law, never had social problems, and had studied and worked. At the 
same time, both of them were prosecuted on the basis of a complaint from other citizens. Such cases 
happen in practice very often, especially in villages where cannabis users are markedly less tolerated 
than in towns.4 Even reports in the media indicate that the police show interest in cannabis growers 
(see the chapter on Developments in Public Attitudes and Debates). 37.4% of the total number of 
persons accused for the criminal offences of the unauthorized production and possession of narcotic 
                                                           
4 These data were obtained from the practice of the Legal Advice Bureau of the Association of Non-Governmental Organizations. 
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and psychotropic substances and poisons (Sections 187, 187a, and 188) were cannabis cases, 
39.1% amphetamines, 7% ecstasy, and only 7.9% involved heroin. At the same time, it holds true that 
the use of so-called hard drugs cause demonstrably more serious health and social damage. 
Cannabis users – when cannabis is the only drug they use – cannot be labelled as problem drug 
users; at the same time, cannabis use is not usually associated with secondary drug-related crime.  
On the contrary, problem users come into conflict with the law more frequently because of property 
crimes by which they get the means for drugs than due to the direct commission of drug-related 
criminal offences.5 Actual estimates for 2002 are not available; the methodology of gathering data 
about the secondary criminal activity of drug users represents one of the tasks of the Criminal Law 
Sector Data working group of the Czech National Focal Point. 
It is positive that the judiciary is making increasing use of alternative sentences even for drug users; 
this involves both the prosecution of drug-related criminal offences and cases of secondary drug-
related criminal offences. There is no doubt that this is mainly promoted by judges being better 
informed about drug issues; in addition, the work of Probation and Mediation Service officers who 
have been in place since January 1, 2001 has also made a significant contribution. However, the 
practice of the courts in these respects even varies in individual regions; e.g. there is no doubt that the 
judges in Prague courts come into contact with drug users during criminal proceedings more often, 
and that therefore they usually have a better idea about the facilities that deal with the prevention and 
treatment of drug addictions and they also have more extensive experience with how they influence 
the behaviour of the accused or the convicted (see the chapter on Alternatives to Prison for Drug 
Dependent Offenders). As far as the imposition of compulsory drug treatment is concerned, the courts 
consistently adhere to the conclusions of expert opinions when these experts often do not 
recommend this treatment with reference to the fact that compulsory treatment would be ineffective or 
it would lack purpose. In this regard, even the judges prefer treatment that the users undergo at their 
own will.  
The above-mentioned problems of application provide evidence of the need to modify the legal 
regulations. The work has already started both in the sense of the clarification of several terms (e.g. 
“large extent”) and in the sense of the reflection of scientific knowledge about the different levels of 
health and social risks of individual types of drugs. This is also supported by the fact that the 
Government of the Czech Republic adopted the Government Resolution No. 1177/01 and directed 
the relevant ministries to implement steps that are geared towards the legislative categorization of 
drugs according to their level of health and social risks (see the chapter on Political Framework in the 
Drug Field). A legislative change in this direction would undoubtedly lead to a more balanced 
approach on the part of the law enforcement bodies during the prosecution of drug-related criminal 
offences. So far, the Penal Code has not been modified at all; however, the Ministry of Justice has 
been working on the re-codification of the Penal Code – it will also reflect drug-related criminal 
offences. Nevertheless, the recodification works have not been completed yet due to the large range 
of all the changes that are required in the whole Penal Code.  
1.4 Developments in Public Attitudes and Debates 
In March 2002, Section 188a of the Penal Code was amended - see the chapter on Legal Framework 
for more information. The House of Commons of the Parliament of the Czech Republic adopted this 
draft bill in February 2002 – there were 147 affirmative votes and 3 negative votes (of 163 MPs 
present) (Poslanecká sněmovna, 2002). The second and third readings took place without any 
debate regarding the modification of Section 188a. The fears expressed in several sections of the 
                                                           
5 See the note above. 
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media, that there will soon be prosecution of journalists and artists who deal with drug issues, have 
failed to come true. If there have been any such cases, they did not win the attention of the media.6 
In September 2002, the newly elected House of Commons of the Parliament of the Czech Republic 
set up a subcommittee for drugs and addiction issues. The subcommittee should consist of a 
maximum of 9 members (at the same time, at least 5 members are also members of the 
subcommittee for social policy and health care).  
Drug issues are not one of the fields where “party discipline” is applied during readings; therefore, the 
attitudes of the individual politicians of individual parties may vary – they range from “tough” 
approaches to the promotion of the decriminalization of several drugs. None of the political parties 
represented in the Parliament has promoted the legalization of an illicit drug. However, one marginal 
political body represented in the Senate purports to favour the legalization of marijuana, at least to the 
extent of putting the logo of www.legalizace.cz on its web page.7 It is the Liberal Reform Party, with 
one Senator.8  
Many non-governmental organizations operate in the drugs field in the Czech Republic. They mainly 
deal with the prevention and treatment of addictions; however, the activities of some of them also 
have an influence on public opinion. The Association of Non-Governmental Organizations (A.N.O.) 
dealing with the prevention and treatment of drug addictions is the umbrella organization and it has 
approximately 70 members.9 The association operates a legal advice bureau for the general public 
(see the chapter on Approache). As far as associations of individuals (physical entities) are concerned, 
we must especially mention the Czech Medical Association of J. E. Purkyně – the Association for 
Addictive Diseases, and the professional organization the Czech Streetwork Association (ČAS)10. 
However, apart from service providers or employees of, and collaborators with, institutions from this 
field and/or politicians and civil servants, there are not many organizations that would deal with drug 
issues.  
On one hand, the so-called cannabis ombudsman Marek Jehlička proposing legalization of 
marihuana is one of the most prominent figures to stand up publicly outside the professional sphere, 
and on the other hand there is the association Parents against Drugs supporting punitive approach in 
the drug policy. Even several high police officials were involved in media debates about drug policy in 
2002.  
Even though the topic of illicit drugs and the use of these drugs received everyday attention in the 
press and was often discussed on television and in radio broadcasts in 2002 - as well as in the 
previous years – what predominated was the conveying of rather simple news information both in the 
sense of content and how it was processed. This is a problem of the Czech media as such and it 
does not only involve the most popular media that belong to the tabloid category in terms of content 
(e.g. the daily newspaper “Blesk” and Nova TV).  
Investigative journalism and the writing of more in-depth analytical articles are only slowly finding their 
way into the sources of information about drugs that are published outside the professional press. 
Nevertheless, it is possible to claim that the level of informedness of the public about drug issues has 
been increasing. 
Most of the information about drug issues has been published in the press. Information about 
individual programmes of drug prevention and the treatment and social (re)integration of drug addicts, 
                                                           
6 A complaint that was lodged by the association Parents Against Drugs in 2003 in connection with the documentary series “When 
you have to, you have to? (Když musíš, tak musíš?)“, K. Vrána published the facsimile in the magazine Týden (Vrána, 2003). 
7 At: http://www.liberalnistrana.cz. 
8 Prof. RNDr. Jiří Zlatuška, CSc., Rector of Masaryk University in Brno. He was elected as an independent candidate on the ticket of 
the Liberal Reform Party; however, he has worked within the Club of Open Democracy in the Senate. 
9 This piece of data was provided by the Association of Non-Governmental Organizations, June 2003. 
10 It associates streetworkers from the field of drug services and other fields – especially services for children and young people.  
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including information about programme funding, has been published relatively frequently (both in the 
national and regional press). Information about individual used drugs, the level of their dissemination, 
and their influence on users has been published less frequently. However, there has been no wide 
public debate about the attitudes to drug use that would be based on relevant arguments.  
The ADIKTOLOGIE11 journal has been published since 2001, and it has taken an interdisciplinary 
approach to the field of addictions; it covers the fields of medicine and psychiatry, psychology, 
pedagogy, social politics and work, sociology, politology, law, criminology, and other disciplines.  
Within the framework of the project Phare Twinning 2000 “Strengthening National Drug Policy”, 
preparatory work on the establishment of a national information server about drugs has been carried 
out. See: http://www.drogy-info.cz/. 
According to the Internet Media Monitoring archive (NEWTON INFORMATION TECHNOLOGY, 
s.r.o.), 2,638 contributions about the topic of “drug issues” were published in the Czech media in 
2002. In 2001, 2,983 contributions were published in the monitored print and electronic media12. In 
2002, the lowest number of contributions were published in July (98) and the highest number in 
February (331 contributions). 1 to 32 contributions were published every day in 2002.  
The regional press publishes a considerable number of drug-related contributions; unfortunately, 
these articles are usually short and do not provide a deep analysis of the problem. However, let us 
mention that information about the possibilities of help for drug addicts in the regions and about 
individual help facilities is published on a regular basis. The regional press is monitored through the 
archive of the Newton company and Monitor médií (Media Monitor), an internal publication of the 
Office of the Government of the Czech Republic processed with the use of information provided by 
the Anopress agency. The media monitor has been available to the public since June 2003 at 
www.drogy-info.cz. 
There are many Czech web pages about illicit drugs; the majority of the pages express “liberal” 
approaches (from anti-repressive to legalization-oriented). At the same time, most of these pages deal 
with marijuana. On the other hand, there also many Internet pages that are mainly operated by 
helping institutions. There is also a growing amount of information from the field of drugs provided by 
regions and municipalities. Even on-line counselling is available; for more information, see the list of 
pages about drug issues that can be found on the Czech web.  
When we entered the word “drugs” on the Atlas server, the engine found 280 pages in the catalogue 
(120 thereof were found in the category ‘marijuana’). The keyword “anti-drug” resulted in 45 pages in 
the catalogue and more than 16,000 full-text references; an overwhelming majority of these refer to 
the “professional” sphere (pages of helping institutions, authorities, municipalities, etc.).  
The Centrum search engine provided 132 catalogue references for the word “drugs”; the first 
positions referred to general information and help to addicts. The Seznam search engine lists 
approximately 80 catalogue references to the word “drugs”.13 
1.4.1 Public Opinion Polls  
At the end of February and beginning of March 2002, the Public Opinion Poll Centre of the Institute of 
Sociology of the Academy of Science surveyed 1,083 persons, representing the population of the 
Czech Republic, aged 15 and more (within the framework of the survey Our Society 2002) (Centrum 
pro výzkum veřejného mínění, 2002).  
                                                           
11 Published by Sdružení Scan twice a year; each issue has approximately 90 pages.  
12 The electronic media only involve television and radio. The Internet is not monitored.  
13 All of the data about the Internet come from June 2003.  
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Table 1-1: Agreement that drug users should be punished by law (Centrum pro výzkum veřejného mínění, 2002)  
 
“Do you think that people who.… should be 
punished by law:” 
Definitely 
yes 
Rather 
yes  
Rather 
not  
Definitely 
not  
Grow marijuana for their personal use  24 23 30 13 
Use a cannabis drug (marijuana or hashish)  20 30 28 12 
Use ecstasy  31 33 19 6 
Offer a cannabis drug to an adult (marijuana 
or hashish)  
39 31 18 6 
Offer ecstasy to an adult  45 32 12 4 
Use “hard drugs”  56 25 10 4 
Offer a “hard drug” to an adult  64 24 7 1 
Make “soft drugs” for further distribution  60 29 6 1 
Make “hard drugs” for further distribution  86 10 1 1 
Note: Refusal to answer and the answers “I don’t know” complete the 100% calculation in the columns.  
It follows from the survey carried out by the Public Opinion Poll Centre that the attitude towards 
criminal sanctions against the users, distributors, and producers of illicit drugs has remained stable in 
comparison with the data presented in the Annual Report on Drug Situation 2001 - Czech Republic 
(Zábranský et al.  2002); however, there are sharp differences in public attitudes to these drugs. It is 
true that citizens of the Czech Republic are highly tolerant towards the use of cannabis and the 
growing of marijuana for personal use (40%, 43% respectively); however, at the same time, 50% and 
47% respectively of respondents require such cases to be penalized (to a greater or smaller extent). It 
is interesting to point out that inhabitants of the Czech Republic are more tolerant towards the growing 
of cannabis for personal use than towards cannabis use, according to the survey of the Public 
Opinion Poll Centre. 
As far as hard drugs (heroin, pervitin, and cocaine) are concerned, public attitudes were strongly in 
favour of the criminal prosecution of distributors and users (96%, 81% respectively). At the same time, 
only 27% of respondents in the same survey answered the question “Do you perceive a drug user as 
a criminal or as a patient?” by saying “more as a criminal”. The extreme public attitudes are balanced 
(22% perceive a drug user “more as a patient”). There is a relatively high share of indecisive answers 
- 51% of respondents chose one of these answers: “neither as a patient nor as a criminal”, “as a 
criminal and a patient”, or “I don’t know”. This indicates that to a great extent society perceives the 
issues associated with “hard drugs” as a criminal matter; however, it does not have a completely 
negative attitude to individual users. 
1.5 Budget and Funding Arrangements 
The 2001 – 2004 National Drug Policy Strategy (Sekretariát Meziresortní protidrogové komise, 2000) 
specifies that drug policy funding will be implemented at two levels: central and local. The government 
directed the National Drug Commission to earmark financial resources from the General Cash 
Administration budget chapter – drug policy expenses. The National Drug Commission adopted the 
intention to support projects at local level via the sectors of the Ministry of Health, Ministry of 
Education, Youth, and Sports, Ministry of Labour and Social Affairs, and the Ministry of Culture. Other 
ministries that had allocations for the Drugs Policy Programme in their budget include the Ministry of 
Finance, Ministry of Justice, and Ministry of Defence. The Ministry of the Interior does not have 
expenses for the Drugs Policy Programme in its budget; however, it supports activities aimed at the 
non-specific primary prevention of drug addiction within the framework of the Programme of Social 
and Crime Prevention. 
In 2002 insufficiencies in the timeliness of the transfers of the subsidies to non-governmental 
organizations from the General Cash Administration budget chapter, according to the subsidy 
proceedings of the National Drug Commission, persisted. The existing model of funding, in which the 
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resources earmarked from the General Cash Administration for drug policy programmes at the local 
level are transferred via the ministries, is inflexible and lengthy. It means that the transfers of financial 
resources to the accounts of programme implementers are delayed by several months; this leads to 
financial uncertainty for these implementers. Therefore, it is necessary to change the system of 
subsidy provision (detailed information is included in the chapter on Major Strategies and Activities ). 
The expenses of central administrative bodies and the National Drug Commission for drug policy in 
2002 are presented in Table 1-2. 
Table 1-2: Expenditure of public administrative bodies and the National Drug Commission for drug policy in the Czech Republic in 
2002 (in thousands of €)  
Expenditure  Subsidy of 
the National 
Drug 
Commission  
Ministry 
of 
Health  
Ministry of 
Education, 
Youth and 
Sports  
Ministry 
of 
Labour 
and 
Social 
Affairs  
Ministry 
of 
Finance  
Ministry 
of 
Justice  
Ministry 
of 
Defence  
Ministry 
of the 
Interior  
Total 
Non-
investment 
expenditure  2,908.1 589.7 300.8 1,112.5 56.8 254.8 126.0 45.1 5,393.9 
Investment 
expenditure  0 224.9 0 0 812.5 50.0 0 0 1,087.4 
Total 2,908.1 814.7 300.8 1,112.5 869.4 304.8 126.0 45.1 6,481.3 
 
1.5.1 Resources of the General Cash Administration Earmarked by the National Drug 
Commission  
CZK 91,895,000 (€ 2,908,100) were drawn for drug policy from the General Cash Administration 
budget chapter in 2002. According to the decision of the National Drug Commission, this amount was 
used for the financial securing of drugs policy projects within the spheres of competence of the 
individual budget chapters in the following manner:  
The Ministry of Education, Youth, and Sports drew the amount of CZK 584,000 (€ 18,500) from the 
General Cash Administration budget chapter for the programmes of competent ministries (central 
level); see Table 1-3. 
Table 1-3: Drawing of resources from the General Cash Administration for programmes of the Ministry of Education, Youth, and 
Sports in 2002 (€ thousand) 
Ministry  Purpose Resources 
drawn  
Educational and treatment programme for boys who have just 
completed compulsory education and are endangered by NPSs  
6.3 
Care for young people endangered by addiction to illicit drugs in the 
course of the school holidays IV 
2.9 
Primary prevention centre  6.3 
 
Ministry of 
Education, 
Youth, and 
Sports  
Educational programme for lecturers of primary prevention of 
addictions and socially pathological phenomena  
2.9 
Total -  18.5 
 
Within the framework of its subsidy proceedings, the National Drug Commission supported 152 
programmes (local level) via the budgets of the Ministry of Health (56 projects – CZK 38,412,000, i.e. 
€ 1,215,600), Ministry of Education, Youth and Sports (26 projects – CZK 6,291,000, i.e. € 199,100), 
Ministry of Labour and Social Affairs (69 projects – CZK 37,708,000, i.e. € 1,193,300), and Ministry of 
Culture (1 project – CZK 5,762,000, i.e. € 182,300), see Table 1-4, Map 1-1. 
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Table 1-4: Drawing of financial resources from the General Cash Administration according to the subsidy proceedings of the National 
Drug Commission for drug policy programmes in 2002 by regions (€ thousand)  
Region Ministry of Health  
Ministry of 
Education, 
Youth and 
Sports  
Ministry 
of Labour 
and 
Social 
Affairs  
Ministry 
of Culture  Total 
Capital Prague 406.7 84.2 315.7 182.3 989.0 
Central Bohemia 64.4 1.3 50.9 0 116.6 
Southern Bohemia  52.6 8.9 51.8 0 113.3 
Pilsen 64.6 11.7 91.1 0 167.5 
Karlovy Vary 0.0 12.2 67.8 0 80.0 
Ústí 120.4 3.2 137.6 0 261.2 
Liberec 37.9 0 0 0 37.9 
Hradec Králové 3.3 0 35.9 0 39.2 
Pardubice 11.9 0 30.9 0 42.8 
Vysočina 36.4 17.8 54.6 0 108.7 
Southern Moravia 170.4 42.2 116.1 0 328.7 
Olomouc 83.3 1.6 87.0 0 171.9 
Zlín 7.4 8.6 64.6 0 80.6 
Moravian-Silesian 156.1 7.6 89.3 0 253.0 
Total 1,215.6 199.1 1,193.3 182.3 2,790.3 
 
Map 1-1: Drawing of financial resources from the General Cash Administration according to the subsidy proceedings of the National 
Drug Commission for drug policy programmes in 2002 (in thousands of CZK per 100,000 inhabitants) 
 
 
 
As far as the budget chapter of the Office of the Government of the Czech Republic (transfer from the 
General Cash Administration chapter for guaranteeing the operations of the Secretariat of the 
National Drug Commission) is concerned, CZK 3,138,000 (€ 99,300) were drawn (more detailed 
information is included in Table 1-5). 
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Table 1-5: Drawing of financial resources from the chapter of the Office of the Government of the Czech Republic for the Secretariat 
of the National Drug Commission in 2002 (€ thousand) 
Purpose Drawn resources  
Project evaluation  3.2 
Translations – a large part of the resources was not used because materials were 
translated within the framework of the Phare Twinning Project “Strengthening 
National Drugs Policy” (including payments for the translations from the EU 
budget)   
1.0 
Project DDRSTP II – work of a team of authors and print preparation of a 
publication ”Drogy a drogové závislosti – mezioborový přístup (Drugs and Drug 
Addictions – Interdisciplinary Approach) (working title “Textbook”)  
15.9 
Project Phare 2000 – costs of guaranteeing the operations of the Phare project, 
labour costs of Czech experts - involvement of the Czech Republic  65.1 
Publishing – reprinting of the PAD publication, publications designed for the work 
of low-threshold facilities ”Když už bereš”, graphics processing, printing of a 
Collection of Contributions from the VIII. National AT Conference  
7.1 
Pilot project of toxicological examinations – refunding of toxicological examinations 
for the presence of narcotic and psychotropic substances among victims of traffic 
accidents  
6.9 
Total 99.3 
 
1.5.2 Ministry of Health   
CZK 57,048,000 (€ 1,805,300) were drawn for non-investment expenditure. These resources were 
mainly used to guarantee the accessibility of detoxification units, the availability of outpatient 
counselling programmes for problem drug users, the capacity of long-term resocialization 
programmes, the operation of programmes geared towards the minimization of health risks among 
drug users, and the support and expansion of substitution treatment. From the budget chapter of the 
Ministry of Health, resources amounting to CZK 1,305,000 (€ 41,300) were transferred to the budget 
chapter District Authorities and they were used for drug policy programmes. 
Investment resources were earmarked for 15 programmes; CZK 7,108,000 (€ 224,900) were 
allocated.  
Therefore, the Ministry of Health provided CZK 64,153,000 (€ 2,030,300) towards the solving of drugs 
issues in 2002; CZK 25,744,000 (€ 814,700) thereof were from their own sources and CZK 
38,412,000 (€ 1,215,600) were means provided by the National Drug Commission.  
1.5.3 Ministry of Education, Youth and Sports  
Financial resources were transferred to the regions for the implementation of Minimum Preventive 
Programmes in schools and school facilities. To be precise, CZK 3,924,000 (€ 124,200) were 
earmarked – see Table 1-6. 
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Table 1-6: Non-investment transfers of the Ministry of Education, Youth and Sports to regions in 2002 (€ thousand)  
 
In total, the financial resources that were allocated for the 
implementation of projects in the field of drugs policy amounted to 
CZK 16,381,000 (€ 518,400); CZK 9,506,000 (€ 300,800) thereof 
were drawn from their own sources. Furthermore, according to the 
decision of the National Drug Commission, CZK 6,875,000 (€ 
217,600) were drawn from the General Cash Administration; CZK 
584,000 (€ 18,500) thereof were earmarked for the support of 
projects in the ministry and CZK 6,291,000 (€ 199,100) were 
allocated to programmes at the local level.  
1.5.4 Ministry of Labour and Social Affairs 
Civic associations were provided with CZK 52,280,000 (€ 1,654,400) 
from the modified budget of non-investment subsidies; humanitarian 
organizations received CZK 10,185,000 (€ 322,300) and public 
community services received CZK 10,397,000 (€ 329,000). 
Therefore, CZK 72,862,000 (€ 2,305,800) were used from the 
modified budget of the binding indicator drugs policy programme. What came from the ministry’s own 
resources represents CZK 35,154,000 (€ 1,112,500) and CZK 37,708,000 (€ 1,193,300) were 
subsidies for the projects approved by the National Drug Commission.  
A critical part of the resources were expended on outreach work and the operation of therapeutic 
communities. The priority funding of the mentioned areas of work complies with the targets of the 
2001 - 2004 National Drugs Policy Strategy. 
1.5.5 Ministry of Culture 
One project was funded via the Ministry of Culture: “Audiovisual work as a means for primary 
prevention”. In accordance with the decision of the National Drug Commission, CZK 5,762,000 (€ 
182,300) were drawn from the General Cash Administration.  
1.5.6 Ministry of Finance  
Drug policy expenditures were allocated to the approved budget of the General Customs 
Headquarters; CZK 1,796,000 (€ 56,800) were drawn for non-investment expenditure. The means 
were especially used for the provision of protective equipment, weapons and materials for the squads, 
service dogs, and materials required for the handling of drugs, and then for specific expenditure 
connected with operational investigative activities. CZK 25,676,000 (€ 812,500) were drawn for 
investment expenditure. CZK 9,796,000 (€ 310,000) were used for the purchasing of special 
technology for the conducting of operational investigative activities; CZK 3,405,000 (€ 107,800) were 
used for the purchasing of means of transport for the Department of Investigation. Furthermore, the 
Motorola system was updated and completed at a cost of CZK 4,420,000 (€ 139,900), and monitoring 
equipment, weapons, and other equipment were purchased for a total of CZK 2,055,000 (€ 65,000). 
Furthermore, the General Customs Headquarters acquired hardware for cryptographic equipment for 
the intelligence system; it cost CZK 3,800,000 (€ 120,300) and the software cost CZK 2,200,000 (€ 
69,600). From the budget of the Ministry of Finance, CZK 27,472,000 (€ 869,400) were drawn for the 
General Customs Headquarters and its implementation of the Drugs Policy Programme.  
1.5.7 Ministry of Justice  
CZK 9,632,000 (€ 304,800) were drawn from the budget of the Ministry of Justice for the Drugs Policy 
Programme. This amount was divided between the Prison Service of the Czech Republic and the 
Institute of Criminology and Social Prevention  (see Table 1-7). 
Region € 
thousand 
Capital Prague 14.4 
Central Bohemia 17.3 
Southern Bohemia  10.1 
Pilsen 10.1 
Karlovy Vary 4.3 
Ústí 10.1 
Liberec 5.8 
Hradec Králové 7.2 
Pardubice 5.8 
Vysočina 7.2 
Southern Moravia 10.1 
Olomouc 7.2 
Zlín 5.8 
Moravian-Silesian 8.7 
Total 124.2 
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Table 1-7: Drawing of financial resources of the Ministry of Justice for the Drugs Policy Programme in 2002 (in € thousands) 
 
1.5.7.1 Prison Service 
The specific resources earmarked in 2002 were used for the improvement of the qualification of 
prison personnel for handling drug users and the differentiated handling of inmates in special 
departments for convicted persons suffering from personality disorders and behavioural disorders 
caused by the use of psychotropic substances. In addition, the financial resources were used for the 
differentiated handling of inmates in drug-free zones and remand prisons and for using utility dogs 
during the detection of the production, possession, and distribution of drugs in prisons and remand 
prisons. 
1.5.7.2 Institute for Criminology and Social Prevention 
A laptop was bought from investment expenditure; current expenditure was used for the other costs of 
the work done by two workers who were conducting a field survey within the framework of a 
penological survey.  
1.5.8 Ministry of Defence  
From the budget of the Ministry of Defence, financial resources were drawn to fund the Drugs Policy 
Programme of the Czech Republic’s Government and the Conception and Programme for the 
Prevention of Socially Pathological Phenomena. CZK 3,981,000 (€ 126,000) were spent in total.  
On the basis of submitted projects approved by the Commission for the Prevention of Socially 
Pathological Phenomena, non-investment financial resources were earmarked for the following 
programmes: 
• LABIS – Laboratorní monitorování zneužívání návykových látek u příslušníků Armády ČR 
(Laboratory Monitoring of Substance Abuse among Members of the Army of the Czech Republic),  
• DROGIS – Drogový informační systém (Drug Information System), 
• EDIS – Koordinace informačních systémů epidemiologie drogových závislostí ČR a Armády ČR 
(Coordination of Information Systems of Drug Addiction Epidemiology in the Czech Republic and 
in the Army of the Czech Republic – the Central Military Health Institute guarantees these three 
projects), 
• Diagnostika – nutnost pro adekvátní prevenci (Diagnostics – a necessity for adequate prevention), 
• Salutogenetický přístup v prevenci závislostí u VŠ populace (Salutogenetic Approach to Addiction 
Prevention in the University Population – Military Medical Academy Hradec Králové is the 
guarantor, 
• ARMY-ZETA – the Brno Military Academy is the guarantor, 
• EKO 2005 – the Brno Military Academy is the guarantor, 
• Monitorování aktuální situace Armády ČR pro oblast prevence SPJ (Monitoring of the Current 
Situation in the Field of Prevention of Socially Pathological Phenomena in the Army of the Czech 
Republic – CASRI Prague is the guarantor). 
The projects especially focused on drug diagnostics and the monitoring of the epidemiological 
situation in the field of drugs, alcohol, tobacco, and lifestyle in the Army of the Czech Republic.  
Earmarked to Running expenses Capital expenses Total 
Prison Service 254.1 47.5 301.5 
Institute for Criminology and Social 
Prevention  0.8 2.5 3.3 
Total 254.9 50.0 304.8 
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1.5.9 Ministry of the Interior  
Within the framework of the specific and non-specific prevention of drug addictions, several projects 
were supported at the local level. They involved leisure time activities (sports, hobbies, and 
educational activities), club and public enlightenment educational activities (holding of preventive 
blocks for children at elementary schools, information seminars for teachers, counselling and 
therapeutic work with parents). This involves counselling facilities focusing on drug prevention, 
helplines, and streetwork). The intersectorial counselling body the Republic Council for Crime 
Prevention earmarked financial resources in the amount of CZK 1,425,000 (€ 45,100) from the 
General Cash Administration budget chapter.  
Data about the total expenses of the Police of the Czech Republic for the solving of drug issues are 
not available. Information about the budget of the National Drug Squad is not provided (this falls under 
the heading of classified matters).  
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Part II: Epidemiological Situation  
2 Prevalence, Patterns and Developments in Drug Use  
2.1 Main Developments and Emerging Trends  
In the field of drug use in the general population, the year 2002 was especially characterized by a 
diverging development in the field of (socially very harmful) problem drug use on the one hand and 
recreational drug use on the other.  
All of the available problem drug use-related indicators14 draw a picture of the slow extinction of the 
“drug epidemic” that was recorded in the second half of the 1990s. This is especially indicated by the 
development of problem drug use prevalence estimates, the ageing of the users who are applying for 
treatment or a service in connection with drug use (first treatment demands), decreasing overdose-
related mortality15, and, last but not least, the still low occurrence of HIV and stable rates of viral 
hepatitis. 
On the other hand, the results of school surveys document an ever-increasing proportion of students 
and pupils who have tried an illicit drug at least once (especially cannabis and/or ecstasy) and also an 
increasing share of those who use these types of drugs “recreationally” – i.e. within the framework of 
social or relaxation activities.  
The most apparent new trend in the field of problem drug use in 2002 is the rapid drop in the hitherto 
increasing share of treatment demands in connection with the (ab)use of opiates (especially heroin). 
Possible causes may involve any combination of the following factors: 
• The instability of the heroin market and floating quality (purity) of heroin. 
• The presence of a pharmaceutical opioid Subutex® on the black market (especially in Prague and 
Northern Bohemia). The users use it for “wild” substitution.  
• Methadone substitution treatment (in specialized centres) and the dissemination of legal 
prescription of Subutex®. 
• The decreasing number of newcomers among opiate users; this is documented by first treatment 
demand data and qualitative information from the drug scene.  
On the contrary, the gradual decrease in the number of “pervitin clients” stopped as early as in 2001; 
the number of these clients then kept increasing in 2002; this may be partly due to the higher 
involvement of treatment and low-threshold facilities in the reporting system of (first) treatment 
demands and improved reporting.  
At the same time, we are witnessing that those making first treatment demands in connection with 
pervitin and heroin are becoming steadily older; this trend was also clearly visible in the previous 
years, and it has become increasingly apparent (see the chapter on Drug Treatment Demand).  
The results of school surveys confirm a progressively increasing lifetime prevalence of drug use 
among pupils and students (in other words, in comparison with the figures from previous years, a 
growing number of Czech adolescents have experimented with a drug or use it for recreational 
purposes – this especially involves cannabis and/or dance drugs). Inhalants (solvents) have retained 
their position as an easily available experimental drug; however, these highly dangerous substances 
(14 deaths in 2002) are used more than “experimentally” almost exclusively in socially marginalized 
groups; there are only exceptional cases of contacts of inhalant users with treatment institutions. It is a 
challenge for the future.  
                                                           
14 according to the definition of the EMCDDA 
15 At the same time, the number of the non-fatal emergencies decreased in 2002. 
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From the point of view of public health, the necessity to develop an effective preventive strategy also 
represents a challenge for the future. It must be geared towards the section of the population that has 
had (experimental or recreational) experience with drugs, and its objective must be not only to 
discourage them from using drugs but especially prevent them from shifting to problem use 
(EMCDDA et al.  2002). 
2.2 Drug Use in the Population 
Population and school surveys implemented in 2002 confirmed a trend towards increased lifetime 
experience of the Czech population with drug use.  
There was again an increase in drug use, namely of the experimental and recreational use of 
cannabis substances, in 2002; there was also an increase in the use of dance drugs, especially 
ecstasy. The increase in drug use is most apparent among young people and young adults.  
Three general population surveys were carried out in the Czech Republic in 2002 and they focused 
on drug issues; in addition, one international survey focused on drug use among the school 
population. The results of the individual surveys vary due to different methodologies – it is difficult to 
compare them and evaluate development trends.  
2.2.1 Drug Use in the General Population 
The Public Opinion Poll Centre has been carrying out a survey focusing on drug issues every year 
since the beginning of the 1990s. Therefore, the time series of the results allows for the monitoring of 
lifetime prevalence in the last ten years (Table 2-1). It is obvious at the first glance that lifetime 
prevalence has at least tripled between 1993 and 2002 (Centrum pro výzkum veřejného mínění, 
2002). 
Table 2-1: Development in lifetime prevalence of illicit drug use,% of respondents (Centrum pro výzkum veřejného mínění, 2002)  
The Czech part of the international survey 
”Gender and Alcohol Comparative 
International Survey” (GENACIS) was 
implemented by the Prague Psychiatric 
Centre. It focused in greater detail on 
differences between genders in the 
prevalence of use of selected drugs in the 
group aged 18 – 64. 21.1% of 2,526 persons 
surveyed report an experience with cannabis; 
at the same time, 10.9% of respondents 
reported using cannabis in the last 12 months 
(Table 2-2) (Psychiatrické centrum Praha, 2003a).  
Table 2-2: Lifetime prevalence and prevalence in the last 12 months by gender and type of the drug,% of respondents (Psychiatrické 
centrum Praha, 2003a)  
 
 
 
 
 
 
 
Note: The values under 0.5% are regarded as zero in population questionnaire surveys. 
Year  Yes No 
1993 5 95 
1994 7 93 
1996 10 89 
1997 11 89 
1998 9 90 
1999 10 89 
2000 9 90 
2001 14 85 
2002 16 83 
Lifetime prevalence  Prevalence in the last 12 
months  
Drug  
Total Males Females Total Males Females 
Cannabis 
substances  
21.1 26.3 16.1 10.9 14.4 7.5 
Opiates  0.7 1.2 0.0 0.0 0.0 0.0 
Amphetamines  2.3 3.5 1.1 1.1 1.8 0.5 
Ecstasy 4.0 5.5 2.5 2.5 3.1 1.9 
LSD 2.2 3.6 0.8 1.0 1.9 0.0 
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Ecstasy is the second most common drug after cannabis substances, and it is followed by 
amphetamines and LSD. Opiates represent the least common drug among those surveyed. The 
survey demonstrated significant differences in drug use between genders - lifetime prevalence and 
prevalence of use of all of the drugs surveyed in the last year are higher among males.  
Experience with drugs is more common among younger age groups and they decrease with age. 
Nearly half of the population aged 18 – 24 has had experience with cannabis, 13.2% have tried 
ecstasy, 5.6% have tried amphetamines, 5.3% have tried LSD, and 1.6% of the respondents have 
tried opiates (Figure 2-1). The population aged 55 and more does not report any experience with drug 
use at all. 
Figure 2-1: Lifetime prevalence  of use of selected drugs in individual age groups, in% (Psychiatrické centrum Praha, 2003a)  
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The Institute for Health Information and Statistics implemented a Sample Survey on the Health Status 
of the Czech Population in 2002, where drug use was also monitored. It is difficult to compare the 
results with the above-mentioned surveys due to the fact that a different methodology was used in this 
survey. 7.3% (8.8% males and 5.9% females respectively) of the 2,476 respondents aged 15 – 64 
reported an experience with an illicit drug, 3.4% (4.5% and 2.4% respectively) reported use within the 
last 12 months, and 1.7% (2.5% and 0.9% respectively) reported use in the last month (Ústav 
zdravotnických informací a statistiky, 2003c). In comparison with the previous survey conducted in 
1999, an increase in drug use was found both among males (from 7.1% to 8.8%) and among females 
(from 4.1% to 5.9%) (Ústav zdravotnických informací a statistiky, 2001). The lifetime prevalence of 
drug use found in this study conducted by the Institute for Health Information and Statistics is twice as 
low, or even more, as the prevalence found in other recent similar surveys of the Czech population. 
One of the possible explanations involves the fact that the data were collected through the method of 
a structured “face to face” interview with a respondent.  
The data collected in general population surveys carried out in 2002 do not allow for the regional 
comparison of the scope of drug use.  
2.2.2 Drug Use in the School-Aged Population  
A survey geared towards drug use among school-aged children was carried out in the Czech 
Republic in 2002. The survey was a part of the international project “Health and Health Behaviour in 
School-Aged Children” (HBSC), focused on the health and lifestyle of children aged 11, 13, and 15. 
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The World Health Organization (WHO) guaranteed the project; and the Prague Psychiatric Centre 
was involved on behalf of the Czech Republic.  
A question about drug use was only included in the questionnaires for 15 – 16-year-old pupils of the 
final grade of basic schools (average age 15.4 years). 31.0% of the total number of 1,660 pupils 
reported an experience with an illicit drug (Psychiatrické centrum Praha, 2003b). Most respondents 
have experience with cannabis smoking; then there follow experience with solvents, hypnotics and 
sedatives, and ecstasy (Table 2-3). Usage within the last month was not investigated.  
Table 2-3: Lifetime prevalence and prevalence of use within the last 12 months of selected drugs by young people by gender, in % 
(Psychiatrické centrum Praha, 2003b), (Psychiatrické centrum Praha, 1999) 
 
A comparison of the HBSC survey results with the ESPAD survey that was implemented in 1999 
(Psychiatrické centrum Praha, 1999) showed that marijuana use among ninth-grade pupils in 2002 
(age 14 - 15) reached the level at which cannabis was used among students of the first grades of 
secondary schools (age 15 - 16) in 1999. Ecstasy use is even more common. On the other hand, the 
use of pervitin and heroin is still markedly lower.  
As in the general population, boys in the school-aged population report or have more experience with 
drug use; the lifetime prevalence of medicaments is the exception; it is traditionally higher among girls. 
It is rather surprising that girls even show a higher lifetime prevalence of amphetamine use.  
Another round of the international project ESPAD is taking place in the Czech Republic in 2003; it 
focuses on alcohol and drug use among young people. This data will serve for the assessment of 
further developments and new trends among drug users in the secondary school population and it will 
also make interregional comparisons possible.  
2.2.3 Recreational and Experimental Drug Use 
The Czech Republic has witnessed a marked increase in experimental and recreational drug use in 
recent years. This trend is especially apparent with regard to cannabis substances and the so-called 
dance drugs. Experimental and recreational drug use is the most prevalent among young people – 
according to available surveys, the average age of those attending dance events is around 20. 
Marijuana is the most popular drug: 82.6% of visitors of these events report that they have tried it; 
53.6% report ecstasy, 49.0% report LSD, 33.4% report pervitin and 18.7% report cocaine (Kubů et al.  
2000). 
The survey among those attending dance events who had their ecstasy tablets tested in 2002 (531 
people) has shown 67% of them also use cannabis on a regular basis (three or more times per 
month) and 14% use pervitin on a regular basis (Valnoha and Národní monitorovací středisko pro 
drogy a drogové závislosti, 2003).  
Lifetime prevalence  HBSC Prevalence in the last year 
HBSC 
Lifetime prevalence  ESPAD Drug  
Total Boys Girls Total Boys Girls Total Boys Girls 
Any illicit drug  31.0 35.3 27.0 27.4 31.4 23.6 34.9 40.2 30.0 
Cannabis and 
derivatives  
30.5 34.6 26.7 26.9 30.9 23.2 34.6 40.1 29.8 
Solvents 7.3 8.2 6.4 3.9 4.9 3.0 7.2 8.1 6.5 
Hypnotics and 
sedatives  
7.0 5.9 7.9 4.4 3.4 5.4 17.7 13.6 21.4 
Ecstasy 4.5 5.0 4.2 3.2 3.0 3.3 3.4 - - 
LSD 3.0 3.7 2.5 2.1 2.2 2.0 5.4 6.5 4.5 
Amphetamines  2.0 1.8 2.1 1.3 0.9 1.7 5.3 4.6 5.9 
Opiates  1.2 1.7 0.7 1.0 1.3 0.7 4.3 3.9 4.6 
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2.2.4 Drug Use in Selected Subpopulations 
General population and school surveys are not able to reflect the situation in drug use in individual 
subpopulations, e.g. national and ethnic minorities, prison populations, sex workers, etc.; in these 
groups, it is possible to expect that the drug use situation will be less favourable in comparison with 
that in the general population.  
The Social Workers Support Programme was implemented in 81 Roma communities in 2002 and it 
also focused on the evaluation of drug issues. The survey showed that drugs are prevalent in 60 
communities (74.1%); the situation is considered to be serious or very serious in 45 of them (56%). 
Marijuana, toluene, pervitin, and heroin are the most common drugs in the Roma communities 
(Kancelář Rady vlády pro záležitosti romské komunity, 2003). More detailed information about the 
situation in Roma communities is included in the chapter on Social Problems.  
2.3 Problem Drug Use 
It is estimated that there are 35,000 – 37,000 problem drug users in the Czech Republic; 30,000 – 
32,000 people are injecting users. Most of them are pervitin and heroin users. It is estimated that 
there are 22,000 problem pervitin users, and 13,000 – 15,000 problem heroin users. The estimated 
number of problem drug users has remained stable during the last four years.  
EMCDDA defines problem use as injecting drug use and/or long-term or regular use of opiates and/or 
amphetamines and/or cocaine. 
In the Czech Republic, the use of amphetamine-type drugs has practically narrowed to pervitin. Since 
the end of the 1990s, amphetamine use has been recorded especially in Northern Moravia, near the 
border with Poland; lately, the name “krajovka” has been used for it (Miovský et al.  2001; Národní 
protidrogová centrála Policie ČR, 2003). The use of homemade opiates or opiates consumed directly 
from poppy heads is rather a seasonal phenomenon in the Czech Republic. Unlike in the period of the 
1970s and 1980s, the injecting of “braun”16 has practically disappeared. There are sporadic reports 
about the injecting of Alnagon® tablets or other medicinal products containing opiates, crushed and 
dissolved in water. The illicit use (including injecting) of Subutex® tablets containing buprenorphine 
represents a current challenge; see the chapter on Substitution and Maintenance Programmes for 
more information. Such “non-traditional” substances from the group of opiates and amphetamines are 
(illicitly) used especially as a drug for overcoming a period when the primary drug, i.e. heroin or 
pervitin, is unavailable or there is a shortage of it.  
The scope of cocaine use is still very limited; there have been recent reports about cocaine use in the 
dance scene; however, available data still confirm very low occurrence (Valnoha, 2001; Valnoha and 
Mravčík, 2003). 
Therefore, in the conditions of the Czech Republic, problem use can be operationally defined as the 
intravenous use and/or long-term/regular use of heroin and pervitin.  
Even though problem use does not involve solvents by the EMCDDA definition, the health and social 
impacts of inhalant use are similar to those of the substances included within the concept of problem 
use. It is difficult to estimate the number of inhalant users in the Czech Republic, because they are a 
completely different social group of people than pervitin and heroin users and because the in-
treatment rate of inhalant users is very low (Polanecký et al.  2003) - see the chapter on Drug 
Treatment Demand - and these inhalant substances are legaly used for other purposes, therefore it is 
difficult to estimate the total extent of inhalant abuse in the Czech Republic. 
                                                           
16 A mix of homemade opiates, mostly codeine, obtained from medicinal preparations containing codeine.  
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The existing estimates of the number of problem drug users in the Czech Republic were carried out 
according to the multiplication method17 with the use of treatment sources. The Capture – Recapture 
Method (CRM) was used as an auxiliary method for the determination of multipliers.   
Table 2-4 provides a summary of the estimates.  
Table 2-4: Overview of multiplier values and the estimated numbers of all problem users, heroin users, pervitin users, and injecting 
users in 1999 - 2002 
Note: * Capture – recapture at the local level - PAD, ** nomination technique, qualitative analysis - PAD, *** In-treatment rate for 
outreach centres. 
A modified estimation of the prevalence of treated persons according to the first treatment demand 
register from the 2000 Final Report of the Prague Hygiene Station was used as the number of treated 
persons in the PAD project (Mravčík and Zábranský, 2001b). In-treatment rates18 collected at local 
level by means of CRM and from the PAD qualitative study (Miovský et al.  2001) were used as 
multipliers. The Prague Hygiene Station repeated this calculation in 2001 using the same 
methodology and multipliers. The estimate for 2002 was carried out using the share of problem drug 
users in contact with low-threshold centres (60%), which was determined using a nomination 
technique from the survey HCV Seroprevalence among Injecting Drug Users (see the chapter on 
Drug-Related Infectious diseases for more information). The calculation was based on an estimate of 
the number of problem drug users in contact with low-threshold facilities found in the final reports of 
projects subsidized by the National Drug Commission (extrapolation from available final reports 
provided an estimation of 8,000 heroin users, 13,100 pervitin users, and 19,000 injecting drug users 
who were in contact with low-threshold facilities in the Czech Republic in 2002), see the chapter on 
Harm Reduction for more information. 
The estimates carried out by means of multiplication methods in 1999 – 2002 are mutually consistent 
even though different source data were used; they suggest that the number of problem drug users in 
the Czech Republic has remained stable in recent years.  
The estimation of the number of problem drug users by regions in the Czech Republic was conducted 
using the same methodology and the same sources as the national estimate for the year 2002. 
Regionally specific proportions of problem drug users who are in contact with low-threshold facilities 
and the number of these users in contact were used as the basis; see Table 2-5. 
                                                           
17 This method is based on a combination of a known number of defined users (e.g. in treatment, prosecuted by the police, or dead) 
and their share (in-treatment rate) in the whole population of problem drug users (the so-called multiplier); it also leads to an estimate 
of the size of the hidden population. 
18 See the note above.  
Year  Multiplier value 
(%) 
Total number 
of problem 
drug users 
(in 
thousands) 
Number of 
heroin users 
(in 
thousands) 
Number of 
pervitin 
users (in 
thousands) 
Number of 
injecting 
users  
(in 
thousands) 
Source  
1999, 2000 15 -20* 
20 -37** 
37.5 (30 -
45) 
15 (12 -18) 22.5 (18 -
27) 
30 (24 -36) (Mravčík 
and 
Zábranský, 
2001b) 
2001 15 -20* 
20 -37** 
23 – 56.6 n.a. n.a. 24.6 - 40 (Polanecký 
et al.  2002) 
2002 60*** 35.1 13.3 21.8 31.8 (NMS, 
2003) 
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Table 2-5: Prevalence of problem drug users in 2002 by regions in the Czech Republic  
Region Number of problem drug users 
Per 1,000 inhabitants 
aged 15 – 64  
Capital Prague 10,950 13.3 
Central Bohemia 3,350 4.2 
Southern Bohemia  1,550 3.6 
Pilsen 1,850 4.8 
Karlovy Vary 1,150 5.3 
Ústí 4,200 7.2 
Liberec 550 1.8 
Hradec Králové 1,050 2.8 
Pardubice 600 1.7 
Vysočina 700 1.9 
Southern Moravia 3,350 4.3 
Olomouc 1,450 3.2 
Zlín 1,550 3.7 
Moravian-Silesian 2,800 3.1 
Total 35,100 4.9 
 
Map 2-1: Prevalence of problem drug users in 2002 by regions of the Czech Republic (per 1,000 inhabitants aged 15 – 64) 
 
 
Despite the sustained domination of pervitin, it has been possible to trace an increase in heroin use at 
the cost of pervitin use and an accompanying spread of heroin to nearly all regions of the Czech 
Republic since 1998 (Zábranský et al.  2002). There was a shift in the number of heroin and pervitin 
users treated in 2002 – a decrease was recorded with regard to heroin, and an increase in pervitin-
related first treatment demands was recorded. See the chapters on Drug Treatment Demand and 
Trends per Drug for more information.  
The share of injecting heroin users in all first treatment demands entered in the register kept by the 
Hygiene Service has been stable, at nearly 90%, for a long time; pervitin users represent 
approximately 80%, with slight fluctuations in individual years (Polanecký et al.  2000; Polanecký et al.  
2003; Polanecký et al.  2001; Polanecký et al.  2002). Fresh data from a HCV prevalence study 
confirm these results; a nomination technique provided a finding that approximately 89% of problem 
drug users use drugs intravenously. In comparison with 2001, there was a favourable trend in the 
share of injecting users in all heroin users and pervitin users among first treatment demands and all 
treatment demands in 2002 (92% vs. 89% of heroin users, 86% vs. 83% of pervitin users).  
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See the chapter on Drug-Related Infectio for other data – needle sharing, sexual risk behaviour, and 
drug use in prison.  
3 Health Consequences 
3.1 Drug Treatment Demand 
The working group “Treatment Demands” was constituted in 2001 within the framework of the Phare Twinning 
2000 project “Strengthening National Drugs Policy”. The groups involved representatives of the Prague 
Hygiene Station and representatives of the Harm Reduction Section of the Association of Non-Governmental 
Organizations; it is possible to summarize the main outputs in three main items:  
• the recording of “all treatment demands” was introduced in the register of treatment demands kept by the 
Hygiene Service. It is a requirement of the EMCDDA in connection with harmonized drug epidemiology 
indicators,19 
• cooperation between representatives of the Hygiene Service and the Harm Reduction Section of 
the Association of Non-Governmental Organizations (HR A.N.O.) was developed, 
• initiation of work on the development of an interface between the System of Uniform Data 
Collection in Low-Threshold Facilities20 and the Register kept by the Hygiene Service; this will 
allow for uniform reporting of first treatment demands and all treatment demands from low-
threshold facilities to the Register of the Hygiene Service; in addition, it will provide for electronic 
data exchange between these institutions. 
3.1.1 Treatment Demand Register of the Hygiene Service  
There is a functioning nationwide system for reporting first treatment demands in the Czech Republic; 
it started to operate within the framework of the Hygiene Service in 1995. All treatment demands have 
been newly monitored within the framework of this system since January 2002. 293 centres 
contributed to the system of the Hygiene Service of the Czech Republic in 2002; a summary is given 
in Table 3-1. The database of facilities was extended with facilities that had not recorded first 
treatment demands; they are mainly involved in the reporting of all treatment demands – e.g. 
therapeutic communities and after-care centres (Polanecký et al.  2003).  
                                                           
19According to the Hygiene Service, the term “all treatment demands” involves each client of treatment/outreach centres only once in 
each monitored year. However, according to the EMCDDA, it is each treatment episode in the course of the year provided that at 
least six months passed between them.  
20 The Harm Reduction Section of the Association of Non-Governmental Organizations (HR A.N.O.) has already worked on the System of 
Uniform Data Collection in Low-Threshold Centres project for five years. In addition to a uniform method of data collection, this system uses the 
coding of anonymous clients; a “Freebase” computer database has been developed in the system for the purposes of documentation and the 
evaluation of data about clients and services provided to them. The Harm Reduction Section and the National Focal Point are planning to 
implement the System of Uniform Data Collection in all low-threshold facilities in 2004. 
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Table 3-1: Treatment and outreach centres in the Register of the Hygiene Service in 2002 (Polanecký et al.  2003) 
Facility  First treatment demands  All treatment demands Type of facility 
number % number % number 
of clients 
per 
facility  
number % number 
of clients 
per 
facility 
Out-patient health 
care 
129 (103) 44.
0 
790  
(770) 
19.6 6.1  
(7.5) 
1,815 19.6 14.1 
Out-patient non-
health care  
32  
(21) 
10.
9 
330  
(245) 
7.0 10.3  
(12.3) 
450 4.9 14.1 
Residential  56  
(26) 
19.
1 
748  
(712) 
15.9 13.4  
(27.4) 
1,760 19.1 31.4 
Low-threshold 
facilities 
76  
(72) 
25.
9 
2,851  
(2248) 
60.4 37.5  
(31.2) 
5,212 56.4 68.6 
Total 293  
(234) 
10
0 
4,719  
(4,228) 
100 16.1  
(18.0) 
9,237 100 31.5 
*Data from 2001 are included in brackets and they serve for comparison  
As was the case in 2001, low-threshold facilities represent the most frequented type of services; they report a 
mean value of at least 69 clients and 38 first treatment demands per facility and year.  
Table 3-2 provides the number of all treatment demands and the numbers reported from the three 
treatment modalities that make the largest contributions to the reporting system; in addition, it provides 
total numbers of facilities and the numbers of facilities in the three most common modalities.  
Table 3-2: Comparison of the number of new treatment demands and the number of reporting centres (Polanecký et al.  2003) 
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1995 2,905 n.a. n.a. n.a. 226 n.a. n.a. n.a. 
1996 3,252 n.a. n.a. n.a. 252 n.a. n.a. n.a. 
1997 3,132 n.a. n.a. n.a. 269 n.a. n.a. n.a. 
1998 3,858 1,704 1,014 551 237 42 126 25 
1999 3,891 1,698 1,030 780 259 56 138 30 
2000 4,148 2,020 896 691 287 69 145 31 
2001 4,233 2,248 770 712 234 72 103 26 
2002 4,719 2,851 790 748 293 76 161 56 
Note: n.a. = non-applicable  
All treatment demands were monitored for the first time in 2002. 9,237 persons were recorded (6,302 
males and 2,895 females – the gender of 40 users was not recorded); 4,719 persons (3,173 males 
and 1,524 females) thereof were first treatment demands.  
The share of females among first treatment demands decreased in comparison with the previous year 
(see Table 3-4). 4,719 newly registered treatment demands (i.e. 46 per 100,000 inhabitants; 4,460 
persons in the group of 15 – 39-year-olds, i.e. 118 per 100,000 inhabitants) represent the highest 
yearly incidence since 1995 (Polanecký et al.  2003). It is likely that the increase in first treatment 
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demands was not caused by an increase in the actual number of drug users but rather by the 
improved quality of the reporting system of the Hygiene Service system (increase in the number of 
reporting facilities, improvement of reporting discipline) or by the increased willingness of users to 
enter treatment. 
The group aged 15 – 19 has remained the most represented among first treatment demands; 1,892 
persons were newly registered in 2002; however, their share decreased from 41.6% in 2001 to 40.1% 
in 2002. The average age of first treatment demands has been increasing since 1998 - see Table 3-3, 
Figure 3-1 (Polanecký et al.  2003). The group aged 20 – 24 is the most represented in all treatment 
demands (3,427 cases). The increasing average age and the related reduction in users in younger 
age groups is a favourable indicator of the development of problem drug use – it is most likely that the 
actual incidence of problem drug users has been decreasing. This trend is especially apparent among 
heroin users. 
Table 3-3: Average age of first treatment demands, Czech Republic, 1999 -2002 (Polanecký et al.  2003) 
Figure 3-1: Average age of first treatment demands in 1995 - 2002 – selected drugs, ČR, 2003 (Polanecký et al.  2003) 
 
The average age of users of stimulants and opiates who demand treatment for the first time has been 
increasing since 1997 (from 20.3 to 22.2 and 21.3 to 24.3 years respectively). The average age of 
users of cannabinoids and solvents has been more or less stable; it has been between 18 and 19 
Drug type  1995 1996 1997 1998 1999 2000 2001 2002 
Heroin and other opiates 23.1 21.2 21.3 22.5 21.8 21.6 22.2 24.3 
Pervitin and other 
stimulants  20.9 20.8 20.3 20.4 21.0 21.4 21.6 22.2 
Cannabinoids 19.3 18.8 18.7 18.4 18.6 18.5 18.3 18.7 
Hallucinogens 20.0 20.5 19.4 19.4 18.0 18.6 19.8 20.6 
Solvents 19.3 18.1 19.0 18.1 17.5 18.6 18.3 18.4 
Sedatives, hypnotics 37.5 36.6 33.9 33.1 38.4 35.3 39.4 36.5 
Other drugs and 
medicaments 31.0 31.4 32.2 21.7 24.4 26.0 33.7 28.2 
Not specified 18.7 21.0 22.2 22.1 27.0 22.6 25.1 27.0 
Total  22.8 21.5 20.8 20.6 20.8 20.9 21.3 21.8 
17 
18 
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years of age since 1996. Users of sedatives and hypnotics, or other drugs and medicaments, do not 
conform to this rule; they are on average ten years older than other drug users who demand 
treatment.  
Problem users21 (see the chapter on Problem Drug Use) represented 80.6% (7,441 cases) of all 
treatment demands in 2002; there were 73.6% problem users (3,472 cases) among first treatment 
demands - see the chapter on Problem Drug Use.  
Table 3-4 (Polanecký et al.  2003) gives a comparison of selected characteristics of all treatment 
demands and problem users demanding treatment. 
Table 3-4: Treatment demands in 2002, a comparison of selected characteristics all treatment demands and problem users in all 
treatment demands and first treatment demands (Polanecký et al.  2003) 
 
Selected characteristics of first treatment demands in 1995 – 2002 are presented in Table 3-5. 
                                                           
21 i.e. according to the Hygiene Service, users who use stimulants (excluding ecstasy) and opiates as a primary and secondary drug  
Characteristics  All treatment 
demands  
First treatment 
demands  
All treatment 
demands. 
problem users  
First treatment 
demands – 
problem users  
Incidence/100,000 inhabitants 89.9 45.9 72.4 33.8 
Incidence in the group aged 
15 – 39 / 100,000 inhabitants 
231.9 118.1 189.8 88.5 
Rate of males/females  2.1 : 1 2.1 : 1 2.1 : 1 1.9 : 1 
Average age 23.4 21.8 n.a. n.a 
Proportion of users aged 
under 19  
28.7 40.1 19.0 25.1 
Proportion of users aged 
under 25  
37.1 33.5 32.2 27.2 
Proportion of injecting users 
aged under 19 in all injecting 
users (%) 
22.2 32.8 - - 
Number of demand – heroin 
users (primary and secondary 
drug) - percentage of all users 
2,707 
29.3% 
947 
20.1% 
- - 
Number of demands – 
pervitin users (primary and 
secondary drug), percentage 
of all users 
5,912 
64% 
2,932 
62.1% 
- - 
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Table 3-5: First treatment demands, selected characteristics, Czech Republic, 1995 – 2000 (Polanecký et al.  2003) 
 
Stimulants represent the most common primary drug among first treatment demands – 2,595 cases 
(55% of first treatment demands); pervitin was involved in 2,389 cases thereof and ecstasy was 
represented in 193 cases (50.6% and 4.1% respectively, of all first treatment demands). 
Cannabinoids represent the second most common primary drug among first treatment demands - 
1,070 cases (22.7% of all first treatment demands). More information about cannabinoids users as 
first treatment demands is given in the chapter on Cannabis problems in context: understanding increased 
treatment demand. Then there follow opiates users, with 788 cases (16.7% of all first treatment 
demands); heroin was involved in 675 cases thereof (14.3% of all first treatment demands); finally, 
inhalant users were involved in 171 cases (3.6% of all first treatment demands).  
Table 3-6 provides a picture of trends in absolute numbers and shares of individual primary drug 
groups.  
Table 3-6: First treatment demands by primary drug group, ČR, 1999 – 2002 (Polanecký et al.  2003) 
First treatment demands Characteristic  
1995 1996 1997 1998 1999 2000 2001 2002 
Incidence/100,000 inhabitants 23.9 31.5 30.4 37.4 37.7 40.3 41.2 45.9 
Incidence in the group aged 15 – 39 
/ 100,000 inhabitants 62.9 78.7 75.1 96.3 99.0 105.5 106.1 118.1 
Male/female ratio 2.4 : 1 1.9 : 1 1.7 : 1 2.0 : 1 1.9 : 1 1.9 : 1 1.9 : 1 2.1:1 
Average age 22.8 21.5 20.8 20.6 20.8 20.9 21.3 21.8 
Proportion of users aged under 19  47.2 57.4 54.1 52.4 49.1 47.5 43.9 40.1 
Proportion of users aged under 25  44.9 54.7 51.2 46.5 40.3 38.3 35.5 32.8 
Proportion of injecting users aged 
under 19 in all injecting users (%) 
529 
21.4% 
1 050 
32.3% 
945 
30.2% 
909 
23.6% 
1 094 
28.1% 
1 229 
29.6% 
1 362 
32.2% 
947 
20.1% 
Number of demand – heroin users 
(primary and secondary drug) - 
percentage of all users 
1 252 
50.7% 
1 757 
54.0% 
1 946 
62.1% 
2 642 
68.5% 
2 554 
65.6% 
2 576 
62.1% 
2 545 
60.1% 
2 932 
62.1% 
Primary drug 
group 
1999 
abs. 
1999% 2000 
abs. 
2000% 2001 
abs. 
2001% 2002 
abs. 
2002 
% 
Change  
2001 - 2% 
(in the 
sample) 
Change  
2001 - 2 (%)  
(in the 
group)  
Heroin and 
other opiates 
869 22.3 1,04
4 
25.2 1,21
3 
28.7 788 16.9 -,11.8 - 35 
Pervitin and 
other 
stimulants 
2,06
4 
53.0 1,91
7 
46.2 2,02
3 
47.8 2,59
8 
55.1 + 7.3 + 28.4 
Cannabinoids 648 16.7 912 22.0 747 17.6 1,07
0 
22.7 + 5.1 +43.2 
Hallucinogens 44 1.1 36 0.9 25 0.6 20 0.4 - 0.2 - 20 
Solvents 166 4.3 161 3.9 147 3.5 171 3.6 + 0.1 + 16.3 
Sedatives and 
hypnotics 
62 1.6 56 1.3 35 0.8 41 0.4 + 0.1 + 17.1 
Other drugs 
and 
medicaments 
19 0.5 17 0.4 28 0.6 25 0.5 + 0.4 + 13.6 
Not specified 19 0.5 5 0.1 15 0.4 6 01 - 0.3 - 40 
Total 3,89
1 
100.
0 
4,14
8 
100.
0 
4,23
3 
100.
0 
4,71
9 
100.
0 
- +11.5 
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The number of first treatment demands with heroin as a primary drug declined in comparison with 
2001 (by 35%); in 2002, the proportion of heroin users (with heroin as the primary or secondary drug) 
among first treatment demands also reached its lowest figure since 1995. The reason may involve the 
impaired availability of heroin in the first half of 2002 (see the chapter on Drug Availability and Drug 
Supply for more information), an increase in the use of substitutes (buprenorphine), and the 
decreasing number of heroin users. The year 2003 will show whether this is a temporary or a long-
term phenomenon.  
On the other hand, the number of first treatment demands with ecstasy as the main drug (from 48 people in 2001 
to 193 in 2002), with cannabinoids as the main drug (by 43.2%), and pervitin as the main drug (by 28.4%) all 
increased. There was also an increase among first treatment demands by inhalant users (by 16.3%) and users 
of sedatives and hypnotics (by 17.1%). Figure 3-2 shows a comparison of the trend of heroin and pervitin-
related first treatment demands.  
Figure 3-2: First treatment demands – problem drug users 1995 – 2002 (Polanecký et al.  2003) 
 
 
As far as all treatment demands are concerned, stimulants are again the most common main drug – 
4,831 cases (52.3% of all treatment demands); pervitin represents 4,589 cases and ecstasy 218 
cases thereof (49.7%, 2.4% respectively of all demands). Opiates were the second most common 
primary drug among all treatment demands – 2,353 cases (25.5% of all users); 2,060 cases thereof 
reported heroin as the primary drug. Cannabinoids represent the third most represented group - 1,489 
cases (16.1% of all demands). 
Injecting drug use (including secondary use) was recorded in 2,760 of 4,719 new treatment demands 
(58.5% first treatment demands in 2002, against 62.3% in 2001). Injecting use was reported in 67.4% 
of all treatment demands, i.e. 6,225 persons used drugs intravenously (Polanecký et al.  2003). 
3.1.1.1 Treatment Demands by Regions 
The relatively highest number of treatment demands (recalculated to the number of inhabitants) was 
reported from the Ústí region, Prague, Southern Moravia and the Olomouc region – see Map 3-1. The 
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highest rates of first treatment demands (in terms of their absolute number) were likewise reported 
from the same regions and in the same sequence. 
Map 3-1: All treatment demands in 2002 by regions (per 100,000 inhabitants), (Polanecký et al.  2003) 
 
There are marked regional differences in the types of drugs used, especially in the proportion of 
pervitin and heroin users.  
Stimulants (especially pervitin) have spread all over the Czech Republic. In the individual regions, 
pervitin users represent 34.3% (Vysočina) to 80% (Pardubice) of first treatment demands. In 
comparison with the users of other drugs, pervitin users form the highest proportion among first 
treatment demands in all regions, with the exception of Vysočina and Central Bohemia, where users 
of cannabinoids occupy the first position. In comparison with 2001, the numbers of pervitin-related first 
treatment demands increased in most regions, with the exception of the Zlín region (same number) 
and the Karlovy Vary and the Vysočina regions (a decrease by 58 persons in total). Pervitin users 
represent the highest share in all treatment demands in all regions (this value ranges from 34% in 
Central Bohemia to 77.7% in the Pardubice region), with the exception of Prague, where opiate users 
occupy the leading position.  
Opiate users represent 3.6% (Zlín) to 38.6% (Prague) of first treatment demands in the individual 
regions. With the exception of the Olomouc region (an increase of 17 people) and the Pardubice 
region (an increase of 6 people), the number of heroin-related first treatment demands went down In 
comparison with 2001. A relatively balanced ratio of heroin and pervitin users among first treatment 
demands can only be found in Prague. Pervitin dominates over heroin in the remaining regions.  
It is likely that these regional differences are not influenced by the spectrum of services provided, 
because substitution treatment is the only difference in the services provided for the treatment of 
addiction to pervitin or heroin respectively. The relatively highest number of inhalant users can be 
found in the Moravian-Silesian region – 9.3% of first treatment demands and 9% of all treatment 
demands. Most treatment programmes, including low-threshold facilities, do not primarily focus on 
inhalant users, and the needs for treatment or other types of help to these users are not met; 
therefore, it is reasonable to believe that the extent of inhalant use is underestimated.  
3.1.2 Other Registers 
The Register of Hospitalizations of the Institute for Health Information and Statistics records the 
number of hospitalizations in psychiatric hospitals. 2,510 hospitalizations were carried out in 19 
psychiatric hospitals due to disorders caused by the use of psychoactive drugs in 2002. In 
comparison with the previous year, the number of hospitalizations went down; 3,253 hospitalizations 
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in psychiatric hospitals and other 1,524 hospitalizations took place in psychiatric departments of 
hospitals in 2001 (these data for 2002 were not available at the time of the deadline of this Annual 
Report) (Ústav zdravotnických informací a statistiky, 2002). More information about this topic is 
included in the chapter on Drug-Free Treatment. 
463 persons were involved in methadone substitution programmes in the Czech Republic in 2002, i.e. 
3.4% of the estimated 12,000 – 15,000 heroin users, of whom the majority (nearly 90%) inject heroin. 
As at December 31, 2002, 353 patients were participating in special substitution programmes; this 
represents approximately 2.6% of the estimated heroin users (Ústav zdravotnických informací a 
statistiky, 2003b); detailed information is included in the chapter on Substitution and Maintenance 
Programmes. 
Final reports of the projects in low-threshold facilities that were subsidized by the National Drug 
Commission were used to extrapolate the estimated number of drug users who were in contact with 
these facilities in 2002.22 This involves 22,100 problem users23 (8,000 heroin users, 13,100 pervitin 
users, 19,000 injecting drug users) and 3,200 cannabis users. The average age of the users who are 
in contact with low-threshold facilities is 22.3 years; there is a 2:1 ratio of males and females; see the 
chapter on Harm Reductionfor more information. 
3.1.3 Shares of Problem Drug Users in Different Types of Care 
Table 3-7: Share of heroin users and pervitin users in different types of care in 2002 
Note: n.a. = not applicable 
3.2 Drug-Related Mortality 
The year 2002 was the second year of operation of an automated system of collection of drug 
mortality data. The software was introduced in 10 out of 1326 departments of forensic medicine and 
toxicology. The remaining three departments provided data in questionnaires. Czech laws (Ordinance 
18/1988 Coll. of the Ministry of Health) specify mandatory dissections in all cases of sudden death 
when the examining practitioner could not determine the cause of death, and in all cases of violent 
deaths; a summary of forensic medicine departments is given in Map 3-2. 
                                                           
22 This involves low-threshold centres, exchange programmes, outreach programmes, and out-patient facilities that provide harm 
reduction services; 93 of them operated in the Czech Republic in 2002; data from 80 facilities were available.  
23 Some of those users who use the services of low-threshold facilities meet the definition of a “treatment demand” and we believe 
that they appear in the Registry of Treatment Demands kept by the Hygiene Service.  
24 Number of patients who were in out-patient care in 2002 due to disorders caused by psychoactive substances (Dg. MKN 10 F11 – 
F19). 
25 Number of hospitalizations in psychiatric hospitals due to disorders caused by psychoactive substances (Dg. MKN 10 F11 – F19); 
the number of hospitalizations for the same diagnoses in hospital psychiatric departments is not available yet.  
26 The software was not introduced in the department of forensic medicine in Brno, Ostrava, and FN Na Bulovce in Prague.  
Problem drugs (heroin + 
pervitin) in total  
  Primary drug  Pervitin 
 
Heroin 
 number % 
Estimated number of all problem users 22,000 12 – 15,000 34 – 37,000 100 
Number of users in contact with low-threshold 
facilities  
13,100 8,000 21,000 
 
59.5 
Number of users in the Register of all treatment 
demands kept by the Hygiene Service  
4,599 2,353 7,441 21 
Number of users in active files of AT clinics and 
outpatient units of psychiatric departments24  
5,438 8,058 13,496 
 
38 
Number of hospitalizations25  n.a. n.a. 2,510  
7,1 
Therapeutic communities (16 facilities)  195 196 391 1,1 
Number of users in substitution treatment  - 463 463 3,4 
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Data about overdoses on narcotic and psychotropic substances are available in a consistent time 
series since 199827; however, it is not yet possible to provide reliable recording of deaths “with the 
presence of narcotic and psychotropic substances”, as three departments were not connected to the 
automated system.28 
The whole automated system and coordination of collection of this type of data in general has been 
developed in close collaboration of the Czech National Focal Point and the Professional Association 
of Forensic Medicine and Toxicology of the Czech Medical Association of J. E. Purkyně. The 
representatives of the council of this association were also conspicuously represented in the 
appropriate working group of the Phare Twinning Project; after the project ended in 2003, the National 
Drug Commission made a decision to award this group the status of a working group of the Czech 
National Focal Point.  
Map 3-2: Locations of 13 toxicological laboratories participating in the system of the Czech National Focal Point for drug mortality 
monitoring (in comparison with the situation in 2001, two departments in FN Na Bulovce in Prague were administratively 
consolidated) 
 
 
 
3.2.1.1 Drug Overdoses in 2002 
Forensic medicine and toxicology departments detected 115 deaths due to overdose on narcotic and 
psychotropic substances in 2002. Regardless of psychotropic medicaments (see below), opiates 
were, as traditionally, the cause of the highest number of these overdoses (21); then, there followed 
solvents (14) and pervitin (8). Not a single death due to overdose on methadone (or buprenorphine) 
was recorded, not even in combination with another drug; at the same time, no fatal overdose of 
cannabis, dance drugs or their fakes, hallucinogens, and/or the relatively rare cocaine and crack was 
recorded.  
Overdoses on psychotropic medicaments represent a very heterogeneous category and it is difficult 
to provide an accurate assessment. The reason is that it includes suicide overdoses, accidental 
overdoses with lege artis prescribed medicaments, and also accidental overdoses on abused 
medicaments. In addition, it is difficult to make a distinction in the last two categories between 
medicaments that were prescribed by a practitioner but were abused or caused an addiction after all.  
                                                           
27 With the exception of data on overdoses on solvents (see below). 
28 Detailed methodological summary of determination of acute drug-related deaths is included in an expert statement (Zábranský and 
Vorel, 2001); a brief terminological summary can be found in last year’s annual report (Zábranský et al. 2002) on pp. 42-46.  
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72 overdoses on psychotropic medicaments were identified; 24 thereof were in the age group aged 
under 40; it is quite likely that these cases took place in connection with abuse. 50 (of 72) overdoses 
on psychotropic medicaments involved benzodiazepines, including flunitrazepame. It is not possible 
to carry out further analysis due to a shortage of anamnestic data; it remains as a challenge for the 
years to come.  
Henceforth, overdoses on psychotropic medicaments will be narrowed to overdoses on 
benzodiazepines, including flunitrazepame (Rohypnol®) in order to ensure compatibility with the 
previous years – this means that the above-mentioned division by age will not be used.  
Figure 3-3: Overdoses in 2002 
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3.2.1.2 Development in Overdoses in 1998-2002 
Figure 3-4: Overdoses on selected narcotic and psychotropic substances in 1998-2002 
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There has been a marked decline in all categories of acute drug-related deaths in 2002, with the 
exception of pervitin. Possible causes may include:  
• Decrease of the “drug epidemic” that occurred after the fall of the Iron Curtain; such an 
interpretation is compatible with the data on the ageing of drug users (thus, about the decline in 
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new, inexperienced young users who are more vulnerable to overdose and other negative 
consequences of drug use) – see the chapter onDrug Treatment Demand,  
• A picture of a fluctuating drug market; this mainly involves opiates and it is connected with the 
geopolitical situation and periodical failures in supplies of opiates – see the chapter on Drug 
Availability and Drug Supply,  
• The influence of the entry of a competitive “licit” drug – buprenorphine29 – to the black market in 
the regions with traditions of high overdose rates (Northern Bohemia and Prague and 
surroundings); this substance is markedly “safer” than illicitly prepared opiates (see the chapter on 
Substitution and Maintenance Programmes),  
• Further development of methadone programmes (see the chapter on Substitution and Maintenance 
Programmes), 
• More accurate diagnoses by several departments of forensic medicine and toxicology; 
hypothetically, it is possible that “overdoses” only used to involve suspect cases of “death with the 
presence of narcotic and psychotropic substances” and it was not possible to carry out 
retrospective source data checks, 
• The reduced number of tests for narcotic and psychotropic substances in several regions; this 
followed from the change in the investigative tactics of the Police of the Czech Republic – due to 
insufficient financial resources, the police did not order such tests when the appropriate 
investigator made a judgment that the liability of another person was ruled out.  
3.2.1.3 Drugs and Driving 
Since 1998, the Forensic Medicine Department of České Budějovice Hospital has been conducting 
drug tests for all drivers that died in a traffic accident. According to preliminary results (Vorel, 2003), 
166 out of 200 drivers examined were tested for drugs in 1998 – 2002. The influence of an illicit drug 
was found in two of them – one case involved pervitin and one THC (marijuana). This represents 
1.2% of the total number of those dissected. Eight drivers (4.8%) were under the influence of 
pharmaceutical psychotropic substances at the time of the accident; eight others were under the 
influence of other medicaments. 72 (37%) out of 194 dead drivers tested were under the influence of 
alcohol.  
The Czech National Focal Point is preparing an analysis of similar data that were collected at the 
nationwide level in 2002. 
3.3 Drug-Related Infectious Diseases 
3.3.1 HIV/AIDS 
As at December 31, 2002, 601 HIV positive persons permanently residing in the Czech Republic 
were registered; 22 persons thereof are injecting drug users (IDUs) (two of them are in the AIDS 
stage) and 7 others are at the same time injecting drug users and homo/bisexuals – accordingly, 
there are two likely ways of transmission; developments are described in Table 3-8 (Brůčková et al.  
2003). 
                                                           
29 In the form of a branded product, Subutex® 
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Table 3-8: HIV+ incidence in the Czech Republic as at December 31, 2002 by the pattern of transmission (Brůčková et al.  2003) 
 
The situation regarding the incidence of HIV infection among injecting drug users and the total 
occurrence of HIV infection in the Czech Republic has been stable since the first half of the 1990s. 
One to four new HIV positive injecting drug users are reported every year. 
819,869 laboratory tests for HIV antibodies were carried out in the Czech Republic in 2002; 49 were 
positive (0.006%). 1,536 HIV blood tests were reported as tests on injecting drug users; none of them 
was positive (a year-on-year comparison is included in Table 3-9). 
Table 3-9: Testing of injecting drug users for HIV antibodies in 1994 – 2002 (Národní referenční laboratoř pro AIDS, 2003) 
 
The mode of detection 
of HIV positiveness 
among injecting users is 
included in Table 3-10. 
Only one of the 29 
cases (3.4%) of HIV 
positive people whose 
anamnesis included 
injecting drug use 
(sometimes in 
combination with 
homosexual 
intercourse) was detected within the framework of testing in connection with risk behaviour “injecting 
drug use”. This is why the Czech National Focal Point, in cooperation with the National Health Institute 
(National Reference Laboratory for HIV/AIDS and the National Programme of Fighting against AIDS), 
initiated activities geared towards the extension of testing of drug users in the facilities that have been 
designed for them – especially in low-threshold programmes that provide harm reduction services. 47 
(out of 93) low-threshold facilities tested drug users for HIV antibodies; 325 saliva tests, 311 venous 
blood tests, and 525 orientation tests from capillary blood were carried out, i.e. 1,158 tests were 
carried out in total (Národní monitorovací středisko pro drogy a drogové závislosti, 2003c). 
                                                           
30 This involved a person who was to be positive as early as in 1998.  
Pattern of 
transmission  
before 
1995 
1996 1997 1998 1999 2000 2001 2002 Total  
Homo-/bisexual 139 31 32 15 19 27 27 28 318 
IDU  7 1 2 3 1 4 3 1 22 
Homosexual and 
IDU  
1 0 1 2 0 0 2 1 7 
Hemophiliacs  17 0 0 0 0 0 0 0 17 
Blood recipients  14 0 0 0 0 0 0 0 14 
Heterosexual  56 16 25 9 23 21 13 17 180 
Mother – child 0 0 1 0 1 1 0 0 3 
Nosocomial  0 0 0 1 1 0 0 0 2 
Not found  15 2 2 1 5 4 6 3 38 
Total 249 50 63 31 50 57 51 50 601 
Year Number of blood 
tests carried out  
Number of 
positive 
results 
Number of saliva 
tests carried out  
Number of 
positive 
results 
1994 202 0 - - 
1995 136 1 - - 
1996 316 0 - - 
1997 1,447 0 895 0 
1998 2,158 0 1,124 0 
1999 2,320 0 1,219 0 
2000 2,091 0 1,001 0 
2001 2,169 1 961 0 
2002 1,536 0 734 130 
Total 12,375 2 5,934 1 
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Table 3-10: Pattern of detection of HIV infection of an injecting user (Jedlička, 2003) 
 
 
There are new data about HIV prevalence from testing conducted in 35 Czech prisons (Generální 
ředitelství Vězeňské služby ČR, 2003c) - see Monitoring of Infections in the Population of 
Incarcerated Drug Users, and from monitoring of testing in low-threshold facilities for drug users – see 
the chapter on Infection Monitoring in Low-threshold . 
3.3.2 Viral Hepatitis 
The data on reported new cases of acute hepatitis B and C virus infection (HBV, HCV) in the Czech 
Republic in 1997 – 2002 make it obvious that there is a decrease in acute cases of both types of 
parenteral viral hepatitis. It is not possible to distinguish between acute or chronic infection in most 
cases of first detection of HCV; therefore, a more objective picture of the situation can be found in an 
overview of all reported HCV cases, including the chronic ones. Even though the share of HCV in all 
cases has been stable in the last years (around 60%, see Table 3-11), HCV incidence among 
injecting drug users (including chronic cases) shows an upward trend.  
Reason for examination  Total number 
of 
examinations  
Positive IDUs 
thereof  
Injecting drug use  14,335 1 
Promiscuous behaviour, 
prostitution  
25,363 4 
Stay at a corrective institution  72,204 2 
Sexual contact with HIV+ 219 2 
Psychiatric patients  17,131 1 
Various clinical diagnoses  573,000 13 
Examination at one’s own request  172,483 3 
Pregnant females 1,711,410 3 
Total 2,586,145 29 
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Table 3-11: Reported incidence of HBV and HCV and the rate of injecting drug users in the Czech Republic in 1997 – 2002 (Beneš 
and Částková, 2003; Polanecký et al.  2003) 
It is necessary to note that recorded 
incidence is not a valid indicator for the 
monitoring and assessment of HBV and 
HCV prevalence in the group of injecting 
drug users because HBV and HCV are 
latent in a considerable portion of the 
cases (HBV in 50% and more and HCV 
in more than 75%); the actual 
occurrence of viral hepatitis is markedly 
higher. 
A far better picture of the occurrence of 
viral hepatitis can be provided by testing 
the population for the presence of 
antibodies against individual causal 
agents of individual types of hepatitis – 
i.e. by means of a seroprevalence31 
survey. The results of several surveys or 
monitoring systems of various user 
groups are available in this field.  
In addition to the studies that were 
published in the Annual Report on Drug 
Situation 2001 - Czech Republic 
(Zábranský et al.  2002), interim results 
from the survey of the Czech National 
Focal Point “HCV Seroprevalence 
among Injecting Drug Users” (see below) 
and the survey “Prevalence of 
Serological Markers of HBV and HCV 
Infections among Drug Addicts Treated in Prague’s methadone centre Drop In o.p.s.” (Wilczek and 
Urbánek, 2003) are also available. Table 3-21 provides a detailed summary of data from these 
surveys. Other newly obtained data about VH prevalence come from testing in 35 Czech prisons 
(Generální ředitelství Vězeňské služby ČR, 2003c), and they are summarized in the subchapter 
Monitoring of Infections in the Population of Incarcerated Drug Users. In addition, the monitoring of 
testing of drug users in low-threshold facilities was used and it is dealt with in the subchapter Infection 
Monitoring in Low-threshold .  
A comparison of these surveys (see Table 3-21) shows considerable differences in the presence of 
antibodies; they follow from local differences and especially from different user characteristics of the 
sample in the surveys. HBV and HCV antibody presence especially depend on the length and 
frequency of injecting use.  
3.3.2.1 Study “HCV Seroprevalence among Injecting Drug Users” 
In the second half of 2002, the Czech National Focal Point initiated a multicentric survey, “HCV 
Seroprevalence Among Injecting Drug Users”. The objective of this survey was to find out about the 
presence of antibodies among active injecting drug users in the Czech Republic and to identify the 
factors that influence this prevalence. Twelve low-threshold facilities were involved in the survey (see 
                                                           
31 Seroprevalence = presence of antibodies against a given infection in blood serum; it is a sign that the person was in contact with 
this infection in the close or distant past. 
 
VH type  Year Total 
number of 
cases  
Injecting 
drug users 
thereof  
Share of 
injecting 
drug users 
(%) 
1994 710 - - 
1995 604 - - 
1996 680 39 5.7 
1997 564 46 8.3 
1998 575 107 18.6 
1999 636 150 23.6 
2000 604 168 27.8 
2001 457 134 29.3 
Acute HBV  
2002 413 118 32.4 
1994 128 - - 
1995 216 - - 
1996 279 95 34.1 
1997 273 132 48.4 
1998 448 261 58.3 
1999 634 362 57.1 
2000 637 365 57.3 
2001 798 499 62.5 
HCV  
 
2002 858 512 59.7 
1997 220 116 52.7 
1998 319 195 61.1 
1999 329 211 64.1 
2000 319 215 67.4 
2001 276 167 60.5 
Acute HCV 
thereof 
(Polanecký 
et al.  2003) 
2002 213 127 59.6 
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Table 3-12); it is planned that the basic part will be completed in the second half of 2003 (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2002). So far, 619 interviews and tests have 
been carried out in the basic part; there were 193 (31.2%) HCV positive persons in this sample. 526 
questionnaires have been processed thoroughly so far. In the sample that has been processed so far, 
there are 177 females (33.7%) and 349 males (66.3%); positive test results were less frequent among 
females (26.3%) than among males (33.5%). In the processed sample, the results of the test were 
also analyzed by age, length of regular intravenous use, needle sharing, incarceration, and injecting 
use in prison (see Table 3-15 and Table 3-16). The results indicate that the likelihood of HCV 
occurrence among injecting users increases with the length of regular injecting use, needle sharing, 
incarceration, and injecting use in prison. Map 3-3 provides data about HCV seroprevalence by 
facilities operating in a given region.  
Map 3-3: Interim results of the survey HCV Seroprevalence among Injecting Drug Users“ by the region where the facility operates 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
 
Table 3-12: Interim results of the “HCV Seroprevalence among Injecting Drug Users” survey by facility (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2003a) 
Note: KC stands for “low-threshold centre”.  
HCV positive Facility  Expected number 
of respondents in 
the basic part of 
the survey  
Number of 
respondents 
tested hitherto 
abs. % 
KC Děčín 35 33 12 36,4 
KC Ústí 90 91 50 54,9 
KC Opava 40 28 2 7,1 
KC Liberec 40 36 5 13,9 
KC České Budějovice 36 28 13 46,4 
KC Tábor 45 36 6 16,7 
KC Brno 70 65 14 21,5 
Drop In Prague 180 90 46 51,1 
KC Plzeň 90 59 9 15,3 
KC Hradec 65 64 10 15,6 
KC Jihlava 25 18 1 5,6 
KC SANANIM Prague 180 55 23 41,8 
Total 896 619 193 31,2 
Ústí
Pilsen
Zlín
Vyso_ina
Central Bohemia
Olomouc
Southern Bohemia
Pardubice
Liberec
Southern Moravia
Moravian-Silesian
Hradec Králové
Karlovy Vary
Capital Prague
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Table 3-13: Interim results of the “HCV Seroprevalence among Injecting Drug Users” survey by age (Národní monitorovací středisko 
pro drogy a drogové závislosti, 2003a) 
 
Table 3-14: Interim results of the “HCV Seroprevalence among Injecting Drug Users” survey by the length of regular injecting use 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
Table 3-15: Interim results of the “HCV Seroprevalence among Injecting Drug Users” survey in connection with incarceration  
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
Table 3-16: Interim results of the “HCV Seroprevalence among Injecting Drug Users” survey in connection with injecting use in prison  
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
3.3.2.2 Monitoring of Infections in the Population of Incarcerated Drug Users 
The results of testing drug users in Czech prisons for selected infections were collected in 2002 
(Generální ředitelství Vězeňské služby ČR, 2003c) - see Table 3-17. 
Respondents HCV positive 
 
 
Age  
abs. % abs. % 
16 - 20  173 33.0 24 13.8 
21 - 25  177 33.8 57 32.2 
26 - 30  69 13.2 33 47.8 
31 - 35  65 12.4 21 47.7 
36 - 40  22 4.2 10 45.5 
More  17 3.3 9 52.9 
Total 523 100.0 164 31.4 
Respondents HCV positive 
 
Length of injecting 
use 
abs. % abs. % 
1 - 6 months 70 13.5 5 7.1 
6 - 12 months 68 13.1 11 16.2 
1 - 2 years 82 15.8 17 20.7 
2 - 5 years 167 32.1 49 29.3 
5 - 10 years  86 16.5 47 54.7 
More  47 9.0 36 76.6 
Total 520 100.0 165 31.7 
Respondents HCV positive 
 
Prison  
abs. % abs. % 
No 296 59.4 73 24.7 
Yes 202 40.6 89 44.1 
In custody thereof  48 9.6 18 37.5 
Total 498 100.0 162 33.1 
Respondents HCV positive 
 
Injecting use in prison  
abs. % abs. % 
Yes 81 40.1 42 51.9 
First time thereof  6 3.0 2 33.3 
No 121 59.9 47 38.8 
Total 202 100.0 89 44.1 
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Table 3-17: Results of testing drug users in Czech prisons for selected infections in 2002 (Generální ředitelství Vězeňské služby ČR, 
2003c) 
 
3.3.2.3 Infection Monitoring in Low-
threshold centres 
Cumulative data were collected on 
testing for selected infections in low-
threshold programmes in the Czech 
Republic in 2002. 34 low-threshold 
centres submitted a questionnaire to the Czech National Focal Point; a summary of the results is 
included in Table 3-18.  
Table 3-18: Results of testing for selected infections among injecting users in low-threshold facilities in the Czech Republic in 2002 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003c) 
 
2002 was the first year in which data 
were collected about testing for 
infections in prisons and in low-
threshold facilities. It is possible to 
assume that the quality and reliability 
of data and the regional coverage will increase in the years to come.  
3.3.3 Risk Behaviour 
The data regarding needle sharing in the last 3 months range from 25% (Minařík and Zahradník, 
2003) to 51% (Mravčík and Šebáková, 2002); sharing in the course of one’s whole drug career 
ranges from 49% (Polanecký et al.  2001) to 91% of injecting drug users (Mravčík and Šebáková, 
2002). According to the survey “Rapid Assessment – Assessment of the Drug Situation in the 
Pardubice region”, 40% of respondents report that needle sharing is absolutely unacceptable for 
them; 33% of respondents use efficient disinfection before injecting; on the contrary, 33% never use 
disinfection (Minařík and Zahradník, 2003). 
Table 3-19 presents the interim results of the survey “HCV Seroprevalence among Injecting Drug 
Users” with regard to sharing injecting materials.  
Table 3-19: Interim results of the survey “HCV Seroprevalence among Injecting Drug Users” with regard to sharing injecting 
materials (Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
Even the data about the sexual 
behaviour of drug users vary. 11% 
(Miovský et al.  2001) to 40% (Minařík 
and Zahradník, 2003) of those surveyed 
have a permanent sexual partner; 9% 
(Národní monitorovací středisko pro 
drogy a drogové závislosti, 2003a) to 
20% (Minařík and Zahradník, 2003) of the respondents reported performing sex for money or drugs. 
4% (Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) to 50% (Minařík and 
Zahradník, 2003) never use a condom, and 20% (Minařík and Zahradník, 2003) to 39% (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2003a) of those surveyed use a condom most 
of the times. 78% of respondents admit that they have had more than five sexual partners – see Table 
3-20. 
                                                           
32 This case involves an infection that had already been detected in 1998  
Infections  Number of 
tests 
Positive 
result 
% 
HIV 674 3   0.4 
HAV 1,341 123  9.2 
HBV 1,438 282  19.6 
HCV 1,319 686  52.0 
Syphilis  1,392 138  9.9 
Infection Number of 
tests 
Positive result % 
HIV 917 1 0.132 
HAV  144 1 0.7  
HCV  998 159 15.9 
Syphilis  176 2 1.1  
Respondents HCV positive 
 
Needle sharing  
abs. % abs. % 
Yes 332 63.2 120 36.1 
Only with a partner  75 14.3 19 25.3 
No 106 20.2 23 21.7 
I don’t know 12 2.3 3 25.0 
Total 525 100.0 165 31.4 
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Table 3-20: Interim results of the “HCV Seroprevalence among Injecting Drug Users“ survey in connection with the lifetime number of 
sexual partners (Národní monitorovací středisko pro drogy a drogové závislosti, 2003a) 
 
3.3.4 Summary – Infectious Diseases in the Group of Drug Users 
The results that are available on seroprevalence and the incidence of HIV and hepatitis B and C virus 
infection among the population of drug users in the Czech Republic suggest that the situation has 
remained stable during the last three years. Among the population of clients of low-threshold facilities, 
HBV prevalence is around 10%, and it is 40 – 50% among the population of long-term and severe 
opiate users in substitution treatment. HCV prevalence among the clients of low-threshold facilities is 
approximately 35%, and approximately 60% among the population of substitution treatment clients. It 
is frequently the case that a combination of both of these types can be found among the population of 
long-term users (40% approximately). HBV and HCV prevalence among incarcerated drug users 
comes close to the prevalence among long-term and severe opiate users in substitution treatment; 
this indicates that this population is at high risk in terms of HBV and HCV transmission. HIV 
prevalence among Czech drug users has been very low from the long-term point of view; see Table 
3-21. 
 
Respondents HCV positive 
 
Number of sexual 
partners  
% abs. %  
0 4 0.8 0 0 
1 – 5 112 21.3 26 23.2 
6 – 10 119 22.6 36 30.3 
More than 10 291 55.3 103 35.4 
Total 526 100.0 165 31.4 
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Table 3-21: Seroprevalence of infections among the group of injecting drug users – overview of available data for the Czech 
Republic in 1998 – 2003 (Generální ředitelství Vězeňské služby ČR, 2003c; Mravčík and Šebáková, 2002; Národní monitorovací 
středisko pro drogy a drogové závislosti, 2003a; Národní monitorovací středisko pro drogy a drogové závislosti, 2003c; Wilczek and 
Urbánek, 2003; Řehák and Krekulová, 2002) 
* This involves the number of tests, not the number of tested persons 
3.4 Other Drug-Related Morbidity 
3.4.1 Non-fatal Drug Emergencies 
The collection of data about non-fatal emergencies is based on the system operated by the Hygiene 
Service (Polanecký et al.  2003). Considerable regional differences in data collection systems have 
persisted, both in terms of quality and quantity. Various types of health care facilities represent a 
source of data about drug-related emergencies. A comparison of the rate of intoxications in 2001 and 
2002 by the individual drugs is provided in Table 3-22. 
Infection Geographic 
region 
Subpopulation Year (period) Number of 
the tested  
Presence of 
antibodies 
(%) 
Karviná Low-threshold facility clients 1998 – 2001 308 8.6 
Czech 
Republic 
Incarcerated drug users 2002 1,438 19.6 
Prague Methadone substitution clients 2000 60 46 
HBV 
Prague Methadone substitution clients Drop 
in 
2000 – 2002 154 49.8 
Czech 
Republic 
Drug users - low-threshold facility 
clients 
2002 998* 15.9 
Karviná Low-threshold facility clients 1998 – 2001 308 21.1 
Czech 
Republic 
Testing within the survey “HCV 
Seroprevalence among Injecting Drug 
Users”  
2002 619 31.2 
Ústí nad 
Labem 
Clients of a low-threshold facility  1999 224 37.1 
Prague Methadone substitution clients 2000 60 68 
Prague  Methadone substitution clients Drop 
in 
2000 – 2002 154 59.1 
HCV 
Czech 
Republic 
Incarcerated drug users 2002 1,319 52.0 
HBV +HCV Prague  Methadone substitution clients Drop 
in 
2000 – 2002 154 37.7 
Czech 
Republic 
HIV tests of drug users recorded by 
the National Reference Laboratory  
2002 2,270 0.04 
Czech 
Republic 
Incarcerated drug users 2002 674 0.4 
HIV 
Czech 
Republic 
Drug users - low-threshold facility 
clients 
2002 617* 0.1 
Czech 
Republic 
Incarcerated drug users 2002 1,392 9.9 Syphilis 
Czech 
Republic 
Drug users - low-threshold facility 
clients 
2002 176* 2 
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Table 3-22: Drug-related non-fatal emergencies in the Czech Republic, comparison of 2001 and 2002 by individual drugs (Polanecký 
et al.  2003; Polanecký et al.  2002) 
 
3.4.2 Psychiatric Comorbidity 
This issue is dealt with in a special chapter, Comorbidity. 
3.4.3 Other Health Consequences 
The surveys focusing on the health of opiate users before they enter substitution treatment (a sample 
of 101 persons, 77 males and 24 females aged 20 - 47) demonstrated that liver functions were 
affected (increased values of liver enzymes – alanin aminotransferase 35%,  aspartate 
aminotransferase 31%, hepatomegaly 28%, and a fatty liver were found in 15% of the sample), 
effects on the immune system signalling hidden infection (hypernormal IgM 38% and C-reactive 
protein 25% of the sample), and testosterone deficiency among males (63% of the sample) (Wilczek 
et al.  2002). 
The occurrence of life-threatening events, i.e. injuries, poisonings, traffic accidents, violence, and 
suicide attempts was monitored in a sample of 158 males treated in the addiction department of the 
Bohnice Psychiatric Hospital (Nešpor et al.  2003). 57.8% of the patients had experienced a life-
threatening event (73.2% of drug addicts, 52.5%, of alcohol addicts, 50.0% of gamblers). There was 
an average of 2.5 life-threatening events among those who had experienced them. As far as illicit 
drug addicts were concerned, overdoses (51.2%) were the most frequent, followed by a tragic life-
threatening event (31.7%) and suicide attempts (29.3%). Then there followed violence (14.6%) and 
other injuries (7.3%). The life-threatening events may complicate addiction treatment; however, they 
can also have a positive effect because they may facilitate a shift from the pre-contemplation or 
contemplation phase to the phase of taking a decision to change or seek treatment (Nešpor and 
Csémy, 2003). 
See the chapter on Drug-Related  for information about the influence of drugs on traffic accidents, or, 
more accurately, the presence of drugs and their metabolites in the bodies of people who were 
involved in traffic accidents.  
2001 2002 Drug  
abs. % abs. % 
Difference 2002 – 
2001 (%) 
Heroin 285 24.1 176 17.6 -38.2 
Methadone  2 0.2 6 0.6 200.0 
Other opiates  16 1.4 23 2.3 43.8 
Pervitin 163 13.8 191 19.1 17.2 
Ecstasy 15 1.3 4 0.4 -73.3 
Cocaine  4 0.3 2 0.2 -50.0 
Amphetamines and other 
stimulants 
4 0.3 12 1.2 200.0 
Marijuana and hashish 63 5.3 101 10.1 60.3 
Barbiturates 19 1.6 16 1.6 -15.8 
Benzodiazepines 137 11.6 89 8.9 -35.0 
Sedatives, hypnotics 176 14.9 121 12.1 -31.3 
LSD 3 0.3 2 0.2 -33.3 
Psillocybin  15 1.3 7 0.7 -53.3 
Solvents 75 17.8 58 5.8 -22.7 
Datura  4 0.3 0 0 -100.0 
Other drugs and medicaments 182 15.4 179 17.9 +2.5 
Not specified 20 1.7 13 1.3 -35.0 
Total 1183 100 1000 30 -15.5 
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The oral health (dentition and oral cavity) of drug users is worse than that of the general population. 
According to the survey of a sample of 30 Czech drug addicts aged 17 – 40 (Krutina et al.  1998), the 
condition of oral hygiene is at a very low level. The average value of the KPE index (an index relating 
to caries, fillings, and teeth extractions) was 16.2; this is higher by one third than is the case among 
the general population (12.4). The condition of the parodontium did not differ significantly. Only 4.5% 
of the users had healthy gums; 45.5% had dental plaque and 27.3% parodontal pockets. Only 45.5% 
had visited a dentist in the last 12 months, and up to 27.2% only brushed sometimes or never at all. 
The survey of alcohol addicts (Pilinová et al.  2002) demonstrated a similarly low level of oral hygiene 
(KPE 16.31). 
The survey carried out by authors from Brno (Kachlík et al.  2002) dealt with the nutritional habits of 
marijuana smokers. A comparison with the general population showed that the marijuana smokers 
(the sample consisted of 32 males aged 20 – 25, of whom 16% smoke marijuana 3 – 5 times per 
week and 84% every day) have a lower intake of animal proteins and vitamins A and B1, a higher 
intake of linoleic acid, an insufficient intake of cereals, vegetables, fruits and milk products, and an 
excessive intake of sweeteners, fats and oils.  
4 Social and Legal Correlates and Consequences 
4.1 Social Problems 
Drug use, especially long-term and problem drug use, does not only affect the health of the user; due 
to the lifestyle of drug users, it is also connected with problems in the social field. The most frequent 
social consequences or correlations involve complicated or completely discontinued relations with the 
family and the work or school environment; then, it also concerns a low level of educational 
achievement or even incomplete education and the related low level of qualification, unemployment, 
and a poor housing situation that sometimes even leads to homelessness; it is often accompanied by 
criminality and prostitution.  
In certain cases, the cumulative effect of the above-mentioned social problems, together with problem 
drug use, leads to social exclusion. Social exclusion is often supported by negative attitudes on the 
part of society towards a given group of citizens. Drug users have become a marginal group 
(Beranová, 1998). However, social exclusion does not necessarily involve drug users only – it is often 
connected with several ethnic and national minorities.  
4.1.1 Social Problems of Drug Users Demanding Treatment  
The Hygiene Service monitors selected social characteristics of those who make treatment demands. 
The data for 2002 allow for comparisons between first treatment demands and repeated treatment 
demands. More than 7% of the total number of 9,237 treatment demands involved homeless people; 
another 5% live or stay in various facilities (e.g. in a diagnostic or educational institution, therapeutic 
community, prison, or shelter). Among the repeated treatment demands, there is an apparent shift 
towards more problematic housing – they involve a higher number of people living in a facility and 
nearly 10% of homeless people (Table 4-1).  
Table 4-1: Selected social characteristics of treatment demands, (%) (Polanecký et al.  2003)  
Most drug-related first 
treatment demands 
involve unemployed 
people; the rate of 
repeated treatment 
demands is even higher 
(nearly 59%). The high 
unemployment rate is 
often accompanied by a 
Characteristic  All clients First 
treatment 
demand  
Repeated 
treatment 
demands  
Homeless 7.4 5.8 9.1 
Living in a facility  5.3 4.6 6.0 
Unemployed, occasional work  50.4 42.7 58.5 
Incomplete primary education  4.7 6.7 2.5 
Primary education only  47.2 48.3 46.0 
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poor financial situation on the part of the drug users – treatment-demanding users who have been 
unemployed for a long time often do not use the social welfare system (they do not collect 
unemployment benefits or other social benefits). Consequently, the lack of financial resources is 
connected with secondary criminality, drug dealing, or prostitution. Another handicap is the low level 
of education among drug users – 52% of those who made treatment demands only had basic or 
incomplete education.  
4.1.2 Social Problems in Roma Communities 
Since the first half of the 1990s, there have been isolated reports about an increasing problem with 
drug use and drug addiction in Roma communities, especially among Roma youth. Systematic 
research into this issue was not available in the Czech Republic until 2002.  
It seems that the different family and community characteristics and lifestyles within the Roma 
community are also revealed in the field of drug use (e.g. multiple-generation use in families). The 
Roma hardly ever use the services in the field of harm reduction, treatment, and resocialization 
programmes for problem drug users. Substitution treatment programs, namely the programme in Ústí 
nad Labem, are the only exception.  
The “Social Workers Support Programme” was implemented in 81 Roma communities in 2002. At the 
beginning and end of the year, the situation in the communities was monitored with regard to selected 
negative social phenomena – unemployment, truancy, drug use, insufficient hygiene, illiteracy, usury, 
gambling, prostitution, criminality, and low-quality housing. In addition to the occurrence of a given 
phenomenon, the seriousness of the phenomenon in the community was always assessed. The level 
of seriousness33 was evaluated by Roma field workers, who received training for this programme; to a 
certain extent, this evaluation may be distorted by the subjective opinions of the workers.  
By the end of 2002, drugs were prevalent in 74% of the communities monitored (Table 4-2). The outputs of 
the programme showed that more than 85% of communities also face unemployment, truancy, and 
low-quality housing; more than 75% have to deal with gambling, criminality, and insufficient hygiene, 
and more than 60% of communities struggle with illiteracy (Kancelář Rady vlády pro záležitosti 
romské komunity, 2003).  
The analysis confirmed that there is a close correlation between the individual negative phenomena 
monitored, e.g. the occurrence of drugs correlates in a significantly with the occurrence of criminality 
(correlation coefficient = 0.541), prostitution (0.526), gambling (0.485), and truancy (0.437). In the 
communities where drugs are prevalent, criminality is 19 times more frequent, truancy 15 times, 
gambling 10 times, and usury 6 times more frequent. The seriousness of other negative phenomena 
also goes up with the increasing seriousness of one phenomenon.  
                                                           
33 Level of seriousness of the phenomenon: 1 the phenomenon is hardly present, 2 somewhat serious (it only occurs randomly), 3 
serious (it occurs among a group with not too many members), 4 more serious (it occurs among a group with more members), 5 very 
serious (it occurs among more than a half of the group).  
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Table 4-2: Prevalence of drugs and seriousness of the phenomenon at the beginning and end of 2002 (Kancelář Rady vlády pro 
záležitosti romské komunity, 2003)  
Note: No Roma community was monitored in the Vysočina region. 
The situation in the field of drug use in Roma communities was found to be the most serious in the 
Liberec region (the Nový Bor locality), the Moravian-Silesian region (the Bruntál locality) and the Ústí 
nad Labem region (the Duchcov, Terezín, Most, and Chomutov localities). The situation is also 
serious in the Olomouc region (localities in Olomouc, Jeseník, and Prostějov), in the Southern 
Moravian region (two localities in Brno), and the Zlín region (three localities in Vsetín).  
To a great extent, the differences between individual communities may also be associated with 
different Roma ethnicities. However, the monitoring of the situation and the programme 
implementation did not distinguish between the individual Roma ethnicities, even though there were 
marked differences in their lifestyles and other characteristics.  
In Roma communities, marijuana is the most widely reported drug (49.4% of communities), followed 
by toluene (44.4%), pervitin (22.2%), heroin (11.1%), and medicaments (11.1%). Ecstasy, cocaine, 
and hashish were only prevalent in a small number of communities (Kancelář Rady vlády pro 
záležitosti romské komunity, 2003). It is very frequent that several drugs are combined – as the 
number of drugs monitored went up, the field workers assessed the situation in the field of drug use 
as more serious. In comparison with the data from general population surveys or data about treatment 
demands, it is possible to estimate that toluene occupies a more prominent position among drugs in 
Roma communities. 
The Commission for National Minorities keeps an eye on social problems in the Roma community. In 
this group of inhabitants, the most serious issues involve unemployment and associated economic 
and social problems, which result in a failure to send children to school and preferring children to work 
than receive education. In addition, social exclusion of the Roma ethnic group, resulting from an 
accumulation of social problems, is promoted by the negative attitudes of the majority towards the 
Roma, discrimination, and manifestations of racism and xenophobia (Rada vlády pro národnostní 
menšiny, 2002). This accumulation of social problems in Roma communities – their poor social 
                                                           
34 See the note above 
Beginning of 2002 End of 2002 Region Number of 
monitored 
communities  
Total 
number of 
people  
Drug 
prevalence  
(% of 
communities)  
Seriousness 
of the 
phenomenon34 
Drug 
prevalence  
(% of 
communities)  
Seriousness of 
the 
phenomenon 
Capital Prague 2 95 50 2.00 50 2.00 
Central Bohemia 5 589 100 2.80 100 2.40 
Southern 
Bohemia  
1 120 100 2.00 100 1.00 
Pilsen 6 303 67 4.25 50 2.67 
Karlovy Vary 1 15 0 0.00 0 0.00 
Ústí 17 1,305 100 3.29 88 3.07 
Liberec 3 499 100 4.00 100 3.67 
Hradec Králové 6 1,272 67 2.50 67 2.25 
Pardubice 13 672 23 3.00 23 2.33 
Southern Moravia 4 303 100 3.25 100 3.00 
Zlín 6 347 67 2.50 50 3.00 
Olomouc 9 1,136 78 2.57 78 3.00 
Moravian-Silesian 8 2,017 88 3.86 88 3.29 
Total 81 8,673 74 3.17 69 2.88 
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situation, discrimination, and manifestations of racism - contribute to the decision of the Roma to 
migrate abroad (Zhřívalová and Kocourek, 2003).  
The Hvězda association is currently implementing two projects - ”Romský terén” (The Roma 
Outreach) and ”Baterie” (Battery); they focus on monitoring the scale and modes of drug use in Roma 
communities and the assessment of service availability to the Roma (Svobodová, 2003).  
4.2 Drug Offences and Drug-Related Crime 
4.2.1 Drug-Related Criminal Offences According to the Data of the Police of the Czech Republic 
The Police of the Czech Republic detected 372,341 criminal offences in 2002, for which 123,964 
offenders were prosecuted (Policejní Prezidium ČR, 2003).  
This number includes 4,330 drug-related criminal offences (i.e. criminal offences according to the 
provision of Section 187 to Section 188a of the Penal Code35); 2,204 offenders were prosecuted36 for 
these criminal offences. There were 122 children among these cases (in these instances, the cases 
are suspended due to their underage status), 329 (15%) juveniles (aged 15 to 18), and 633 (29%) 
habitual offenders.  
There is still a relatively high clear-up rate for drug-related criminal offences (i.e. the number of 
detected criminal offences where the offender was found) – in 2002, it ranged from 90.2% (Section 
187a of the Penal Code) to 95.4% (Section 188 of the Penal Code); the mean clear-up rate of all 
criminal offences was 40.7%. This difference especially follows from the nature of drug-related 
criminal offences – in most cases, the offender is already known (or suspected) when the offence is 
detected.  
Due to the shift in police statistics regarding the reporting of criminal offences that was described in 
the Annual Report on Drug Situation 2001 - Czech Republic (Zábranský et al.  2002), only the data 
reported by the police since 2000 have been relevant for monitoring the trends in detected criminal 
offences (Table 4-3, Figure 4-1). It is possible to use data from previous periods for a comparison of 
the number of persons prosecuted (Table 4-4, Figure 4-2). The number of detected drug-related 
criminal offences has been relatively stable in the last three years, but the number of offenders 
prosecuted keeps increasing every year. There was a relatively significant increase in the number of 
criminal offences detected and persons prosecuted for criminal offences of the unauthorised 
production and possession of narcotic and psychotropic substances and poisons, according to 
Section 187 and Section 188; on the contrary, a decline in both indicators was reported for criminal 
offences of the promotion of drug addiction, according to Section 188a. 
 Table 4-3: Number of detected drug-related criminal offences, according to data of the Police Presidium of the Czech Republic  
                                                           
35 The Sections 187, 187a and 188 of the Criminal Code - Unauthorised Production and Possession of Narcotic and Psychotropic 
Substances - involve different forms of unauthorised handling of narcotic drugs and psychotropic substances and precursors (and poisons): 
Section 187 of the Criminal Code involves unauthorized production, import, export, transit, offering, mediation, sale or another manner of 
provision of a drug for another person and possession of a drug for another person;  
Section 187a of the Criminal Code involves unauthorized possession for personal use of a drug in a quantity “greater than small”; 
Section 188 of the Criminal Code involves production, provision and possession of tools intended for unauthorized production of drugs.  
Section 188a of the Criminal Code - Promotion of Drug Addiction - involves temptation, support, stimulation or promotion of drug abuse. 
36 In criminal statistics, the term “prosecution” is also used in cases where the persons were not formally accused (e.g. offences 
committed by children) – it involves persons that are suspected and investigated in connection with drug law offences.  
Year Section 
187 
Section 
187a 
Section 
188 
Section 
188a 
Total 
2000 3,292 212 122 832 4,458 
2001 3,198 241 157 613 4,209 
2002 3,359 285 216 470 4,330 
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Table 4-4: Number of persons prosecuted, according to the data of the Police Presidium of the Czech Republic  
 
Figure 4-1: Development in the number of drug-related criminal offences detected by the Police of the Czech Republic  
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Figure 4-2: Development in the number of people prosecuted by the Police of the Czech Republic for drug-related criminal offences  
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 Year Section 
187 
Section 
187a 
Section 
188 
Section 
188a 
Total 
1996 827 0 20 126 973 
1997 887 0 45 131 1,063 
1998 1,075 0 49 231 1,355 
1999 1,436 98 42 177 1,753 
2000 1,412 139 78 186 1,815 
2001 1,525 166 80 181 1,952 
2002 1,757 178 120 149 2,204 
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At the same time, it was the first time that the National Drug Squad provided data about prosecuted 
persons accused of the criminal offences of the unauthorized production and possession of narcotic 
and psychotropic substances and poisons, according to Section 187, Section 187a, and Section 188 
(2,000 persons, according to the data of the National Drug Squad) that were divided by the type of the 
drug that was involved in the given case - see Table 4-5. In those cases where more types of narcotic 
and psychotropic substances were seized, the offender is always reported only once, namely by the 
type of the narcotic and psychotropic substances of which he/she possessed the most.  
Table 4-5: Persons accused in 2002 by the type of the drug (NPC, 2003) 
 
4.2.1.1 Share of Juveniles in 
Drug-Related Criminal Activities  
Drug-related criminal activities 
have remained the field with the 
highest involvement of underage 
offenders. Juveniles represented 
6.2% of the 123,964 offenders 
involved in all solved criminal 
offences, while they were involved 
in 14.9% of drug-related criminal 
offences.  
According to the data reported by the police (Ministerstvo vnitra ČR, 2003b), the number of juvenile 
drug offenders increased by nearly 50% in 2002 (from 221 in 2001 to 329 in 2002) while the share of 
these offenders in all criminal offences in general decreased by 17% (to 7,698 persons). This increase 
was the most apparent in criminal offences prosecuted according to the provision of Sections 187 and 
Section 187a respectively. 
4.2.1.2 Regional Differences 
As expected, the highest number of criminal offences – including drug-related criminal offences – was 
recorded in Prague. 1,762 drug-related criminal offences were detected in 2002; this represents at 
least 40% of all drug-related criminal activities in the Czech Republic. As far as other regions are 
concerned, Southern Moravia, Central Bohemia, the Moravian-Silesian and Ústí regions were those 
most affected; the Pardubice region was the least affected (Table 4-6). Regional statistics of the share 
of drug-related criminal activities in all detected crimes are more balanced. The share ranges from 
0.55% in the Pardubice region to 1.71% in Prague; the mean value for the whole Czech Republic is 
1.16% (Table 4-6, Map 4-1).  
Drug type Trafficking, 
production 
(Sections 
187, 188) 
Possession 
for personal 
use (Section 
187a) 
Total Share 
(%) 
Marijuana and 
hashish 
665 83 748 37.4  
Heroin 141 16 157 7.9  
Cocaine  9 1 10 0.5  
Amphetamines  707 74 781 39.1  
Ecstasy 120 20 140 7.0  
LSD 3 1 4 0.2  
Other drugs 146 14 160 8.0  
Total 1,791 209 2,000 100.0  
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Table 4-6: Drug-related criminal offences detected by the Police of the Czech Republic by regions  
Region Criminal offences  
Drug-related 
criminal 
offences 
Share (%) 
Drug-related 
criminal offences 
per 100,000 
inhabitants  
Capital Prague 102,873 1,762 1.71 152 
Central Bohemia 42,149 390 0.93 35 
Southern Bohemia  16,304 146 0.90 23 
Pilsen 16,076 155 0.96 28 
Karlovy Vary 11,154 116 1.04 38 
Ústí 31,492 299 0.95 36 
Liberec 16,422 158 0.96 37 
Hradec Králové 13,345 107 0.80 20 
Pardubice 11,285 62 0.55 12 
Vysočina 8,971 97 1.08 19 
Southern Moravia 35,496 396 1.12 35 
Olomouc 16,535 118 0.71 19 
Zlín 12,507 163 1.30 27 
Moravian-Silesian 37,732 361 0.96 29 
Czech Republic  372,341 4,330 1.16 42 
 
Map 4-1: Drug-related criminal offences by regions according to the Police of the Czech Republic 
 
 
4.2.2 Drug-Related Criminal Offences According to the Data of Public Prosecutors’ Offices and 
Courts  
Public Prosecutors’ Offices made 77,210 formal accusations in the Czech Republic in 2002; 2,247 
thereof were aimed at the offenders of drug-related criminal activities, who committed 3,664 drug-
related criminal offences (Ministerstvo spravedlnosti ČR, 2003). With effect from January 1, 2002, the 
so-called shortened proceedings were introduced within the framework of the amendment of the 
Code of Criminal Procedure (see the chapter on Legal Frameworkfor more information); it makes 
possible faster proceedings in cases of prosecution of the least serious forms of criminality.  
17,422 cases were settled by means of shortened proceedings; a proposal for penalization was put 
forward in 16,671 of these. 10 drug-related criminal offences were dealt with and 7 proposals for 
penalization were put forward.  
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The number of persons convicted for all criminal offences increased from 60,182 in 2001 to 65,098 in 
2002 (this was the highest number since 1988). 1,216 offenders of drug-related criminal offences 
were convicted by courts. Suspended sentences prevailed; in particular, unsuspended sentences 
were often awarded to the offenders according to the provision of Section 187 of the Penal Code. 
The number of offenders of drug-related criminal offences accused and convicted continued to 
increase slightly in 2002 (Table 4-7, Table 4-8, Figure 4-3 and Figure 4-4). There has been a long-
term increase in the number of persons accused and convicted for the criminal offence of 
unauthorized production of narcotic and psychotropic substances and poisons, according to the 
provision of Section 187 of the Penal Code. More people were convicted and fewer people were 
accused in 2002 than in 2001 for the unauthorized possession of narcotic and psychotropic 
substances for personal use (the provision of Section 187a of the Penal Code). 
Table 4-7: Persons accused for drug-related criminal offences in 1996 – 2002 
Table 4-8: Convicted offenders of drug-related criminal offences in 1996 - 2002 
Year  Section 
187 
Section 
187a 
Section 
188 
Section 
188a 
Total 
1996 608 0 165 183 956 
1997 789 0 140 223 1,152 
1998 1,029 0 159 342 1,530 
1999 1,102 115 119 429 1,765 
2000 1,276 158 190 419 2,043 
2001 1,418 215 195 332 2,160 
2002 1,444 206 223 374 2,247 
 Year Section 
187 
Section 
187a 
Section 
188 
Section 
188a 
Total 
1996 283 0 27 24 334 
1997 357 0 32 30 419 
1998 702 0 55 45 802 
1999 765 26 38 70 899 
2000 819 92 29 61 1,001 
2001 905 86 62 41 1,094 
2002 1,007 103 58 48 1,216 
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Figure 4-3: Development in the number of persons accused by Public Prosecutors’ Offices of drug-related criminal offences  
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Figure 4-4: Development in the number of persons convicted of drug-related criminal offences  
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There is a time shift in the reporting of individual cases by these institutions and so it is not possible to 
compare data about the number of those accused and those convicted in a given year. A case is 
entered in the statistics of Public Prosecutors’ Offices at the moment when a judgment on the merits 
of the case is passed (formal accusation, discontinuance of prosecution et al.) while it is only entered 
in court statistics at the moment when the final, legal decision is taken.  
Therefore, it is only possible to compare the mentioned data from different stages of criminal 
proceedings on the basis of long-term monitoring. It is logical that the numbers of persons recorded 
by the mentioned institutions should decrease at the individual stages of the criminal proceedings. 
This also corresponds with the comparison of the total number of offenders prosecuted in 2002, 
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according to the Police of the Czech Republic (123,964 persons), with the data on all accused 
(77,210 persons) and convicted persons (65,098).  
However, the above-mentioned assumption does not hold true when comparing the aforementioned 
indicators of drug-related criminal offences. For the period between 1996 and 2000, the Police of the 
Czech Republic reported fewer offenders of drug-related criminal offences than the Public 
Prosecutors’ Offices accused - see Table 4-9. At the same time, the differences caused by the time 
shift in the implementation and recording of individual cases should be eliminated over a period of 
seven years. It is likely that this distortion is largely caused by inconsistencies in the completion of 
statistical reports. 
Apart from exceptions, the curve of the number of those convicted adequately reflects the changes in 
the numbers of those accused. The cases prosecuted according to the provision of Section 187 of the 
Penal Code (63%) represent the highest percentage of cases leading to convictions between 1996 
and 2002; the cases prosecuted according to Section 188a brought about the lowest number of 
“successful” accusations (14%). Less than a half of the cases for which charges were brought in the 
given period ended up in a legal decision (see Table 4-9, Figure 4-5 to Figure 4-8).   
Table 4-9: Ratio between prosecuted, accused, and convicted offenders of drug-related criminal offences in 1996 – 2002 (summary)  
Figure 4-5: Development in the number of prosecuted, accused, and convicted offenders of drug-related criminal offences in 1996 -
2002, Section 187 
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 Section Prosecuted 
(Police of the 
Czech Republic) 
Accused Sentenced  Accused/ 
prosecuted (%) 
Sentenced/ 
accused (%) 
Section 
187 
8,919 7,666 4,838 86.0  63.1  
Section 
187a 
581 694 307 119.4  44.2  
Section 
188 
434 1,191 301 274.4  25.3  
Section 
188a 
1,181 2,302 319 194.9  13.9  
Total 11,115 11,853 5,765 106.6   48.6  
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Figure 4-6: Development in the number of prosecuted, accused, and convicted offenders of drug-related criminal offences in 1996 -
2002, Section 187a 
Comparision of the number of persons prosecuted, accused 
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Figure 4-7: Development in the number of prosecuted, accused, and convicted offenders of drug-related criminal offences in 1996 -
2002, Section 188 
Comparision of the number of persons prosecuted, accused 
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Figure 4-8: Development in the number of prosecuted, accused, and convicted offenders of drug-related criminal offences in 1996 -
2002, Section 188a 
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The share of the number of persons investigated for drug-related criminal offences and convicted has 
been growing in the last two years; this may be explained by the growing effectiveness of preliminary 
proceedings and the acceleration of the work of Public Prosecutors’ Offices and courts after the 
amendment to the Code of Criminal Procedure - see Table 4-10. 
Table 4-10: Relationship between accused and convicted offenders of drug-related criminal offences in 1996 – 2002 
 
4.2.3 Incarcerated Offenders of Drug-
related criminal Offences 
There was a marked decrease in the number 
of persons incarcerated in 2002; this involves 
both the number of the accused in custody 
(year-on-year decrease of 26%) and the 
number of prisoners who are undergoing 
punishment (decrease of 12.9%). 16,213 persons were in prison in the Czech Republic by the end of 
2002; this is 3,107 persons less than at the end of 2001 (see Table 4-11). This trend is even more 
prominent in the statistics that record the number of all admissions to custody and admissions to 
execution of sentence in the given year. There was a decrease of more than 30% (admission to 
custody) and 20% (admission to execution of sentence) (Generální ředitelství Vězeňské služby ČR, 
2003b). 
This significant decrease in the number of persons sentenced to custody was undoubtedly influenced 
by the amendment to the Code of Criminal Procedure that changed the conditions for the imposition 
of custody and terms of custody (see the chapter on Legal Framework). This trend can also be partly 
explained by an increase in the use of diversions of criminal proceedings and alternative sentences 
(see the chapter on Alternatives to Prison for Drug Dependent Offenders). 
In 2002, the trend of the proportion of persons incarcerated for drug-related criminal offences in the 
total prison population to increase continued. This finding also corresponds with the increase in drug-
related criminal offences; this number increased from 885 in 2001 to 965 in 2002 (Table 4-11). 
Therefore, the number of drug-related criminal offences per person serving a sentence for a drug-
related criminal offence increased from 1.4 to 1.6 criminal offences.  
Year Accused Convicted  Share (%) 
1996 956 334 34.8 
1997 1,152 419 36.3 
1998 1,530 802 52.4 
1999 1,765 899 50.9 
2000 2,043 1,001 49.0 
2001 2,160 1,094 50.7 
2002 2,247 1,216 54.1 
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Table 4-11: Development in the number of persons prosecuted and convicted for drug-related criminal offences in 1996 – 2002 
(Generální ředitelství Vězeňské služby ČR, 2003b) 
 
4.2.4 Drug-Related Administrative Offences 
The provision of Section 30 of Act 200/1990 Coll. On Administrative Offences regulates administrative 
offences in the field of protection against alcoholism and other drug addictions. Summary data about 
the number of administrative offences committed, or, more accurately, reported to the police, are only 
available for those according to Section 30 article 1 letter j) of this Act, i.e. the unauthorized 
possession of narcotic and psychotropic substances for personal use in a small quantity.37  
The Police of the Czech Republic recorded 761 such administrative offences in 2002 (Ministerstvo 
vnitra ČR, 2003a). This number is stable in comparison with the previous years (Table 4-12). Two 
cases thereof were settled by a reprimand, 16 by a fixed penalty (ticket), and 406 complaints were 
dealt with in administrative proceedings; 279 of these ended in the suspension or discontinuance of 
the case or its submission to another body. 14 were placed in the hands of the bodies responsible for 
criminal proceedings because of facts that indicated the commission of a criminal offence according to 
the provision of Section 187a of the Penal Code, i.e. the possession of drugs in a greater than small 
quantity. Statutory penalties amounting to CZK 605,400 (€ 19,160) were imposed for the commission 
of these administrative offences.  
Table 4-12: Administrative offences of the unauthorized possession of narcotic and psychotropic substances in a small quantity for 
personal use (Ministerstvo vnitra ČR, 2003a) 
 
4.2.5 Secondary Drug-Related Crime  
Criminal offences related to drug use or unauthorized trafficking in drugs are not recorded at the 
central or regional level at all (this, for instance, involves property crime committed in order to procure 
the means to obtain drugs, violent and endangering criminal offences under the influence of drugs, 
the laundering of profits from drug-related crime, corruption, and the like).  
One of the tasks that were assigned to the Minister of the Interior by means of Government 
Resolution No. 549/2003 on the basis of the outputs of the Project Phare Twinning 2000 
“Strengthening National Drug Policy” (Sekretariát Rady vlády pro koordinaci protidrogové politiky,  
2003) was to implement a system of monitoring of secondary drug-related criminality. In this 
connection, the Police of the Czech Republic are collaborating with the Czech National Focal Point on 
                                                           
37 The law does not specify this attribute; police bodies use the instruction of the Supreme Prosecutor 6/2000 for determination of the 
quantity of narcotic and psychotropic substances; they also use it for cases of a criminal offence according to Section 187a of the 
Criminal Code.  
Year (as at December 31) 1996 1997 1998 1999 2000 2001 2002 
Number of persons undergoing 
punishment  
12,973 13,824 14,942 16,126 15,571 14,737 12,829 
Number of persons in custody  7,887 7,736 7,125 6,934 5,967 4,583 3,384 
Total in prisons 20,860 21,560 22,067 23,060 21,538 19,320 16,213 
Persons undergoing punishment 
for drug-related criminal offences 
176 212 505 502 543 652 615 
Share in the number of persons 
undergoing punishment (%) 
1.4 1.5 3.4 3.1 3.5 4.4 4.8 
Drug-related criminal offences of 
persons undergoing punishment  
182 208 505 542 766 885 965 
Year 2000 2001 2002 
Administrative 
offences  
762 804 761 
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the preparation of a pilot project that will focus on the monitoring of secondary drug-related criminality 
in several police teams in different regions; this pilot project will start in 2004.  
4.3 Social and Economic Costs of Drug Consumption  
Social costs involve an economic expression of the burden that society has to bear in connection with 
drug use. In the field of drugs, the methodology of these surveys was defined by the American NIDA38 
at the end of the 1960s (Rice, 1967) and it was internationally standardized under the supervision of 
the CCSA39 at the turn of the millennium (Single et al.  2001; Single et al.  1996). Social costs are 
currently considered as the most general expression of the burden arising from drug use; when 
related to national product, they are increasingly often used as an indicator that allows for comparison 
between individual states. Surveys of this type use the following operational definition of drug use: 
”drug use that involves any other costs than the costs of the actual procurement of the drug” (Single et 
al.  2001). Therefore, it does not involve the money that the user will “spend on his/her drug” – i.e. the 
actual price of the drug; other than that, it includes all the costs to the user and to society (such as 
treatment costs, costs of prosecution, prevention costs etc.). The concept of the so-called “contra-
scenario” may also provide a different explanation: the surveys of social costs examine the current 
condition against a hypothetical condition in which drugs did not exist at all.  
A social costs study was carried out in the Czech Republic in 1999 - 2000 within the framework of the 
PAD project (Zábranský et al.  2001b). The actual procedure for obtaining an estimate of Czech social 
costs is dealt with in detail in an extensive article published in the professional press (Zábranský et al.  
2001a); we only provide a summary of the main results here.  
Figure 4-9: Direct social costs of drug abuse in the Czech Republic in 1998 – CZK 2.3 billion (€ 73 million) (Zábranský et al.  2001a) 
13%
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správy)
 
The social costs of the abuse of illicit (street) drugs reached CZK 2.8 billion (€ 89 million) in the Czech 
Republic in 1998. This represents 0.2% of the gross national product; surveys that have been 
conducted around the world have arrived at approximately the same value (with the exception of the 
United States of America, where the costs of the “war on drugs” are continually extremely high) 
(Single, 1996). 
                                                           
38 National Institute for Drugs Abuse - NIDA 
39 Canadian Centre on Substance Abuse – CCSA 
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Law enforcement agencies40 consume the highest share of the direct social costs (i.e. “physically 
expended money taken out of the budget or pocket”; lost productivity is not included)  – in 1998, it was 
82% of the total direct costs of CZK 2.3 billion (€ 73 million). 
As far as indirect costs (which involve lost productivity, i.e. the social production that would 
hypothetically occur if illicit drugs did not exist at all) are concerned, lost productivity due to criminal 
careers would represent the biggest burden on society – 61% of the total CZK 0.5 billion (€ 16 million) 
of lost productivity. 
Figure 4-10: Indirect social costs of drug abuse (lost productivity) in the Czech Republic in 1998 – CZK 0.5 billion (€ 16 million) 
(Zábranský et al.  2001a) 
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Figure 4-11 provides a general picture; it combines direct and indirect social costs into one graph.  
Figure 4-11: Summary proportion graph of social costs of drug abuse in the Czech Republic in 1998 (CZK 2.8 billion) (€ 89 million) 
(Zábranský et al.  2001a) 
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Loses caused by drug-related property crime were estimated to approximately CZK 1.9 billion (€  
60 million) in 1998. 
                                                           
40 This includes the work of the Police of the Czech Republic, the judicial system, including Public Prosecutors’ Offices, and the 
prison system (i.e. for the carrying out of custody and punishment). 
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5 Drug Markets 
5.1 Drug Availability and Drug Supply 
Drug supply in 2001, the most recent year for which data are available, showed an upward trend in 
comparison with the previous period; 27% of adults were offered drugs. This mostly involves 
marijuana, which was offered to 25% of the population in 2002; hard drugs were offered to 12% of the 
population. 
It follows from local data that 80% of problem users have a direct contact to a producer or a dealer 
who is directly connected with the producer. Travelling to large centres in order to purchase drugs is 
common for drugs that are not available locally (heroin, ecstasy, or LSD) or in the cases of temporary 
shortages of pervitin.  
Domestic drug sources and the production of drugs in the Czech Republic (pervitin, marijuana) have 
also increasingly started to appear outside large centres. The distribution of drugs to users (on the 
street) takes place in smaller quantities, with the aim of minimizing the penalty in the case of arrest. 
Cannabinoids represent the most commonly trafficked drug in the Czech Republic. Postal 
transportation is the most common route for drug trafficking, according to the number of seizures. Bus 
transportation has started to be used increasingly often, especially for imports of cannabinoids and 
ecstasy from the Netherlands. The southern part of the Balkan route is increasingly often used for 
heroin imports; the Kosovo Albanian community dominates the heroin trafficking. The quantities of 
cocaine imported to the Czech market are still relatively low. Pervitin predominates among drugs 
produced in the Czech Republic and exported to neighbouring countries, especially Germany.  
5.1.1 Drug Availability and Supply in the General Population 
There is a general upward trend in drug supply in the Czech population (Centrum pro výzkum 
veřejného mínění, 2001) - see Table 5-1. 
Table 5-1: Drug supply in the population aged 15 or more (%) (Centrum pro výzkum veřejného mínění, 2001) 
Note: The answers “I don’t know” complete the 100% calculation in the columns   
A steady increase in the share of the Czech population that had ever been offered a drug was 
recorded between 1994 and 1996. Since then, the results have remained stable at around 20%. The 
number of respondents who have ever been offered a drug increased markedly, to as much as 27% 
of the respondents in 2001.  
The 2001 data show marked sociodemographic differences by age; the older the respondents are, 
the fewer report ever having been offered a drug - see Table 5-2. 
Table 5-2: Drug supply in the population aged 15 and over by age (%), (Centrum pro výzkum veřejného mínění, 2001) 
Note: Line percentage, the answers “I don’t know” complete the 100% calculation in the columns.  
As far as the respondents surveyed in 2001 who had been offered a drug are concerned (n=267), 
69% of these cases involved marijuana, 6% pervitin, and 3% LSD and alcohol respectively. 10% of 
Offered drug  1994 1996 1997 1998 1999 2000 2001 
Yes  19  23  23  22 21 20 27 
No  81  76  76 77 78 79 72 
Age category A drug has 
been 
offered  
Never offered  
15 - 19  65 33 
20 - 29  48  51  
30 - 44  24  74 
45 - 59  18 81  
60 and more   5 94 
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the respondents did not know the name of the drug. The figures for the other drugs mentioned were 
very low.  
Marijuana has been offered to 25% of the adult Czech population, and 12% of the population have 
been offered hard drugs (heroin, pervitin, cocaine) according to the 2002 Public Opinion Poll Centre 
report (Centrum pro výzkum veřejného mínění, 2002). Similar data from previous years are not 
available.  
5.1.2 Local Drug Markets in the Pardubice Region 
A survey, “Assessment of the Drug Situation in the Pardubice Region” (Minařík and Zahradník, 2003), 
was carried out using the Rapid Assessment methodology (Stimson et al., 1998) in the second half of 
2002. 36 injecting drug users were surveyed; 94% of them reported pervitin as their main drug; heroin 
is rarely used in the Pardubice region. Therefore, the following data mostly involve pervitin sources.  
5.1.2.1 Drug Sources in the Region  
The survey demonstrates the high and easy availability of pervitin in the region. A relatively high 
number of small producers operate in this area and there are relatively few middlemen in the cascade 
of dealers. 64% of participants mention that they have a direct contact with a producer, or they have a 
contact with a dealer who is directly connected to a producer (19%). 19% of participants have 
experience of pervitin production, frequently for personal use. The participants agree that pervitin 
quality has remained stable and high and that prices have also remained stable. 
The availability of heroin in the drug scene in the Pardubice region is only limited; it is rather available 
on request from localities with its high availability (Prague, Northern Bohemia). Users in the Pardubice 
region do not show much interest in heroin. One of the explanations is based on the easy availability 
of relatively high-quality pervitin. Only approximately a quarter of drug users report that they have tried 
heroin.  
As far as other secondary drugs are concerned, ecstasy use is common. Drug sources are usually 
located outside the region. Ecstasy use is mostly recreational.  
It is characteristic of the region that natural sources of drugs are used (opium, magic mushrooms, and 
sporadically datura).  
5.1.2.2 Drug Sources outside the Region 
Most of the participants have some experience of travelling for the purpose of purchasing drugs. They 
buy both the primary drug (pervitin) and the secondary drugs (heroin and other opiates, ecstasy, 
cannabinoids, and LSD). Most of the users have steady sources; purchasing from a stranger on the 
street is rather rare.  
Only approximately 23% of the participants deny that they travel to obtain drugs. These users usually 
have several stable sources of a quality drug directly in the place where they live. At least one of 
these sources is usually a direct producer or a middleman directly connected to the producer. 39% of 
participants report that they seldom or sometimes travel for drugs. 39% of participants travel to drug 
sources often or regularly. A desire to try a drug other than pervitin is very often the reason for 
travelling. Prague is the most frequent destination – more than 2/3 of participants – and Hradec 
Králové – more than a half of participants. Drug purchases outside the republic were entirely 
exceptional (Poland – this involved the purchasing of precursors for drug production and the 
purchasing of amphetamines). 
5.1.3 Drug Markets and Drug Availability in the Czech Republic – Law Enforcement Branches 
5.1.3.1 Drug Market in the Czech Republic 
According to the Annual Report, Illicit Drugs Situation in CR in 2002 of the National Drug Squad of the 
Police of the Czech Republic, drugs have started to appear in smaller towns and municipalities of the 
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Czech Republic more frequently (Národní protidrogová centrála Policie ČR, 2003); at the same time, 
manufactories of narcotic and psychotropic substances have been dislocated to small municipalities. 
Drug dealers and the drug market as a whole respond to changes in the law; minimum quantities of 
drugs are possessed and juvenile distributors are employed. In comparison with previous periods, 
dealers do not purchase large quantities of drugs; they rather purchase 10 to 50 grams as often as 
several times per day. This eliminates the risk of the seizure of a large quantity of a drug they have on 
them.  
According to the report, the share of drug addicts in property crimes (thefts in supermarkets, car 
burglary, thefts of mobile phones etc.) is increasing; detailed quantitative data about this field are not 
available. 
The first cases of hydroponic cannabis growing on a large scale in remote localities and abandoned 
buildings were recorded in 2002 (see, for instance, (Doležal, 2002). 
5.1.3.2 Export of Narcotic and Psychotropic Substances from the Czech Republic 
According to the Annual Report Illicit Drugs Situation in CR in 2002 (Národní protidrogová centrála 
Policie ČR, 2003), the export of pervitin to neighbouring countries, especially Germany, has continued 
to increase. It is exported in quantities that can be measured in kilograms. Pervitin is sold under the 
name Crystal in Germany; its street purity ranges from 60 to 70%, and the price is €30 to €80 per 
gram. Both German and Czech citizens organize the export of pervitin; there have been some reports 
that efforts are being made to build laboratories for the production of this substance in Germany.  
No export of considerable quantities of other narcotic and psychotropic substances from the Czech 
Republic was recorded.  
5.1.3.3 Transit and Import of Narcotic and Psychotropic Substances to the Czech Republic 
The southern part of the Balkan route is used for the transit of heroin from Near East areas, namely 
by sea or via Bulgaria, Greece, Macedonia, Kosovo, and Albania, according to the 2002 Annual 
Report of the National Drug Squad (Národní protidrogová centrála Policie ČR, 2003). Bulgaria also 
plays an important role as a reloading area.  
The Kosovo Albanian community has retained a dominant position in the heroin trafficking in the 
Czech Republic; however, it is increasingly interconnected with citizens of Bulgaria, Croatia, Bosnia 
and Herzegovina, and Albania; this is directly connected with the commonly-used courier routes. The 
Kosovo Albanian groups are joined on the domestic scene by Arabs, Roma, and Vietnamese. Poles 
and Czechs are increasingly mingling with these criminal structures; in these cases, the transportation 
of narcotic and psychotropic substances is masked by legal trade with a connection to Turkey.  
Shipments of heroin have gone down in size to 1 – 3 kilograms (against their previous size of several 
dozen kilograms). 
Cocaine availability has not changed considerably. This drug is not very common in the Czech 
Republic (see the chapters on Problem Drug Use and Drug Treatment Demand). As far as the illicit 
trafficking in cocaine is concerned, the main trend observed in the period monitored was based on 
larger quantities of smaller consignments from South America. This means a decrease in the 
quantities of one-off consignments of cocaine and an increase in the total number of consignments. It 
is a trend in the whole of Europe.  
According to the report of the National Drug Squad, imports and sales of hashish by Arab dealers 
have declined. Hashish was practically the only drug imported to the Czech Republic from Arabian 
countries. It is estimated that several kilograms of hashish per month were imported and that, aside 
from exceptions, they were destined for use in the Arab community. The decrease in (Moroccan) 
hashish was caused by the cancellation of the only direct air line of the Air Algeria company that used 
to fly to Prague once a week. Until then, hashish was shipped from Morocco to Algiers and then to 
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Prague. However, the cooperation of the National Drug Squad with the General Customs 
Headquarters did not lead to tip-offs about and seizures of drug consignments destined for the Czech 
market. Persons from Arabian countries started to employ intermediaries and import hashish from 
Spain and the Netherlands. Customs bodies seized 3.8 kg of hashish, 2.6 kg of which were from 
Spain; a part of the consignment usually stays in the Czech Republic, and a part travels to Poland and 
then to the north to the Scandinavian countries. 
The report of the National Drug Squad does not contain information about the importation and 
manner of distribution of cannabinoids for domestic consumption outside the Arab community.  
According to the 2002 Annual Report of the Drug Unit of the Department of Investigation of the 
General Customs Headquarters, the situation regarding drug trafficking has remained stable 
(Generální ředitelství cel Ministerstva financí ČR, 2003).  
As was the case in the past, marijuana and hashish are the most frequently smuggled drugs. In most 
cases, the drugs are shipped to the Czech Republic via airmail. In comparison with the previous 
period, there was an increase in the number of drug seizures from bus passengers, especially from 
Spain and the Netherlands. In 2002, this involved 57 cases; 48 of these involved bus lines from the 
Netherlands.  
As far as regular bus services are concerned, the number of hashish seizures increased (in 2001, 18 
g were seized in 4 cases, and in 2002, there were 24 cases and 2,671 g of hashish were seized) and 
marijuana  (in 2001, there were 14 cases and 645 g were seized, and in 2002, there were 43 cases 
and 3,248 g of this drug was seized).  
Buses from the Netherlands were also often used for imports of ecstasy in 2002.  
There is an apparent trend away from using postal transportation for shipments of narcotic and 
psychotropic substances – the number of seizures of narcotic and psychotropic substances in the 
post decreased from slightly over 70% in 2000 and 2001 to 58% of cases in 2002.  
5.1.4 Consumption of Drugs 
Estimating the total drug consumption in the Czech Republic follows from an estimation of the number 
of users of individual drugs and their average annual consumption; the most recent published 
estimate involves the year 2000 - see Table 5-3 (Vopravil, 2001).  
Table 5-3: Estimated annual consumption of drugs in the Czech Republic in 2000 (Vopravil, 2001) 
Note: 840,000 ecstasy tablets were consumed in the Czech Republic in 2002, according to a preliminary estimate of the Czech 
Statistical Institute for the year 2003. 
The 2000 data basically correspond with the current situation; ecstasy is the only exception – the 
preliminary estimate of yearly consumption of ecstasy, made by the Czech Statistical Institute 
(Vopravil, personal communication, 2003), has nearly tripled in 2002. 
Drug  
Number of 
consumers  
Average 
consumption 
(year/person) 
Consumption in 
the Czech 
Republic 
Cannabis (g) 250,000 100 25,000,000 
Ecstasy (tablets) 5,820 50 291,000 
Pervitin (g) 22,500 180 4,050,000 
Heroin (g) 15,000 360 5,400,000 
LSD/hallucinogens (pc) 6,540 12 78,480 
Cocaine (g) 1,860 30 55,800 
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5.2 Drug Seizures 
The National Drug Squad of the Police of the Czech Republic and the General Customs 
Headquarters of the Ministry of Finance record data about drug seizures in the Czech Republic at the 
central level.  
Both of these statistics overlap with one another. This is especially caused by the fact that police and 
customs branches carry out some operations together but they use different criteria for recording joint 
seizures. There is another factor that complicates the possibility of obtaining accurate data about the 
total number and volume of drug seizures – the fact that nearly all cases of the detection of illicitly 
possessed and transported drugs implemented by customs branches immediately become subject to 
criminal proceedings and they are also recorded by individual police branches. It is extremely 
complicated to eliminate these overlaps, especially when they are not eliminated continuously but only 
during the final preparation of annual statistics.  
The start of the operations of the Common Analytical Workstation of the National Drug Squad and the 
General Customs Headquarters should lead to the establishment of uniform, or at least better 
interconnected, recording of seizures of narcotic and psychotropic substances in the following years. 
This will make the data concerning the total volume of seized drugs more accurate.  
5.2.1 Seizures Implemented by the General Customs Headquarters 
The General Customs Headquarters records the operations of customs bodies in which drugs were 
seized and it uses a relatively reliable and, in the long term, uniform electronic system.  
Customs bodies reported 313 cases in which 74 kg of narcotic and psychotropic substances and 
precursors were seized in 2002. Inter alia, 6,154 tablets of ecstasy (see Table 5-4, recalculated to 
grams), 27.5 kg of heroin, 4.5 kg of cocaine, 17.9 kg of marijuana, 3.8 kg of hashish, 0.9 kg of pervitin, 
and 16.3 kg of ephedrine were seized in these operations (Generální ředitelství cel Ministerstva 
financí ČR, 2003).  
The total amount of narcotic and psychotropic substances and precursors seized decreased by two 
thirds (by approximately 156 kg) in comparison with 2001; this represented the lowest volume of 
drugs seized since 1995 – see Table 5-4. The highest decrease was reported for seizures of pervitin 
and amphetamines; this also involved ecstasy (however, the seizure of 78,000 ecstasy tablets that 
was carried out during a joint operation of the Police of the Czech Republic and the General Customs 
Headquarters was not included - this seizure is only reported in the police statistics). The highest 
seizures involved a seizure of 27 kg of heroin transported to the Czech Republic from Turkey, via 
Greece, Italy and Austria. Seizures of small quantities of heroin were involved in other cases; 
therefore, the total quantity of heroin seized was the lowest in the last five years. There was an 
increase in the quantity of hashish seized (by more than a third) and marijuana (more than three 
times) in comparison with 2001; at the same time, there was an increase in cocaine and ephedrine 
seizures.  
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Table 5-4: Seizures of narcotic and psychotropic substances and precursors implemented by customs branches in 1996 - 2002 (g)  
Note: Other narcotic and psychotropic substances and precursors are the cause of the difference between the sum of quantities of 
drugs and the “total” value in several years  
5.2.2 Total Seizures According to the Police of the Czech Republic and the General Customs 
Headquarters  
Total statistics for drug seizures in the Czech Republic are considerably influenced by the overlap 
between the data of the Police of the Czech Republic and the General Customs Headquarters. The 
ongoing elimination of duplication within the framework of the mandatory monthly processing of 
reports (amended internal management acts are expected to order the police bodies to carry out this 
processing) should bring about a considerable improvement.  
Summarized data on all seizures of narcotic and psychotropic substances in the Czech Republic 
reported by police and customs branches in 2002 are included in Table 5-5.  
Table 5-5: Seizures of narcotic and psychotropic substances in 2002 according to the data of the Police of the Czech Republic and 
the General Customs Headquarters   
 
The National Drug Squad carried out a total of 74 operations and seized more than 13 kg of narcotic 
and psychotropic substances, 843 marijuana plants, and 5,649 ecstasy tablets (Národní protidrogová 
centrála Policie ČR, 2003) – see Table 5-6.  
Change 2002/2001 Drug type 1996 1997 1998 1999 2000 2001 2002 
abs. % 
Amphetamine  20,767.1 11.0 16,021.4 4,129.1 222.3 5,047.6 164.5 -4,883.1 -96.7 
Ecstasy 0.0 2.2 124.2 202.7 3,737.0 27,333.1 1,845.0 -25,488.1 -93.2 
Ephedrine  1,600,400.00 17,900.0 113.0 22,534.0 4,047.0 6,929.1 16,344.0 9,414.9 135.9 
Hashish  2,806.2 324.3 2,654.9 1,188.1 19,021.9 2,823.4 3,832.9 1,009.5 35.8 
Heroin 15,670.0 21,442.5 240,296.0 96,830.8 98,657.9 92,012.0 27,445.7 -64,566.3 -70.2 
Cocaine  23,133.5 66,828.0 42,969.1 131,488.9 11,947.4 2,986.5 4,544.5 1,558.0 52.2 
Marijuana  11,866,134.6 5,402.8 3,986.8 20,675.3 15,202.4 5,855.6 17,920.1 12,064.5 206.0 
Pervitin 650.0 596.2 277.5 1,501.6 2,576.3 2,317.8 859.5 -1,458.3 -62.9 
Total 13,533,661.4 112,507.0 306,444.0 334,327.8 177,917.5 228,578.2 72,956.2 -155,622.0 -68.1 
Total Customs bodies Police  Drug type  Units of 
measurement  Seizures Quantity  Seizures Quantity  Seizures Quantity  
kg 386 112.12 334 21.75 52 90.37 Marijuana and 
hashish plants (pc) 58 3,173 0 0 58 3,173 
Heroin kg 55 34.34 7 27.45 48 6.89 
Cocaine  kg 12 6.04 8 4.55 4 1.50 
Methamphetamine  kg 297 4.3 13 0.57 284 3.73 
Other 
amphetamines  
kg 10 0.41 7 0.16 3 0.25 
tablets  36 88,391 6 6154 30 82,237 Ecstasy 
kg 1 0.02 0 0 1 0.02 
LSD doses (trips)  3 107 2 47 1 60 
Total  kg 858 157.23 377 54.47 481 103 
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Table 5-6: Seizures of narcotic and psychotropic substances implemented by the National Drug Squad in 2001 and 2002  
 
It is estimated that police and customs 
branches seized 0.25% of the annual 
consumption of drugs in the Czech Republic 
in 2002 (from 0.1% of pervitin to 
approximately 10% of ecstasy and cocaine  
(see also the chapter on Trends per Drug). 
The aforementioned estimated seizure rates 
of drugs consumed in the Czech Republic 
(i.e. distributed on the Czech black market) 
may be distorted – on the one hand, the estimate does not consider the share of consignments that 
were destined for foreign markets in the total volume of drugs seized (that is, overestimation of the 
seizure rate), and, on the other hand, it does not reflect the differences in the concentrations of drugs 
seized in large quantities and drugs distributed to final consumers (i.e. underestimation of the seizure 
rate).  
5.2.2.1 Responses of Local Markets and Drug Scenes to Police Interventions 
Among other things, the survey ”Zhodnocení drogové situace v Pardubickém kraji (Assessment of the 
Drug Situation in the Pardubice Region” (Minařík and Zahradník, 2003) described the local impacts of 
police interventions aimed at the producers and large-scale dealers of pervitin (pervitin is more 
common than heroin in this region). Information from semi-structured interviews and focus groups and 
direct observation of the drug scene by field workers were used as sources for the description. The 
impacts of these interventions recorded or analyzed by the Police of the Czech Republic were not 
investigated in this survey.  
The authors of the survey described three stages in the response of the local drug scene after a 
police intervention: 
Stage 1 – Stagnation  
It starts immediately after the intervention; it takes several days or weeks.  
Only a part of the drug scene is usually directly affected by a police intervention. The drug users who 
belong to the affected group close in on themselves due to fear of the intervention’s consequences for 
themselves; they are invited to police interrogations. Some of them try to abstain. The drug scene 
closes in on itself. In this phase drug availability decreases for experimenters and occasional drug 
users; however, drug availability among the “hard core” of the drug scene does not change much.  
Drug users begin to look for and activate alternative drug sources; they often start to travel in order to 
purchase drugs. Some users leave their primary drug for another drug – most commonly the legal 
alcohol.  
Risk behaviour increases. Users do not want to risk contact with helping institutions in order to avoid 
identification. There is little chance that specialized programmes are able to influence the increased 
occurrence of risky behaviour – the number of injection sets exchanged decreases by more than 
60%, and there is a 20 – 30% decrease in contacts with low-threshold facilities. 
Phase 2 – Reactivation of the drug scene  
It starts several days after the police intervention; it takes several weeks or months.  
The closed nature of the drug scene persists; however, drug users gradually calm down. The group of 
users that were immediately affected by the police intervention begins to look for alternative drug 
sources. Most of those who tried to abstain from drugs after the intervention gradually return to drug 
use. The “unaffected” already have stable sources of drugs. Pervitin is sufficiently available for a part 
Drug type  2001 2002 
Heroin (kg) 4 6.07 
Methamphetamine (kg) 9 1.66 
Amphetamine (kg) 0.5 - 
Marijuana and hashish 
(kg) 
5.5 4.02 
Marijuana – plants - 843 
Cocaine (kg) 0.17 1.49 
Ecstasy (tablets) 20,247 5,649 
Total (kg) 19.17 13.24 
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of the drug scene in this phase. Drug availability for experimenters and first-time users is slightly 
limited.  
New sources start to appear in the area of the intervention. 
Risk behaviour is still relatively common. The availability of sterile injecting equipment is still markedly 
limited. Helping institutions still have problems contacting drug users.  
Phase 3 – Regression to the original condition  
This takes place several months to one year after the police intervention.  
The drug scene is very similar to that before the intervention. There are stable local sources; 
availability is comparable to that before the police intervention. It is less common for people to travel to 
get to drug sources; users prefer drug sources in the region. The insertion of a middleman between 
the producers and final consumers, by which the drug market protects itself, represents one of the 
possible consequences of the intervention.  
In this phase, the drug scene is more open – this represents a better opportunity for helping 
institutions to contact drug users and positively influence them towards safer modes of drug use.  
Summary of impacts of police interventions on the local drug scene:  
• Drugs are less available for the group of less experienced and starting drug users immediately 
after the intervention. On the other hand, drug availability does not change for well-established 
users. Within one year at the very latest, drug availability returns to its original condition; there is a 
certain transitory phase when many alternative sources within the region and the whole of the 
Czech Republic are utilized.  
• Temporary limitation of availability and impairment of quality of the hitherto main drug (pervitin) 
open the door for the entrance of other drugs (especially heroin).  
• It is a consequence of the intervention that the drug scene becomes more closed in and therefore 
there are fewer opportunities for interventions on the part of helping institutions geared towards a 
reduction in risky behaviour.  
• The secondary consequences of a police intervention involve the impaired availability of injecting 
equipment; injecting drug users are afraid to purchase the equipment in pharmacies and 
exchange it via exchange programmes. The impaired availability of sterile injecting equipment and 
consequent travel bring about a higher risk of the spread of infectious diseases, especially viral 
hepatitis and HIV.  
• Secondary consequences may also involve a higher level of “hierarchization” of the drug scene; 
this brings about greater safety for producers. There appear new middlemen between the source 
and the final consumer; consequently, the quality decreases, or, more accurately, the price of the 
drug undergoes a relative increase.  
5.3 Price and Purity of Drugs 
5.3.1 Price 
The National Drug Squad processed data about the price of drugs offered in the territory of our 
country. According to the data reported by the National Drug Squad, prices of drugs ranged across 
the figures mentioned in Table 5-7.  
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Table 5-7: Drug prices in 2002 according to the National Drug Squad (€ per gram/dose)  
 
As is common in general patterns, not only in drug markets, the price increases at the individual levels 
of sales; the smaller the quantity purchased, the more expensive it is. It is more difficult to obtain 
information about “wholesale” trading than about “retail” sales. It is easier to get information from the 
final customer than from the manufacturer or from the middleman in the trafficking in narcotic and 
psychotropic substances. It is possible to claim that police data about retail sales are more readily 
available and they provide a better picture of the current state of illicit markets than data about 
wholesale drug prices.  
At the beginning of 2002, the police recorded an increase in the price of pervitin because of 
insufficient supplies of ephedrine (precursor) on the illicit market due to the discontinuation of 
operations of the biggest Czech manufacturer, ICN a.s. Roztoky. Pervitin prices went up to CZK 1,500 
(€ 44.3) per gram. Starting from April 2002, there was again a relatively sufficient quantity of 
ephedrine on the illicit market in the Czech Republic; therefore, the street price of pervitin has again 
stabilized at CZK 1,000 (€ 31.6) per gram (Národní protidrogová centrála Policie ČR, 2003). 1 kg of 
ephedrine sold for CZK 120,000 to CZK 200,000 (€ 3,800 – 6,300); 0.6 – 0.7 kg of pervitin is usually 
made from this quantity. No information is available about an increase in the price of pervitin following 
the complete discontinuation of ephedrine production by the aforementioned manufacturer during the 
floods in August 2002.  
Aside from the fluctuations mentioned, pervitin prices have remained stable; this is also supported by 
the regional survey in the Pardubice region (Minařík and Zahradník, 2003). The task of this survey 
was to map the regional drug scene and, especially, the habits of users and behaviour of injecting 
drug users. However, this report also mentions that one dose of pervitin (i.e. 100 mg) may cost up to 
CZK 500 (€ 15.8) on the street.  
According to the National Drug Squad, ecstasy prices “have kept decreasing rapidly” in the previous 
year; this may indicate increasing availability. However, the situation seems stable as compared to the 
data about average prices of this substance in 2001 (Národní protidrogová centrála Policie ČR, 2002). 
The minimum price has decreased substantially, according to the data of the National Drug Squad. 
The price for individual purchases of one tablet ranged from CZK 120 to CZK 250 (€ 3.8 – 7.9); they 
were sold by the hundred for about CZK 80 (€ 2.5), and by the thousand for CZK 50 to CZK 60 (€ 1.6 
– 1.9); when several thousand are bought abroad (especially in the Netherlands and in Belgium), the 
price often does not even reach CZK 40 (€ 1.3).  
The average “retail” price of marijuana was around CZK 175 (€ 5.5) per gram in 2002, according to 
the data of the National Drug Squad from this year; this would mean that the price decreased as 
compared to data from the previous year (Národní protidrogová centrála Policie ČR, 2002). According 
to other available data (Miovský, 2003), the price of marijuana has remained rather stable and it 
usually costs the final consumer CZK 200 – 250 (€ 6.3 – 7.9) per gram. It is practically impossible to 
Wholesale level Retail level 
Drug type  
Min. Max. Average  Min. Max. 
Most common 
(average) price  
Hashish  1.6 7.0 4.3 4.7 7.9 6.3 
Marijuana  1.6 4.7 3.2 3.2 7.9 5.5 
Heroin 12.7 38.0 25.3 22.2 63.3 42.7 
Cocaine  31.6 57.0 44.3 47.5 94.9 71.2 
Methamphetamine (pervitin) 9.5 38.0 25.3 12.7 38.0 31.6 
Ecstasy (tablet price) 1.9 4.7 3.2 3.8 7.9 4.7 
LSD (price of 1 dose – trip)  4.7 5.7 5.2 4.7 9.5 7.1 
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determine the bottom price of marijuana. The top price of extraordinarily strong41 marijuana of 
domestic or foreign provenance may be as high as CZK 300 to CZK 350 (€ 9.5 – 11.1).  
There have been substantial changes in the marijuana market due to the expansion of hydroponic 
“indoor” growing in the last two to three years; for instance, the share of marijuana distributed for free 
(especially among friends) has gone down and there is an increase in the proportion of users who 
purchase it.  
5.3.2 Purity 
Individual departments of criminal and technical expertise of the regional administrations of the Police 
of the Czech Republic carry out analyses of the content of seized drugs; more demanding analyses 
are conducted by the Institute of Criminology in Prague. The National Drug Squad provides annual 
summary results of the laboratory analyses carried out by the departments mentioned (see Table 
5-8). 
According to the knowledge obtained within the framework of the regional survey in the Pardubice 
region (Minařík and Zahradník, 2003), the purity (concentration of the active substance) of pervitin has 
remained stable.  
Table 5-8: Purity (concentration of the active substance) of drugs seized in 2002 according to the National Drug Squad (%) 
 
It follows from the data that narcotic and psychotropic substances are “cut” in order to increase the 
profit for the dealer. Of course, this practice does not apply to drugs that cannot be “cut” (e.g. 
marijuana, ecstasy, LSD); in these cases, the price usually increases on the way from the producer to 
the user. Heroin and pervitin are “cut” on the way from the producer to the user in nearly all cases. 
Cocaine cutting is also common. Piracetame has started to be used for pervitin cutting recently.  
Long-term monitoring of the purity of narcotic and psychotropic substances has shown that heroin 
purity (content of the active substance) has decreased significantly. According to the National Drug 
Squad, this is a consequence of the ban on poppy growing in Afghanistan and a consequent real 
shortage of opium on the market. According to the same source, this also resulted in further 
decreases in the amount of heroin in individual doses sold on the street, down to a threshold limit of 4 
mg of heroin in a dose.  
It is not possible to provide a reliable determination of the type and quantity of active substance in 
ecstasy tablets according to the shape, colour, size, and logo of the tablet. According to police 
sources, the absolute majority of the tablets analyzed contained MDMA as the active substance; 
however, there were even tablets that looked very similar or identical but contained MDEA and/or 
MDA instead. Several cases of PMMA were recorded; this substance is very dangerous because the 
effects arrive later and therefore it is easy to overdose when several tablets are taken. There are also 
considerable differences in the quantity of the active substance. The size of the tablets does not 
determine the quantity of the active substance in the tablet. The weight of a pill ranges approximately 
from 140 mg to 540 mg, and the content of the active substance ranges approximately from 25 mg to 
140 mg per tablet. Most of the tablets analyzed weighed 200 – 300 mg and there was 60 – 80 mg of 
                                                           
41 i.e. containing a higher quantity of psychotropic THC  
Wholesale Retail  Drug type 
  Min. Max. Average Min. Max. 
Marijuana  3 21 2.6 0.2 5.1 
Hashish  2.5 10 6.3 2.5 10 
Heroin 20 41.3 22.5 4.6 41.3 
Cocaine  75 86 68 50 86 
Methamphetamine (pervitin) 60 75 40 5 75 
Ecstasy 10 20 15 10 20 
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the active substance in them. The extremely light tablets, for instance, included a tablet with a Dolphin 
logo (149 mg) and 69 mg of MDMA, and a no-logo tablet (144 mg) containing 43 mg of MDMA. On 
the other hand, the heaviest pills involved an AUDI TT tablet (341 mg) with 31 mg of MDMA and an 
Apple tablet (363 mg) containing 143 of MDMA.  
6 Trends per Drug 
Data on long-term trends concerning the use of individual drugs, trends in the field of the treatment 
and services provided to drug users, and trends in acute drug-related deaths are available in the 
Czech Republic. In addition, there are long-term data about drug seizures implemented by the 
customs administration (General Customs Headquarters) and the National Drug Squad of the Police 
of the Czech Republic; nevertheless, duplications were not removed from these data42; the year 2002 
was the first year when the National Drug Squad supplied data about drug-related criminal activities 
by individual types of drugs.  
6.1 Cannabis 
Cannabis substances represent the most common illicit drug in the Czech Republic. Cannabis use in 
the population has been rising since the 1990s. 16 - 20% of the Czech population have tried them, 
approximately 11% of the population report use within the last 12 months (i.e. 1.4 – 1.7 million, 950 
thousand people respectively). Cannabis use is increasing especially among young people 
(approximately 30% of pupils in the final grades of basic schools (age 14 – 15) and approximately 
50% of secondary school students (age 15 – 19) have tried it). The share and the absolute number of 
cannabis-related first treatment demands has a slowly-increasing trend, with minor variations. There 
were 1,070 such first treatment demands in 2002 (see the chart below). This complies with the 
increasing prevalence of use of these substances in the population. About 3,500 cannabinoid users 
were in contact with low-threshold facilities. 
Figure 6-1: Number of cannabis-related first treatment demands in 1997 -2002 (data source: Hygiene Service)  
In the last years, domestic “self-supply” 
outdoor growing has been replaced by 
indoor growing or purchasing of marijuana 
and hashish on the black market. In 2002 
the Police of the Czech Republic detected 
the first large-capacity hydroponic marijuana 
growroom.  
Cannabinoids are the most commonly 
smuggled drugs, according to the number of 
police seizures. The quantity of cannabis 
seized by customs increased from 
approximately 8.7 kg in 2001 to 21.8 kg in 
2002. 112.12 kg of marijuana and hashish and 3,173 plants were seized in total in the Czech 
Republic in 2002; this represents approximately 1% of the quantity of cannabis consumed in the 
Czech Republic annualy.  
6.2 Synthetic Drugs 
Synthetic drugs have become increasingly common in the world and they represent a rather 
heterogeneous group of drugs. The position of the Czech Republic in the European context is 
completely unique, due to a history more than thirty years long of home-made pervitin; pervitin has 
been a dominant problem drug in the Czech Republic on a long-term basis. The recreational use of 
                                                           
42 i.e. seizures from joint operations or seizures by the customs administration that were again reported by the police in the course of 
criminal proceedings 
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“dance” synthetic drugs has become increasingly common – this has especially involved ecstasy. 
LSD is rather associated with experimental (and rarely recreational) use.  
6.2.1 Pervitin 
Pervitin is the most common problem drug in the Czech Republic. Approximately 2% of the adult 
population report experience with amphetamines; approximately 1% report use within the last 12 
months. The experience of the school population with pervitin has stagnated in recent years. It is 
estimated that there are approximately 22,000 problem pervitin users in the Czech Republic. This 
estimate has remained stable in the last three to four years. Pervitin users represent approximately 
two thirds of all problem drug users in the Czech Republic. Pervitin has been the most common drug 
in treatment demands for a long time. There were 2,595 amphetamine-related first treatment 
demands in the Czech Republic in 2002 (i.e. 55% of all first treatment demands); pervitin was the 
cause of 2,389 cases (i.e. 51%). It is estimated that 13,000 pervitin problem users used the services 
of low-threshold facilities in 2002. 
Figure 6-2: Number of first treatment demands related to pervitin and/or other amphetamines in 1997 – 2002 (data source: Hygiene Service) 
There has been a steady high supply of 
pervitin on the Czech market; there were 
some fluctuations due to shortages of 
precursors; in addition, there were local 
fluctuations due to police operations. 
Organized crime has been taking over the 
production and distribution of pervitin in 
recent years; there is a decrease in 
production in “home” laboratories. Law 
enforcement bodies seized 4.3 kg of pervitin 
and 0.41 kg of other amphetamines in 2002. 
The quantity of pervitin seized by the National Drug Squad has decreased from 9 kg in 2001 to 1.7 kg 
in 2002. 
There was a rapid decrease in fatal pervitin overdoses between 2000 and 2001 (see Figure 6-3). 
Possible explanations involve both the higher quality of the reporting system in toxicological 
laboratories and the ageing of the population of problem pervitin users – in other words, there are 
fewer “newcomers”, who are those most endangered by overdoses.  
Figure 6-3: Number of pervitin overdoses in the Czech Republic in 1998 - 2002 
 
6.2.2 Ecstasy 
Ecstasy use no longer involves the 
alternative “dance scene” only; it is 
also connected with mass “nightlife” 
activities in general. 4% of the adult 
Czech population have used ecstasy 
at least once (approximately 350,000 
people), 2.5% (approximately 200,000 
people) report use within the last 12 
months). 7% of the school population 
report that they have used ecstasy (i.e. 
approximately 27,000 students). The 
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number of ecstasy-related first treatment or service demands increased from 48 in 2001 to 193 in 
2002 (i.e. 4.9% of all first treatment demands in 2002). 
There is no significant domestic source of production of dance drugs in the Czech Republic, 
according to police and customs data since 1995;43 most ecstasy tablets on the Czech market come 
from the Netherlands and Belgium. Ecstasy prices have been declining since 1993, when they were 
monitored for the first time (from CZK 350 (€ 11.1) in 1993 to approximately half that in 2002). Law 
enforcement bodies seized 82,237 tablets in 2002; this represents approximately 10% of the yearly 
ecstasy consumption in the Czech Republic.  
Not a single acute death related to ecstasy or ecstasy fakes was recorded in the Czech Republic in 
2002. Three deaths in connection with, or with the presence of, dance drugs have been recorded in 
the history of the Czech Republic. 
6.2.3 LSD  
LSD is the best-known synthetic hallucinogen; LSD abuse is mostly experimental in the Czech 
Republic according to the available information44. Approximately 2% of the Czech adult population 
report that they have used LSD at least once in their life (i.e. approximately 170,000 people), 1% (i.e. 
90,000 people approximately) report using LSD within the last 12 months; 9% of students and 
apprentices report experience with LSD and other hallucinogens.  
Hallucinogen-related treatment demands have been declining since 1999. There were 20 such cases 
in 2002 (i.e. 0.4% of all first treatment demands). 
Figure 6-4: Number of first treatment demands related to LSD and/or other hallucinogens in 1997-2002 (data source: Hygiene 
Service) 
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The Czech Republic is an important producer of LSD precursors – ergotamine, ergometrine, and 
lysergic acid are made at IVAX a.s. in Opava. Law enforcement bodies seized 107 "trips” in 2002; this 
represents approximately 0.1% of the annual consumption in the Czech Republic. 
6.3 Heroin and Other Opiates 
The use of medicaments containing opiates has been popular in the Czech Republic since the 1970s. 
Even the so-called “braun” – a home-made mixture of opiates made from available medicaments – 
achieved considerable popularity. Heroin has started to appear in Prague and Northern Bohemia 
since 1993; then it spread to other regions of the Czech Republic from 1999 to 2001; it gradually 
reached the level of the availability of pervitin that had dominated until then. The pharmaceutical 
                                                           
43 A manufactory for the production and tableting of MDMA was detected shortly before commencing operations in Central Bohemia 
in 1995. 
44 Herbal hallucinogens are also used in the Czech Republic; magic mushrooms are the most common. There are sporadic cases of 
high-risk abuse of datura (which contains delirious atropine and scopolamine), fly mushrooms (containing psychotropic muscarine), 
and other plants and mushrooms.  
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opioid Subutex®, containing buprenorphine, entered the black market in several areas of the Czech 
Republic in 2002 (it is a leakage of legally prescribed substitution substance). 
0.7% of the Czech adult population have had an experience with illicit opiates; use within the last 12 
months is close to zero. The upward trend of (at least single) experience with opiates among sixteen-
year-old pupils and students peaked in 1997; it has been decreasing since then (see the graph 
below). 
Figure 6-5: Lifetime experience with opiates among sixteen-year-old pupils and students (%) (data source: (Mravčík and Zábranský, 
2001a)) 
 
It is estimated that there are 13,500 problem heroin users in the Czech Republic; the estimated 
number has been slightly declining in the last three years (from an estimated 15,000 in 1999). The 
absolute number (and share) of treatment or service demands in connection with opiate use has been 
more or less constantly increasing between 1997 and 2001; it went down abruptly in 2002, when it 
declined to 788 persons, i.e. 16% of all first treatment demands (see Figure 6-6). Heroin-related first 
treatment demands represented 675 cases. It is estimated that 8,000 heroin users used the services 
of low-threshold facilities in 2002.  
Figure 6-6: First treatment (help) demands related to the use of opiates (especially heroin) in  1997 - 2002 (data source: Hygiene Service) 
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Law enforcement bodies seized 34.4 kg of heroin in the Czech Republic in 2002 (0.6% of estimated 
annual consumption in the Czech Republic), i.e. approximately one third of the quantity seized in 
2001.  
Fatal overdoses on heroin and other opiates increased in 1998 – 2001; there was a rapid decline in 
2002 (21 cases) - see the graph below.  
 page 77 
Figure 6-7: Development in identified acute deaths with the presence of opiates in the Czech Republic in 1998 - 2002 
40
45
47
56
21
0
10
20
30
40
50
60
1998 1999 2000 2001 2002
 
6.4 Cocaine and Crack 
Cocaine-type drugs are not very common in the Czech Republic. Cocaine use frequency is under the 
level of sensitivity of population surveys and statistical estimates in the Czech Republic. There were 
10 treatment or service demands in connection with cocaine use in 2002 (3 thereof were first 
treatment demands). 
No attempts to produce cocaine in the Czech Republic have been recorded and nothing is known 
about a contingent conversion of cocaine to crack.  
Czech customs bodies seized 6.04 kg of cocaine in 2002 (approximately 11% of estimated domestic 
consumption); however, most of the cocaine seized was not destined for the Czech domestic market. 
No acute death with the presence of a cocaine drug has yet been recorded in the Czech Republic.  
6.5 Solvents 
The use of solvents in the Czech Republic has had a relatively long history, since 1960s. Almost all 
abused solvents are made domestically45. General population surveys do not inquire about the use of 
solvents. 7% of students and apprentices have tried solvents at least once, according to school 
surveys (i.e. approximately 27,000 people). 4% (i.e. approximately 15,000 people) report use within 
the last 12 months; the figures concerning the experience of the school population with solvents have 
been stable for a long time.  
The share of inhalant users in first and all treatment demands has traditionally been relatively low (see 
the following graph). It is possible to assume that the offer of traditional services does not appeal to 
the specific population of users of these substances. 
Figure 6-8: First treatment demands related to the solvent use in 1997-2002 (data source: Hygiene Service) 
 
Reliable monitoring of acute deaths with 
the presence of solvents has only been 
available since 2001; 14 fatal poisonings 
with abused solvents were identified in 
2002 (15 in 2001). Solvents represent the 
                                                           
45 This especially involves industrial solvents (toluene, trichloroethylene, benzene), then gasoline, and 
other fuels and lighter fuels  
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third most common cause of acute deaths (after benzodiazepines and opiates).  
6.6 Polydrug Use 
Polydrug use is very common among Czech drug users. Users combine drugs; they shift from one to 
another according to the situation on the black market and they very frequently combine them with licit 
alcohol, tobacco, and psychotropic medicaments. Benzodiazepine series medicaments and 
especially Rohypnol® are the most popular. 
7 Discussion 
7.1 Consistency between Indicators 
7.1.1 Epidemiological Data 
Data from the field of epidemiology of drug use are mutually consistent, with the exception of the 
general population survey “Sample Survey on the Health Status of the Czech Population” carried out 
by the Institute for Health Information and Statistics. Data on drug use prevalence, together with data 
about the health consequences of drug use (infection, overdose), provide a convincing picture of two 
concurrent and yet contradictory phenomena: the gradual fading of the epidemic of problem drug use 
and a concurrent rise in experimental and recreational use.  
Low HIV/AIDS seroprevalence among injecting drug users (around 0.01%) on the one hand and the 
relatively higher prevalence of viral hepatitis – namely HCV (30 – 40%) on the other hand may appear 
as an inconsistency. However, it only appears to be inconsistent; both trends are relatively favourable 
(i.e. low) in comparison with neighbouring EU states or the USA46 and it is very likely that this is a 
result of the early implementation of harm/risk reduction measures in the mid-1990s. The difference in 
prevalence of HCV and HIV/AIDS is also caused by the different characteristics of both infections. 
7.1.2 Data from the Criminal Justice Sector 
The number of persons that were arrested, accused, and convicted for drug-related criminal offences 
kept gradually increasing even in 2002; as in the previous year, it is possible to see this as a reflection 
of the increases in capacity of specialized branches of the Police of the Czech Republic (this is, for 
instance, expressed in the setting up of branch offices of the National Drug Squad in former regional 
towns) and a consequent increase in knowledge on the part of the police regarding local drug scenes. 
There is also a continual increase in the number of persons prosecuted according to Section 187a 
(possession of drugs for personal use); cannabis-related prosecutions represent the highest share in 
this number.  
The spectrum of drugs for which prosecution took place agrees with epidemiological knowledge about 
drugs in society: amphetamine-related drug-related criminal offences are the most common 
(especially in connection with pervitin, the most common “problem” drug in the Czech Republic) and 
they are closely followed by drug-related criminal offences related to cannabis (the most common illicit 
drugs in our country; they are used both experimentally and recreationally). 
The value of the data from the criminal law sector is reduced by a lack of cohesion in the data from 
individual law enforcement branches; for instance, the number of persons accused of drug-related 
criminal offences (according to statistics from Public Prosecutors’ Offices) has been higher than the 
number of persons prosecuted (police statistics) for a long time.  
In collaboration with the Czech National Focal Point, the joint analytical station of the National Drug 
Squad and the General Customs Headquarters that was set up within the framework of the Phare 
Twinning Project should make a significant contribution to the improvement of quality and reliability of 
                                                           
46 HCV seroprevalence among injecting drug users in the European Union is 40 – 90% (EMCDDA, 2002); and more than 80% in the 
USA (NIDA, 2000); HIV/AIDS seroprevalence in the same population in the European Union varies from 1% (United Kingdom) to 
25% (Spain); it is estimated that it reaches approximately 27% in the United States of America (EMCDDA, 2002), (NIDA, 2001) 
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data from the criminal law sector in the future; consistent elimination of duplication in police and 
customs service reporting and the implementation of a study for the estimation of secondary drug-
related criminality represent some of the main targets for the immediate future. In the long-term 
perspective, this will especially involve linking up with data from the sector of the Ministry of Justice, 
providing for mutual comparison and deeper analyses. 
7.2 Methodological Limitations and Data Quality 
7.2.1 Epidemiological Data 
As far as the field of population surveys is concerned, we dispose of the results of semi-representative 
surveys of the Public Opinion Poll Centre with quota selection sampling (approximately 1,000 
persons) in a longitudinal time series. Even though the samples are not fully representative for the 
Czech Republic, the results of the surveys of the Public Opinion Poll Centre are consistent in time and 
they match the results of representative surveys (GENACIS was the most recent one). The results 
(especially lifetime prevalence of drug use) of the general population survey ”Sample Survey on the 
Health Status of the Czech Population” carried out by the Institute for Health Information and Statistics 
are twice as low, or even more, as in other similar surveys – a different methodology used for data 
collection is the most likely reason: questionnaires in the survey carried out by the Institute for Health 
Information and Statistics were filled in “face to face” with the respondent, therefore, it is possible that 
answers to delicate questions were not always forthcoming.  
Nationwide school surveys implemented within the framework of international projects (ESPAD, 
HBSC) involve representative inquiries; the results are mutually consistent and comparable with other 
similar surveys that were carried out in the past, e.g. the surveys implemented by the Hygiene Service 
(Polanecký et al.  2001) and the NEAD survey (Miovský and Urbánek, 2001). 
Key questions used for data about drug use comply with standard questionnaires (ESPAD, EMCDDA 
questionnaires). 
In the field of the monitoring of recreational use of drugs, and dance drugs in particular, the Czech 
National Focal Point coordinated the collection of data about those attending dance events in 2002 
(and has continued with this in 2003); data were collected with the help of organizations that carried 
out preventive and harm reduction activities at dance events, namely the Podané Ruce Brno civic 
association. The reliability of these data is limited by the fact that they come from people who make 
use of the on-site services of these organizations – i.e. from dance drug users. Field surveys of drug 
use in the dance scene such as the multicentric survey from 1998 – 2000 (Csémy et al.  2000) have 
not been repeated since. A questionnaire survey “Tanec a drogy” regarding drug use in the dance 
scene that is similar to the survey from 2000 (Kubů et al.  2000) has also been carried out in 2003 
through the XMAG magazine and a web form available at www.drogy-info.cz.  
New data about the extent of drug use by the Roma population in 2002 were made available through 
Roma field workers. The advantage of these data is that they cover Roma communities in nearly the 
whole country; the disadvantage is that they provide a very rough and benchmark description of the 
drugs situation among the Roma population. 
7.2.2 Problem Drug Use 
All available prevalence estimates of problem drug users in the Czech Republic were based on a 
multiplication method, with the use of treatment sources. The capture-recapture methods were used 
for estimations at the local level. The most recent prevalence estimation published in this report uses 
the in-treatment rate of problem drug users in contact with low-threshold facilities obtained in the 
“HCV Seroprevalence among Injecting Drug Users” study by means of a nomination method and the 
number of problem drug users in contact with these centres. The number of drug users in contact with 
low-threshold facilities was obtained from the final reports of projects participating in the subsidy 
process of the National Drug Commission; this may mean an overvaluation of the numbers. The 
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Czech National Focal Point is implementing a nationwide prevalence study with the capture-recapture 
method in 2003. 
7.2.3 Treatment Demands 
The trends read from the Treatment Demands Register of the Hygiene Service are partly distorted by 
changes in the reporting system (increasing number of various facilities of different types and changes 
in the reporting discipline of the facility). The coverage of different types of treatment facilities is not 
complete; see Table 7-1. Regional non-uniformities in the spectrum of types of reporting facilities and 
in the definitions of a treatment demand have persisted. Detailed information about these issues is, for 
instance, included in the chapter on Cannabis problems in context: understanding increased treatment 
demand. 
Table 7-1: Comparison of the number of facilities reporting to the Treatment demand register kept by the Hygiene Service with the 
total number of these facilities  
Note: * without outpatient non-health facilities  
7.2.4 Drug-Related Deaths 
Data about acute drug-related deaths have been collected in compliance with the EMCDDA 
methodology from the network of toxicological laboratories at forensic departments for five years. A 
database system for registration and reporting was introduced in 2002; however, it was not possible to 
implement it in all departments. Lack of uniformity in investigative practice and equipment of individual 
departments represents a system disadvantage; nationwide coverage of acute deaths is the 
advantage. 
7.2.5 Infectious Diseases 
A system of testing for infections in low-threshold facilities and the facilities of the Prison Service was 
finally introduced in 2002. The improvement of the quality of these systems is a key issue for the 
future. The Czech National Focal Point started to implement a nationwide study ”HCV 
Seroprevalence among Injecting Drug Users”; the results are consistent with the results of similar 
local studies.  
7.2.6 Criminal Law Data 
A lack of cohesion in the data from different phases of the criminal law process (prosecution, 
accusation, conviction) has persisted; this is the result of a time shift and inconsistencies in reporting. 
It was reported that more people have been accused of drugs-related criminal offences in the last 
seven years than were prosecuted. The police managed to get data about prosecutions by individual 
drugs in 2002. 
There are still insufficient data about the field of secondary drug-related criminality; it is planned that a 
joint study of the Czech National Focal Point and the National Drug Squad will be carried out in 2004.  
The definition of an “addict” or “user” is still unclear in the field of prisons; persons are filed in this 
category according to different criteria; see the chapter on Interventions in the Criminal Justice 
System for more information. It was possible to get more detailed information about drug screening 
urine tests; selection is not always random and the records do not allow for the identification of 
persons that were tested several times.  
Type of facility Number in the 
Register of the 
Hygiene Service  
Number in other sources 
(source) 
Outpatient health care  129 342 (ÚZIS) 
Outpatient non-health care  32 n.a. 
Residential  56 92 (ÚZIS, RVKPP) 
Low-threshold  76 93 (RVKPP) 
Total 293 527* 
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As far as the field of data about drug seizures is concerned, eliminating the problem of duplications of 
seizures by the Police of the Czech Republic and the General Customs Headquarters has not yet 
been managed.  
7.2.7 Notes Regarding Publication Culture 
Frequent quoting of well-established and simplified claims unsupported by facts and numbers (for 
instance about the constantly decreasing age of drug users, constantly worsening situation, about 
marijuana with a 30 – 40% THC content, about seizure rates) is a relatively frequent attribute of 
information published in both professional publications and the media; this information is not in 
accordance with data about recent trends in the field of drug use and its consequences. 
Epidemiological data are sometimes also misinterpreted or simplified. The introduction of the 2002 
Annual Report of the Prague Hygiene Station (Polanecký et al.  2003) can be mentioned as an 
example: it misinterprets trends in drug-related treatment demands and data about prevalence and 
testing for infectious diseases among drug users. 
The failure to meet high publishing standards in official materials and the frequent use of 
unsubstantiated claims represent a common problem with data from the criminal law sector. Let us, 
for instance, mention relatively typical and frequently secondarily-quoted data such as the long-term 
reporting of the “latency of drug-related criminal offences” by the Institute for Criminology and Social 
Prevention. Even the most recent publication of this type (Cejpl et.al., 2001) suffers from an extremely 
narrow and selective spectrum of sources (only 3 quotations) that are not processed according to any 
standard at all. The professional level of this text is then decreased by frequent references to 
anonymous “experts”. The data about the latency of “drug-related criminal offences” that the 
publication provides are statements that can be disproved by simple arithmetic47.  
 
                                                           
47 For instance, this publication mentions 20 – 30% of “detected cases of possession of drugs for personal use” (of all cases that 
were committed in the territory of our country); in fact, the police prosecuted 285 cases of possession of drugs for personal use and 
187 offenders who committed these offences; in addition, 761 administrative offences were detected. With regard to the number of 
problem users (37,500) or, more accurately, the number of those who used a drug at least once in the last year (11% of the adult 
population, i.e. approximately 950,000 persons), it is possible to assume that the proportion of detected activities of this type was 
significantly lower.  
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Part III: Demand Reduction Interventions 
8 Strategies in Demand Reduction at National Level  
8.1 Major Strategies and Activities  
The 2001 – 2004 National Drug Policy Strategy specifies the basic demand reduction strategies. It is 
the third conceptual document in the history of the Czech Republic (the previous ones were published 
in 1993 and 1998 respectively). It follows from the previous concepts and develops the strategies and 
activities that were defined in these documents. The strategies are based on the principle of a 
balanced approach and comprehensive, interdepartmental, interdisciplinary, and intersectorial 
procedures and cooperation in problem-solving (Sekretariát Meziresortní protidrogové komise, 2000). 
It especially applies to low-threshold facilities and resocialization programmes that they are 
guaranteed by the state through NGOs. Therefore, the costs of services provided by NGOs make up 
approximately 90% of the expenditures from the General Cash Administration budget chapter – drug 
policy expenses. These financial resources are completed with expenditure from the budgets of the 
Ministry of Labour and Social Affairs, Ministry of Health, and Ministry of Education, Youth, and Sports, 
and from local budgets (see the chapter on Budget and Funding for more information). It has shown 
that there is not sufficient coverage of treatment programmes for juveniles, for drug users in prisons, 
and for the Roma community. Even after-care programmes with sheltered housing and sheltered 
work for people who completed treatment programmes and substitution treatment are undersized.  
A substantial part of the Phare Twinning Project was carried out in 2002 (Sekretariát Rady vlády pro 
koordinaci protidrogové politiky,  2003). The goal of the project was especially based on the 
establishment of the necessary conditions for EU acquis communautaire enforcement. The specific 
aim was to develop and reinforce an efficient legal and institutional system and the planning and 
implementation of an efficient drug policy in the Czech Republic.  
The Phare Twinning Project focused on three areas that correspond with the main principles 
of the 2001 - 2004 National Drug Policy Strategy: 
1. Setting up and guaranteeing the operations of the Czech National Focal Point and guaranteeing 
drug data collection in compliance with the methodology of the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA)  
This field focused on further development of the Czech system of drug epidemiology monitoring and 
improvement of the system of collection, processing, and analysis of data on the one hand, and the 
distribution of these data to experts, national, international institutions, and the general public including 
the central information server at www.drogy-info.cz. A joint analytical station of the General Customs 
Headquarters and the National Drug Squad was set up to monitor the field of drug supply reduction; it 
should become fully operative in the course of 2003.  
2. Improvement of Horizontal and Vertical Cooperation  
This field especially focused on the development and improvement of structures for collaboration and 
the coordination of the drugs policy in the Czech Republic. The position of a drug coordinator was 
gradually introduced in regional authorities as a consequence of the reform of public administration. 
The newly-established drug coordinators were provided with training and counselling within the 
framework of this project; it focused especially on the further professional and management activities 
of the coordinators in their regions. The objectives of other activities involved the improvement of 
collaboration between sectors that deal with drug issues, the introduction of standard procedures for 
the evaluation of the efficiency of measures implemented, and the design of changes to the existing 
system of drugs policy programme funding.  
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The analysis of the state of horizontal coordination found out that the Ministry of Health, Ministry of 
Labour and Social Affairs, Ministry of Education, Youth, and Sports, and Ministry of Justice do not 
possess a sufficient number of experts in drug policy. A suggestion was made to the government that 
it should reinforce the staff of the appropriate departments of these ministries. The situation of regional 
drug coordinators is similar: their workload exceeds a 1.0 workload. (In these cases, regional 
presidents were recommended to establish a drug policy coordination department.)  
The draft of the model of decentralized funding of prevention and treatment services is the most 
important output in this field. This model takes into consideration the weaknesses identified in the 
existing system and the public administration reform and the efficient spending of public resources. 
The model is based on the financial participation of the state and the regions. Basic tools for quality 
control and the efficiency of the services provided should involve a regional plan for prevention and 
treatment, financial standards for services, minimum service standards, the certification of service 
providers, and annual reports (of regions, service providers). A detailed plan should be drawn up by 
June 30, 2004.  
3. Education of Workers in the Field of Drug Supply and Drug Demand 
Activities in this field focused on the drawing up of teaching and conceptual materials for the field of 
primary prevention, substitution programmes, prisons, and the police. This field involved team training, 
counselling, and the development of the quality of educational curricula for further training and data 
collection. A substantial effort was also dedicated to the methodological education of key experts, 
workers in different professions in the field of drugs and drug addiction, and the arrangement of 
existing conceptual materials.  
The most important outputs in this field involve the preparation of intersectorial and interdisciplinary 
standards of evaluation of the quality of the services delivered that will take into consideration the 
existing sectorial standards in the field of treatment and resocialization, the preparation of a first draft 
of minimum standards of primary prevention, a dictionary of primary prevention, and a manual of good 
practice. The final objectives are to draw up uniform intersectorial standards for services in the field of 
the treatment and resocialization of drug users and to implement the accreditation system in practice 
– see the chapter on Quality Assurance  for more information.  
8.2 Approaches and New Developments 
Several new or innovative programmes and approaches appeared during 2002. This was partly due 
to the Phare Twinning Project 2000 “Strengthening National Drugs Policy” (Haas et al.  2003; 
Sekretariát Rady vlády pro koordinaci protidrogové politiky,  2003), that managed to collect experts in 
the field of conceptualization and planning new activities.  
A needs analysis for the field of primary prevention was carried out within the framework of the Phare 
Twinning Project. According to this analysis, the number of implementers of primary prevention 
activities in the non-profit-making sector is higher than that estimated from a summary of primary 
prevention programmes subsidized from public budgets (Miovský, 2002a). This means that there are 
other entities that participate in primary prevention; most of them are outreach centres that operate in 
centres of regions with 100,000 to 150,000 inhabitants. A working subgroup was set up within the 
Phare Twinning Project for the purpose of describing and analyzing this phenomenon. In the course 
of 2002, this subgroup carried out an analysis of services provided by these facilities (Libra, 2003; 
Miovský, 2002b). It has shown that these centres prefer an agency-style type of work (this is why they 
are called “drug agencies”); this means that they serve as multipurpose facilities that respond to new 
trends and the needs of the local community and they do not strictly stick to the concept of providers 
of low-threshold facilities defined by standards of drug services (Ministerstvo zdravotnictví ČR, 
2001a). The analysis has also shown that it is necessary to solve the whole issue conceptually.  
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A needs analysis in the field of substitution treatment was carried out within the framework of the 
Phare Twinning Project (Zábranský, 2002). Two fields of priority for 2002 – 2003 were identified on 
the basis of this analysis. Decentralization of the supply of substitution treatment is the first priority. It 
has been shown that the existing manner of provision of substitution treatment displays significantly 
limited potential for further expansion and that this reduces availability. Setting up this type of 
treatment in prisons, remand prisons, and police cells was the second priority. Substitution treatment 
has not been provided in these facilities even though this type of treatment is totally legal and 
standard in the civil sector. Close collaboration was established with the General Directorate of the 
Prison Service and the Prisons working group of the Phare Twinning Project. The goal of introducing 
substitution in prisons by the end of 2004 is also expressed in the Government Decree regarding the 
Phare Twinning Project (Sekretariát Rady vlády pro koordinaci protidrogové politiky,  2003) - see the 
chapter on Substitution and Maintenance Programmes for more information. 
As far as the field of school-based prevention is concerned, several localities in the Czech Republic 
witnessed the development of activities that use tools from fields outside primary prevention in 2002. 
These involved two types of activities: urine tests for the presence of metabolites of illicit drugs among 
pupils and students of primary and secondary schools, and the use of sniffer dogs for drug detection 
as a demonstration within the framework of a preventive action; sniffer dogs are occasionally used for 
the actual detection of drugs in a particular school. Both of these approaches received media 
attention; this required the formulation of an official statement on the part of the Secretariat of the 
National Drug Commission and other ministries involved (Ministry of the Interior, Ministry of Education, 
Youth, and Sports); it was published as a press release. The statement clearly declares that none of 
these approaches belong to the primary prevention strategy supported by the state and that they are 
not primary prevention per se; in addition, it makes it clear that the approaches are not components of 
blanket programmes and points to legal issues related to these activities (Sekretariát Rady vlády pro 
koordinaci protidrogové politiky, 2003) – see the chapter on Prevention for more information.  
Interventions in the field of synthetic drugs have also developed. The National Drug Commission 
established the Synthetic Drugs Abuse Prevention working group in October 2002. The group met 
five times between November 2002 and May 2003, when the working group was dismissed after it 
had fulfilled its tasks. The task was to analyze the current situation and design appropriate measures 
in the field of synthetic drugs like ecstasy (MDMA) and other substances used in the milieu of dance 
events (i.e. dance drugs). The group consisted of representatives of the Ministry of Health, Ministry of 
Justice, Ministry of the Interior, Association of Non-Governmental Organizations, Czech Medical 
Association of J. E. Purkyně – Association for Addictive Diseases, Secretariat of the National Drug 
Commission, and two independent experts. Inter alia, the group drew up a “Recommended 
Procedure for Execution of Preventive Actions at Dance Events” (Valnoha, 2003); the goal of this 
document is to harmonize the existing activities that are conducted especially by field programmes 
with basic professional and legislative criteria. Other outputs involve the publication “Safer Dancing”, 
that summarizes the main recommendations for the safer organization of dance events (Zábranský 
and Kubů, 2003). The group recommended the preparation of a research project that will focus on the 
use of licit and illicit drugs in the milieu of dance events and on the evaluation of the efficiency of 
preventive activities in this milieu. In 2002, prevention and harm reduction activities on the dance 
scene developed particularly due to the work of the Podané ruce civic association – the leader of this 
process. This involves combinations of informative and educational work among drug users on the 
drug scene (information about risks connected with ecstasy use, first aid in different situations, etc.), 
structured influencing of attitudes, and programmes for the qualitative testing of ecstasy (Miovský, 
2003); the network of field programmes that carry out qualitative testing is linked with the 
Pharmacology Department of the 3rd Medical Faculty at Charles University in Prague, which has 
carried out the quantitative testing of ecstasy tablets (see the chapter on Harm Reduction Activities 
Designed for Users of Dance Drugs for more information). The programmes meet with a negative 
attitude on the part of the police. Even the statement of the Brno-based Office of the Supreme 
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Prosecutor from October 17, 200248 (Nejvyšší státní zastupitelství , 2002) did not bring about a 
substantial shift in the attitude of the police regarding these activities. In one case, a complaint was 
lodged for suspicion of the commission of the criminal offence of propagation of drug addiction 
(Section 188a of Penal Code); the Public Prosecutor rejected the charge. The Ministry of the Interior 
and the Ministry of Health have declared their clear disapproval of ecstasy testing in dance events.  
The Legal Aid Counselling Service of the Association of Non-Governmental Organizations started to 
operate in 2002. In the beginning, the project was especially supported by the Open Society Fund. 
The main objectives of the project involve legal aid to organizations dealing with treatment and help to 
drug users; it also provides help to drug users who have got into significant problems with the law 
(Gajdošíková, 2002). Legal aid used to be a missing element in the range of drug services offered in 
the Czech Republic. As the reform of public services has not yet been fully implemented, a large part 
of the social services provided for drug users (streetwork, half-way houses, community care 
programmes, etc.) operate in something of a legal vacuum. This is why the organizations often have 
to deal with peculiar legal situations. In addition, this legal aid also involves help to specific drug users 
in complex legal cases; these people often have problems finding quality legal aid, especially in the 
field of the penal law.  
The so-called user fora started to emerge in the Czech Republic in 2002; their aim is to draw (ex) drug 
users and methadone programme clients into a discussion about the treatment of drug addicts. These 
user fora should participate in the mapping of drug use within the community of users, collaborate with 
professionals in the field, and try to influence the quality of services for drug users. A non-
governmental organization, Společnost Hvězda, is involved in the project and cooperates closely with 
a Dublin user forum, UISCE. The Prague user forum is an association of ex-users and it has started 
to publish the Dr. Ufo magazine.  
9 Prevention  
Primary prevention is one of the four pillars of the Czech drugs policy according to the 2001 - 2004 
National Drugs Policy Strategy; it defines goals, aims, and objectives in this field.  
Stopping the increase of drug use, especially among children and young people, is the most 
significant goal of primary prevention. A very positive trend in epidemiological indicators in the Czech 
Republic can be observed with regard to the fulfilment of this goal. It is true that there has been an 
increase in the experimental and recreational use of cannabis and dance drugs in particular (but this 
trend is gradually slowing down in the population of adolescents); on the other hand, the experimental 
use of heroin and pervitin has been stagnating (Mravčík and Zábranský, 2001a); at the same time, the 
increase in problem drug use has also stopped in recent years. This means that there has been no 
further increase in the use of the most risk-laden drugs or the most risk-laden modes of drug use in 
the Czech population, especially among children and young people. This differentiation can be 
regarded as an indisputable success of the Czech drugs policy and partly also as a success of 
primary prevention.  
Objectives and targets defined in the 2001 – 2004 National Drugs Policy Strategy mainly involve the 
field of conceptions, coordination, standardization, and education. The fulfilment of targets in these 
fields has been delayed. An overall analysis of the state of primary prevention in the Czech Republic 
was carried out within the framework of the Phare Twinning Project (Miovský, 2002a). The analysis 
found that there was insufficient collaboration and networking both at the vertical and the horizontal 
(intersectorial) level.  
Target 5B from the 2001 – 2004 National Drug Policy Strategy was newly formulated within the 
framework of the Evaluation Report about the Fulfilment of Targets from the 2001 – 2004 National 
                                                           
48 This statement also contains a list of conditions under which criminal responsibility could be eliminated in specific cases. 
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Drug Policy Strategy (Government Resolution No. 1110/2002). The Ministry of Education, Youth, and 
Sports is responsible for the creation of a functional and interconnected system of preventive activities 
within its own sector, and not in general and outside the sector, as the 2001 – 2004 National Drugs 
Policy Strategy originally put it. Even the fulfilment of targets following from the Phare Twinning 
Project (Government Resolution No. 549/2003) should improve the coordination and quality of 
services in the field of primary prevention. The targets are:  
• To establish a Primary Prevention working group consisting of institutions responsible for the 
implementation of primary prevention according to the 2001 – 2004 National Drugs Policy 
Strategy (until September 30, 2003). This will be carried out by the Minister of Education, Youth, 
and Sports in collaboration with the Minister of Health, the Minister of the Interior, the Minister of 
Defence, the Minister of Labour and Social Affairs, and the Executive Vice-Chairman of the 
National Drug Commission.  
• To prepare Minimum Standards of Primary Prevention, a Manual of Good Practice of Preventive 
Programmes, and a terminological dictionary of terms from the field of primary prevention and 
submit them to the National Drug Commission (by December 31, 2003). This will be carried out by 
the Minister of Education, Youth, and Sports in collaboration with the executive chairman of the 
National Drug Commission.  
• To prepare a conceptual framework for primary prevention and submit it to the National Drug 
Commission (by December 31, 2003). This will be carried out by the Minister of Health and 
Minister of Labour and Social Affairs.  
• To legislatively anchor the position of a school prevention methodologist to the appropriate law 
and ensure appropriate conditions for the execution of this work (by July 31, 2003). This will be 
carried out by the Minister of Education, Youth, and Sports. 
It is practically impossible to get a complete picture of the total volume, quality, content, and costs of 
the implementation of primary prevention activities, due to the fact that they are implemented by 
different ministries, regions, municipalities, all schools, and nearly all providers of services in the field 
of treatment and help to drug users. The basic available information about types of primary prevention 
programmes follows.  
9.1  School Programmes 
School-based prevention programmes represent the highest volume of primary prevention 
programmes. A general definition of a primary prevention strategy for schools and educational 
facilities can be found in the strategies of the Ministry of Education, Youth, and Sports and 
continuation instructions (Ministerstvo školství, mládeže a tělovýchovy, 2000; Ministerstvo školství, 
mládeže a tělovýchovy, 2001; Ministerstvo školství ČR, 2000).  
School-based prevention in the Czech Republic is carried out within the framework of two basic types 
of programme. This involves the so-called “Minimum Preventive Programme” at schools and 
educational facilities and the so-called prevention of socially pathological phenomena within the 
sphere of competence of the Ministry of Education, Youth, and Sports.  
Minimum Preventive Programme 
This programme is directly implemented by schools. The persons who are responsible for the field of 
drug prevention at each school – school prevention methodologists - play a key role (this position is 
established and filled at each school in the Czech Republic). The basic prerequisites and conditions 
for the execution of this work have not yet been provided for systematically (pedagogues are not paid 
for the work or their direct teaching workload is not proportionally reduced) (Miovský, 2002a); the 
fulfilment of the target that resulted from the Phare Twinning Project might bring an improvement – 
see above. Emphasis is laid on holistic approaches; the prevention of drug use and drug addictions is 
a part of education towards a healthy lifestyle. The projects carried out within the framework of the 
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Minimum Preventive Programme are based on the conception of the model programme for 
kindergartens and basic schools, “Škola podporující zdraví (Health Supporting School)” 
(www.brana.cz/zdrskola). It is the effort of the Ministry of Education, Youth, and Sports to integrate 
these programmes with out-of-school programmes and community programmes at the regional level. 
Information about financial resources for the support of minimum preventive programmes in 2002 is 
included in the chapter on Budget and Funding.  
Prevention of socially pathological phenomena within the competence of the Ministry of 
Education, Youth, and Sports  
The projects in this field are of a supraregional and nationwide character and they focus on:  
• the creation of an integrated system of prevention in the field of special education, 
• the education of pedagogical workers in compliance with the National Curriculum for the 
Education of Methodologists of Prevention in Schools and School Facilities, 
• the activization of parents in the field of prevention, with a focus on a healthy lifestyle, 
• target groups of young apprentices, minorities, and young people faced with an increased risk of 
the occurrence of socially pathological phenomena. 
Programmes are implemented by public service organizations, civic associations, subsidized 
organizations operated by the Ministry of Education, Youth, and Sports, and other organizations 
outside the sphere of competence of the Ministry of Education, Youth, and Sports. It is currently 
impossible to determine the exact share of primary prevention programmes and leisure time activities 
within the framework of the implemented programmes.  
The Police of the Czech Republic are implementing some addiction-oriented primary prevention 
projects in schools within the framework of crime prevention programmes; a considerable part of 
these activities is implemented by police prevention information groups (pilot projects ”Malá policejní 
akademie (Small Police Academy”, ”Učíme se s policií (Learning with the Police)” or ”Ajaxův zápisník 
(Ajax’s Notepad)”). Even some non-governmental organizations are entering this field systematically; 
they focus exclusively on drug prevention in schools and the education of pedagogues – e.g. Institut 
Filia (http://web.telecom.cz/filia). 
The control of the implementation of primary prevention programmes in schools and school facilities 
falls within the sphere of competence of the Czech School Inspection; it mostly focuses on 
administrative control; inspection of quality and effectiveness is carried out only exceptionally.   
9.2 Youth Programmes outside School 
Specific extracurricular primary prevention programmes are especially implemented by NGOs and 
pedagogical-psychological counselling offices.  
Several functioning models of community programmes exist in the field of specific programmes. They 
deal with work with at-risk youth groups, especially in densely populated areas (on the street or in 
clubs and various entertainment facilities). The community programme of drug prevention in Prague 6 
(www.Praha6.cz/bezpecnost/protidrogove.php) or community activities of Prague's Prev-Centrum 
(www.prevcentrum.cz) can be mentioned as examples of good practice.  
Programmes focusing on at-risk young people in socially segregated groups or ethnic minorities 
appear only sporadically.  
9.3 Work with Families 
Four groups can be distinguished in the field of preventive work with families:  
• Educational programmes for parents (purpose-written publications, popular education, and 
lectures),  
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• Programmes geared towards the prevention of high-risk behaviour among parents (use of alcohol 
and other drugs, etc.), 
• Preventive programmes with active parental involvement,  
• Programmes geared towards early diagnosis and efficient intervention by parents (especially at 
the level of cooperation with a school). 
Parent groups allow for barrier-free communication about drug issues between experts and parents 
and they often represent an essential and important part of the activities of community prevention 
centres, counselling offices, and low-threshold outreach centres.  
9.4 Other Programmes 
Internet-based prevention continued to develop in 2002 (Kubů et al.  2000). www.drogovaporadna.cz 
(accessed approximately 5,000 times per month) and www.extc.cz (accessed approximately 4,000 
times per month) were the most frequently visited on-line counselling services in the Czech Republic 
in 2002; they are both operated by NGOs (o.s. SANANIM, o.s. Podané ruce). 
Drug use prevention in different target groups is increasingly often a part of the work of outreach 
centres in areas outside large municipal agglomerations; these centres use the so-called “agency 
type” of work and provide comprehensive drug services in a given community – see the chapter on 
Approache for more information. 
Prevention in the workplace has been neglected for a long time. No integrated preventive programme 
that would focus on NPSs was prepared or implemented in this field in the Czech Republic in 2002.  
9.5 Research and Evaluation Studies in the Field of Primary Prevention 
Primary prevention programmes are not subject to a sufficient level of evaluation. Most implementers 
of preventive programmes limit themselves to several types of internal evaluation of programmes. In 
most cases, this involves non-structured verbal assessments of implementers or participants, or 
questionnaires, etc.  
It is the objective of the research project that started in 2002 to develop and verify a methodology for 
the implementation of the evaluation of community primary prevention programmes. The civic 
association Prev-centrum is implementing this project in collaboration with the Academy of Science of 
the Czech Republic, and the Czech National Focal Point is guaranteeing it.  
10 Harm Reduction 
10.1 Definition and Priorities 
Harm reduction is one of the four pillars of the 2001 – 2004 National Drugs Policy Strategy 
(Sekretariát Meziresortní protidrogové komise, 2000). This document defines harm reduction as a set 
of specific approaches with the objective of:  
• Helping drug addicts to survive and minimize health and social damage and to motivate them to 
change their risky behaviour with the goal of a drug-free life,  
• Protecting society against the negative consequences of drug use, including blood-borne 
diseases. 
10.2 Description of Interventions 
Low-threshold facilities in particular (outreach centres, field programmes/streetwork, exchange 
programmes) provide harm reduction services to drug users. The target population of low-threshold 
facilities involves problem drug users, experimenters and people in their close environment; some 
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facilities also provide specific services to recreational dance drug users. Low-threshold facilities in 
small towns are often involved in the field of primary prevention.49  
Basic specific targets of services provided in the field of harm reduction: 
• To increase the motivation of drug users to less risky behaviour in connection with drug use. 
• To increase the motivation of drug users to change their lifestyle towards one of abstinence. 
• To lead drug users to regular exchanges and the safe disposal of used injecting materials. 
• To decrease rates of HAV, HBV, and HCV among drug users. 
• To maintain the low level of occurrence of HIV/AIDS among drug users. 
• Data collection in the field of drug use, monitoring of trends in drug use.  
10.2.1 Scope of Harm Reduction Services in the Czech Republic 
There is a relatively stable network of low-threshold facilities in the Czech Republic: at the end of 
2002, it consisted of 93 projects50 - outreach centres, field programmes, streetwork, and needle and 
syringe exchange programmes (see Map 10-1). The range of services offered involves the exchange 
of injecting materials, including motivation training focusing on the safe disposal of used injecting 
materials, the mediation of contact with facilities that deal with abstinence-oriented treatment and 
substitution treatment programmes, counselling in the field of infectious diseases and overdose 
prevention, and health and social services for drug users or the mediation of such services; most 
outreach centres provide a hygiene and food service.  
 
Map 10-1: Low-threshold facilities  in the Czech Republic in 2002 
 
Several facilities (approximately 15) operate a programme of secondary replacement of injecting 
materials.51 15 projects provided an information service accompanied by the on-site benchmark 
testing of tablets offered as ecstasy in 2002. Three low-threshold facilities deal primarily with 
contacting and supplying services to Roma drug users. Employees of 4 low-threshold facilities are 
                                                           
49 41 out of 80 facilities investigated reported activities in the field of primary prevention in 2002. 
50 The number of facilities follows from the data available to the National Focal Point (subsidy process of state institutions, publicly 
accessible address books, information of the Harm Reduction Section of the Association of Non-Governmental Organizations). 
51 Involvement of active drug users who exchange injecting materials and provide information to other drug users.  
 page 90 
authorized to enter some of the Czech prisons, where they provide information about harm reduction 
services or mediate contact with treatment institutions; this topic is dealt with in more detail in the 
chapter on Assistance to Drug Users in Prisons. 
The Harm Reduction Section of the Association of Non-Governmental Organizations (HR A.N.O.) 
was set up within the framework of the Association of Non-Governmental Organizations in October 
1999. It is the main job of the Harm Reduction Section to ensure fluent communication between 
individual facilities, to help to professionalize the existing programmes, guarantee the observance of 
minimum standards of care among its members, and to help to establish uniform definitions of terms 
that relate to the services provided in the field of harm reduction. The Harm Reduction Section had 35 
members by the end of 2002. 
Some of the professionals who work in the field of harm reduction are associated in a professional 
organization, the Czech Streetwork Association, that was established in 1997.  
10.2.1.1 Model of a Specific Local Programme 
In 2002, the professional public opened a discussion about low-threshold facilities that operate in the 
centres of regions with 100,000 – 150,000 inhabitants. These low-threshold facilities differ from 
facilities in larger towns in terms of the structure of their clientele and the structure of the services they 
provide (especially in the conduct of primary prevention activities) (Libra, 2003). A model of such a 
facility – a so-called drug agency - was drawn up within the framework of the Phare Twinning Project - 
see the chapter on Approaches and New Developments.  
10.2.2 Data Collection and Monitoring in Low-Threshold Facilities 
The network of low-threshold facilities struggles with a non-uniform methodology for the collection of 
data about drug users and services provided to them. Services are usually provided anonymously 
and this complicates data collection.  
All facilities are currently able to provide information about the number of syringes and needles 
exchanged and about the number of contacts52 in a given period (see Table 10-1 to Table 10-3, and 
Map 10-1); most facilities report the volume of services delivered and there is an increase in the 
number of projects that also report the number of people that use the services of the facility. 
 Table 10-1: Exchange programmes in low-threshold facilities subsidized by the National Drug Commission in 2001 - 2002 (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2003c) 
 
Table 10-2: Exchange programmes in the Hygiene Service database in 1998 - 2002 (Polanecký et al.  2000; Polanecký et al.  2003; 
Polanecký et al.  2001; Polanecký et al.  2002; Polanecký et al.  1999) 
                                                           
52 Each visit/situation when a client and programme worker interact (i.e. provision of a certain service, information or counselling – 
including group counselling). 
Year Number of 
projects  
Number of 
contacts  
Number of syringes 
and needles  
exchanged (pc) 
2001 77 230,327 1,567,059  
2002 80 260,180 1,423,754 
Year Number of 
programmes  
Number of needles 
and syringes  
exchanged (pc) 
1998 42  486,600 
1999 64  850,285 
2000 80  1,152,334 
2001 82  1,179,011 
2002 11753 1,410,057 
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Table 10-3: Number of syringes and needles exchanged in exchange programmes in the Czech Republic in 2002 by regions 
(Polanecký et al.  2003) (Národní monitorovací středisko pro drogy a drogové závislosti, 2003c) 
 
Map 10-2: Number of syringes and needles handed out in exchange programmes in the Czech Republic in 2002 by regions where 
the facilities operate (per 100,000 inhabitants) (Polanecký et al.  2003) (Národní monitorovací středisko pro drogy a drogové 
závislosti, 2003c) 
 
 
The Harm Reduction Section of the Association of Non-Governmental Organizations (HR A.N.O.) has 
been working on the project “System of Uniform Data Collection in Low-Threshold Facilities” for five 
years; 35 facilities participate in this project. In addition to a uniform methodology of data collection, 
they also use identical coding of anonymous clients. A “FreeBase” computer database has been 
developed within the framework of this system for the documentation and evaluation of data about 
clients and services delivered to them. Within the activities of the Treatment Demands working group 
of the Phare Twinning Project, representatives of the Prague Hygiene Station, Harm Reduction 
Section of the Association of Non-Governmental Organizations, and the Czech National Focal Point 
                                                                                                                                                                                               
53 The year 2002 was the first year when syringes distributed directly in low-threshold facilities and in the field (streets, flats) were 
recorded separately.  
Region 
Number of 
exchange 
programmes  
Number of syringes  
exchanged (pc) 
Capital Prague 10 858,507 
Central Bohemia 9 12,561 
Southern Bohemia  7 14,883 
Pilsen 3 23,221 
Karlovy Vary 5 16,608 
Ústí  15 256,071 
Liberec 3 12,273 
Hradec Králové 3 22,250 
Pardubice 2 23,622 
Vysočina 5 11,254 
Southern Moravia 7 134,285 
Olomouc 5 21,809 
Zlín 4 19,973 
Moravian-Silesian 10 41,907 
CZECH REPUBLIC  88 1,469,224 
Ústí
Pilsen
Zlín
Vyso_ina
Central Bohemia
Olomouc
Southern Bohemia
Pardubice
Liberec
Southern Moravia
Moravian-Silesian
Hradec Králové
Karlovy Vary
Capital Prague
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have started to develop an interface between this system and the Register of the Hygiene Service; 
this will make possible the uniform reporting of first treatment demands and all treatment demands 
from low-threshold facilities54 to the Hygiene Service Register and then provide for electronic data 
exchange between these institutions. The Association of Non-Governmental Organizations and the 
National Focal Point plan to implement FreeBase in low-threshold facilities in the Czech Republic in 
2004. 
10.2.2.1 Outputs of Data Collection in Low-Threshold Facilities 
The Czech National Focal Point possesses data from final reports of bodies involved in the subsidy 
process of the National Drug Commission; 80 low-threshold facilities participated in these proceedings 
in 2002. Analysis of data from the final reports of the individual facilities and consequent extrapolation 
resulted in data that can be used for a description of an average low-threshold facility55 and a total 
estimate of individual indicators for all 93 Czech low-threshold facilities in 2002 – see Table 10-4. 
Table 10-4: Estimated data about low-threshold facilities in the Czech Republic in 2002 (Národní monitorovací středisko pro drogy a 
drogové závislosti, 2003c) 
Note: * These average data refer to out-of-Prague facilities; the nationwide estimate includes the data from Prague facilities. ** In 
2002. approximately 64% of financial resources for the field of harm reduction were earmarked from the state budget via the subsidy 
process (CZK 45 million – National Drug Commission. 15 million – Ministry of Labour and Social Affairs. 1 million – Ministry of 
Health) and 10% represent the resources that were earmarked via the subsidy process in regions and municipalities (12 million).  
 
Table 10-5 provides an overview of services provided in 80 facilities that participated in the subsidy 
process of the National Drug Commission.  
                                                           
54 In the year 2002, low-threshold facilities represented 26% of the database of treatment-outreach centres registered with the 
Hygiene Service  
55 These average data refer to out-of-Prague facilities. The reason is that the capacity of Prague facilities differs markedly from the 
capacity of other low-threshold facilities in the Czech Republic; the nationwide estimate includes the data from Prague facilities  
Average facility 
 
Indicator 
Number  Share in all 
clients (%) 
Total estimate for 
the Czech Republic  
Number of employees / number of positions  4.6 / 3.5 - 440 / 330 
Number of contacts (visits)  2,460 - 290,000 
Number of clients 289 - 33,200 
Average age of a client (years) 22 - 22 
Number of clients – males 156  
  
54  19,400 
, Number of clients – females 133  46 13,800 
Number of clients – intravenous users  146  51 19,000 
Number of clients who reported pervitin as their 
primary drug  
113  39 13,100 
Number of clients who reported heroin as their 
primary drug  
43  15 8,000 
Number of clients who reported cannabinoids 
as their primary drug  
40  14 3,400 
Number of clients – non-users  110  38 9,300 
Number of first contacts  127 - 11,300 
Number of exchanges – performances  551 - 111,600 
Number exchange syringes  8,028 - 1,526,800 
Costs of operation of the facility** 1,277,605 - 118,817,000 
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Table 10-5: Low-threshold facilities – services (Národní monitorovací středisko pro drogy a drogové závislosti, 2003c) 
  
10.2.2.2 Harm Reduction Activities Designed for Users of Dance Drugs 
15 facilities provided on-site verbal information and preventive materials (flyers) about dance drug 
issues, crisis intervention, and the contingent possibility of benchmark qualitative tests of ecstasy 
tablets in 2002; 6 of these facilities provided more detailed information about the services they 
delivered (see Table 10-6). 
Table 10-6: Harm reduction activities designed for dance drug users in 2002 
The Podané ruce civic association (Brno) 
started to operate on-line Internet counselling 
in 2000 (http://www.extc.cz); it still focuses on 
issues associated with dance drug use.  
A database of ecstasy tablets used in the 
Czech Republic, with a quantitative analysis of 
their content, (http://www.lf3.cuni.cz/drogy/) was published under the auspices of the Institute of 
Pharmacology of the 3rd Medical Faculty of Charles University in Prague in 2002. 
It is an overview of randomly collected ecstasy tablets, with a complete quantitative analysis and 
documentation, including photo documentation (Fišerová and Páleníček, 2001; Fišerová and 
Páleníček, 2002). 39 tablets were added to the database in 2002; 146 tablets have been entered into 
the database since 1996.  
39 pills were tested in 2002: 
• 20 tablets (i.e. 51.3%) only contained MDMA and a binding substance, the doses of MDMA in the 
tablets usually ranged from 30 mg – 90 mg; the minimum MDMA content was 7 mg, the 
maximum 150 mg. 
• 17 tablets and two crystalline substances (i.e. 48.7%) showed zero reaction to an MDMA 
presence test.  
• 6 of them were described as potentially dangerous – in addition to the binding substance, they 
contained an unknown substance (2 tablets); caffeine and piracetame were found in 2 tablets. 
Facility providing the 
service  
Service 
Number  % 
Number of 
instances of 
provision 
Exchange programme 75 93.8  153 977 
Outreach room  52 65.0  97 475 
Hygiene service  43 53.8  19 624 
Food service  46 57.5  71 449 
Medical attendance  56 70.0  12 026 
Individual counselling 64 80.0  19 373 
Group counselling 20 25.0  112 
Crisis intervention 61 76.3  3 112 
Referral to treatment  61 76.3  2 061 
Referral to outreach centre  52 65.0  2 468 
Referral to substitution treatment  44 55.0  197 
HIV tests 47 58.8  1 288 
HCV tests 44 55.0  1 539 
Counselling over the phone  56 70.0  10 988 
Number of projects 6 
Number of events where the services 
were provided  
39 
Number of contacts  cca 5 800 
Number of tested tablets  3 966 
Number of distributed condoms  cca 2 300 
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1 tablet contained amphetamine and caffeine, 1 tablet contained ephedrine, and 1 tablet was 
an anabolic substance.  
• thy crystalline substances contained cocaine hydrochloride and a mixture of potassium iodide 
and an unknown substance. 
• as far as the remaining non-reacting tablets are concerned, there were cough medicines, 
painkillers, medicines for inflammatory diseases, nootropic drugs, and antiallergics.  
The database includes several tablets that looked identical; however, the contents of the tablets 
varied, especially when they were collected at different times. 
The “Synthetic Drug Abuse Prevention” working group was set up within the framework of the 
National Drug Commission in October 2002 due to the extent of dance drugs consumption in the 
Czech Republic. Its tasks involved an analysis of the current situation and a proposal of appropriate 
measures in the field of the use of these substances; the results are summarized in the chapter on 
Approache.  
10.2.2.3 Prevention of Infectious Diseases  
The prevention of infectious diseases is a standard component of the services provided in low-
threshold facilities.  
The prevention of infectious diseases involves the following activities: 
• the delivery of information on infectious diseases,  
• education and motivation towards safer modes of drug use,  
• an exchange programme – including the safe disposal of used syringes – provided by more than 
90% of low-threshold facilities,  
• a secondary exchange programme56 - provided by at least 15% of facilities, 
• education and motivation towards safer sex and the distribution of condoms,  
• motivation and training for finding out about one’s own health – motivation for testing.  
• testing (from venous blood, or benchmark testing from saliva and capillary blood) – nearly 60% of 
facilities provide this service (Národní monitorovací středisko pro drogy a drogové závislosti, 
2003c), 
• mediation of vaccination, 
• mediation of contact with a practitioner when the client is or becomes ill. 
 
The final reports required for the subsidy process at the National Drug Commission also involve a 
questionnaire with regard to testing for infectious diseases in low-threshold facilities; a summary is 
given in Table 10-7 (34 facilities provided information) – see also the chapter on Drug-Related 
Infectio. 
                                                           
56 Involvement of active drug users who exchange injecting materials and provide information to other drug users (in the exchange 
programme operated by SANANIM Prague, 468,412 syringes were distributed, and 110,332 syringes thereof were distributed by the 
so-called „external field workers“ (i.e. active drug users who have received training and carry out exchange on difficult-to-reach 
places – flats, squats. This takes place under professional supervision.)  
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Table 10-7: Testing for infectious diseases in low-threshold facilities in 2002 (Národní monitorovací středisko pro drogy a drogové 
závislosti, 2003c) 
 
 
10.2.2.4 Overdose Prevention  
According to the survey Alcohol, Drugs, Hazards, and Life-Threatening Events (Nešpor et al.  2003) 
21 (51.2%) of the sample of 41 respondents addicted to illicit drugs have experienced an overdose at 
least once in their life – see the chapter on Other Drug-Related  for more information.  
Overdose prevention in the Czech Republic is only carried out by means of educating drug users 
within the framework of the services provided to them in low-threshold facilities and treatment 
facilities. The main topics of this education involve first aid in the event of an overdose, the risks of 
combining drugs, and principles of safe use.  
There are no other specific activities in the Czech Republic that we could consider as strategies that 
lead to overdose prevention, apart from the implementation and expansion of substitution 
programmes.  
10.2.2.5 Injecting Rooms 
There are no injecting rooms for drug users in the Czech Republic, the intensive debates about the 
establishment of injecting rooms that took place in 2000 – 20001 failed to continue in 2002; the 
establishment of injecting rooms does not appear to be a current need in the Czech Republic, with the 
exception of Prague, where there is an open drug scene.  
10.3 Standards and Evaluations 
Standards for low-threshold facilities and evaluation tools for the evaluation of the efficiency of 
services in the field of harm reduction are part of the standards of professional competency 
(Ministerstvo zdravotnictví ČR, 2001a) and the defining of indicators of evaluation of quality and 
effectiveness of these facilities; more information can be found in the chapter on Quality Assurance . 
Service  Number of 
facilities 
providing this 
service  
Number of 
tests carried 
out  
HIV tests from saliva 7 325 
HIV tests from capillary 
blood  
18 522 
HIV tests from venous 
blood  
10 311 
HAV tests from venous 
blood 
7 176 
HBV tests from capillary 
blood 
18 250 
HBV tests from venous 
blood 
8 265 
HCV tests from capillary 
blood 
25 942 
HCV tests from venous 
blood 
8 260 
Syphilis tests from venous 
blood 
2 176 
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11 Treatment 
11.1 Drug-Free Treatment and Health Care at National Level 
11.1.1 Definition 
Addiction treatment can be described as professional, goal-directed, and structured work with a client 
that is based especially on the bio-psycho-social model. For the purposes of treatment, it is possible 
to use many methods and approaches and combine them differently: pharmacotherapy, 
psychotherapy, family therapy, social work, art therapy, sociotherapy etc. The following types of 
treatment are distinguished: outpatient treatment (AT clinics, day-care programmes), residential 
treatment (specialized hospital departments, psychiatric hospitals), and residential care (therapeutic 
communities). According to the length of treatment, we can distinguish between short-term treatment 
(4 - 8 weeks), medium-term (3 - 6 months), and long-term treatment (7 months and more) (Kalina et 
al.  2001). 
11.1.2 Criteria for Admission to Treatment 
Individual types of treatment establish different criteria for admission. There are also differences 
between individual facilities providing a certain type of service (modality). Intensive outpatient care 
especially requires sufficient motivation on the part of the clients, and secured housing is also a 
condition for admission. Residential treatment has the most precisely defined criteria.  
Most therapeutic communities use the following general conditions: written application with a CV, 
detoxification, blood testing for HIV and VH, toxicological examination, and a recommendation for 
treatment from an expert. The criteria for admission to detoxification vary in each unit, sometimes they 
are markedly different. Some detoxification units have a very low threshold; others require special 
conditions, e.g. even a guarantee of after-care after the end of detoxification etc.  
The lack of cohesion between the individual types of service provided represents a defect in the 
system. Only 180 of 448 clients of 12 therapeutic communities have also sought another type of care, 
according to available data (Sekce terapeutických komunit A.N.O., 2002); in most cases, this involved 
after-care; in the case of relapse, this again involved a therapeutic community or psychiatric 
treatment.  
11.1.3 Delivery of Services 
342 health facilities were providing outpatient care in 2002 (Ústav zdravotnických informací a 
statistiky, 2003e); i.e. there were 342 outpatient psychiatric surgeries that provided services to drug 
users. 41,136 males and females using psychoactive substances underwent active treatment in these 
surgeries; more than a third of them were illicit drug users (Ústav zdravotnických informací a statistiky, 
2003e). Most of them were 30 – 39 years old; most illicit drug users were 20 - 29 years old (Ústav 
zdravotnických informací a statistiky, 2003e). Opiate (mainly heroin) abuse represents the most 
common form of illicit drug treatment (approximately 8,100 patients). Stimulant (especially pervitin) 
users formed the second largest group (approximately 5,400 patients). 
It is still impossible to provide an exact number of how many non-health facilities provide outpatient 
care, i.e. counselling and therapeutic services reflecting individual needs of clients. The Hygiene 
Service mentions 33 non-health outpatient facilities and 450 clients of these facilities (Polanecký et al.  
2003). In addition to the exclusively outpatient facilities, a large number of preventive and low-
threshold centres also provide outpatient services. Short-term intensive outpatient treatment is only 
provided in one day-care centre in Prague; it has a capacity of 12 people. This intensive day-care 
programme provided treatment to 43 clients in 2002; the average length of stay was 2.3 months.  
Residential care consists of specialized hospital departments, psychiatric hospitals, and clinics. There 
are 15 psychiatric hospitals for adults in the Czech Republic (1,194 beds for the treatment of 
alcoholism and other addictions) and 4 psychiatric hospitals for children (536 beds). 2,510 
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hospitalizations in connection with drug use took place in 2002, and the average length of treatment 
was 40 days (Ústav zdravotnických informací a statistiky, 2003a); detailed data are given in Table 
11-1. Data from hospital psychiatric departments for 2002 are not available so far. 32 hospital 
psychiatric departments operated in 2000 and their capacity was 1,534 beds for all MKN 10 
psychiatric diagnoses (Ústav zdravotnických informací a statistiky, 2002). 19 health facilities provide 
detoxification; it usually takes one to two weeks and it focuses on the management of withdrawal 
symptoms.  
Table 11-1: Psychiatric hospitals in the Czech Republic in 2002 (Ústav zdravotnických informací a statistiky, 2003a) 
Note: n.a. – data is not available  
16 communities were providing residential care in 2002 (215 beds, and approximately 520 clients). 12 
of them are associated in the Section of Therapeutic Communities of the Association of Non-
Governmental Organizations. The total capacity of these communities was 197 beds in 2002 and they 
reported 564 treatment demands, with 448 users entering treatment. 116 clients successfully 
completed treatment (after 324 days on average), 170 clients dropped out of treatment (after 194 
days on average). The average age of those treated was 23.6 years (Národní monitorovací středisko 
pro drogy a drogové závislosti, 2003c; Sekce terapeutických komunit A.N.O., 2002). 
Domov Agapé, a facility that specializes in the target group of drug-using clients aged 12 to 15, was 
set up in Opava in 2002. The facility was designed for 15 girls or boys, and it offers individual, group 
and family therapy, counselling, work therapy and other services. Domov Agapé started to operate in 
the second half of 2002, and 9 clients were treated there (average age 14.5). The average length of 
the stay was 2 months (Domov Agapé, Závěrečná zpráva dotačního řízení RV KPP 2002, 2003). 
There are two special education facilities in the Czech Republic that complement educational and 
resocialization activities with treatment; they provide 31 beds for drug users.  
The Prison Service ensures detoxification within the framework of treatment, therapeutic, and 
educational programmes (at the Praha-Pankrác and Brno prison hospitals); in addition, the so-called 
drug-free zones and specialized departments for differentiated sentences and the carrying-out of 
compulsory treatment. The capacity of specialized departments for differentiated sentences was 188 
beds (the Plzeň, Příbram, and Bělušice prisons) and the number of beds in drug-free zones (22 
zones) increased from 593 to 1,114 in 2002. There was an increase in the capacity to administer 
compulsory addiction treatment that is carried out in three prisons (Rýnovice, Opava, Znojmo) 
(Generální ředitelství Vězeňské služby ČR, 2003a); for detailed information see the chapter on 
Assistance to Drug Users in Prisons.  
NGOs provide external drug services in prisons. The interventions in prisons carried out by 
independent external experts are beneficial for both the clients and the prison service, which is offered 
a guarantee, supervision, education, and cooperation during the preparation of methodologies and 
conceptual frameworks. Work with clients is based on individual and group therapy (self-knowledge, 
drama therapy, art therapy, relapse prevention, and the like), counselling, crisis intervention, 
mediation of service, and social and legal services. These services are voluntary for clients; they are 
used in 12 out of 35 prisons and provided by 5 NGOs (Miovský et al.  2003; Škvařilová, 2003).  
11.1.4 Process Evaluation and Output Evaluation 
An internal model of therapy was tested at the Prague – Bohnice psychiatric hospital from June 2000 
to February 2002; it assumes that it will lead to increasing insight into the disease, integration of the 
ego, self-confidence, communicativeness, acknowledgment of treatment, and the disappearance of 
Gender  Number of 
beds  
Number of 
hospitalizations  
Average length of stay (in days)  
Males n.a. 1,776 39.1 
Females n.a. 734 41.3 
Total 1,194 2,510 39.8 
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anxiety and depressive moods in the course of treatment. The test sample consisted of 131 females 
(aged 16 - 58) who were in residential care for addiction to alcohol or another NPS for an average of 
86 days. Analysis of a questionnaire survey of their responses to residential treatment shows that a 
marked decline in anxiety and depressive moods took place among the patients (especially at the 
beginning of the treatment) and that there was a permanent slight increase in their insight into the 
disease, the integration of their ego, and increase in communicativeness and self-confidence. 
Appreciation of treatment (and especially the daily regime) did not change among these females 
during the course of treatment (Kubička and Csémy, 2003). 
11.2 Substitution and Maintenance Programmes 
There were 9 substitution centres in the Czech Republic as at December 31, 2002. There is no 
coverage in the following regions: Zlín, Pardubice, Vysočina, Southern Bohemia, Pilsen, and Karlovy 
Vary. 859 persons were clients of substitution programmes in the Czech Republic between May 2000 
and May 200357. 
All programmes provided exclusively oral substitution treatment with methadone prepared from an 
imported generic substance. The sublingual preparation Subutex®, containing buprenorphine, was 
registered on the Czech market in 2001. It is administered to suitable patients within the framework of 
the above-mentioned substitution programmes; at the same time, it can be prescribed and so each 
practitioner, regardless of his/her specialization, can prescribe it to patients.  
463 patients were treated in 9 substitution programmes in 2002 – 105 of these were in substitution 
treatment for the first time in their lives in this year; others were transferred from previous years. 213 
completed substitution treatment in the same year. Table 11-2 summarizes the state of the 
Substitution Treatment Register by December 31, 2002. 
The “Substitution Treatment” working group was working within the Phare Twinning Project and 
relevant ministries were involved (Ministry of Health, Ministry of the Interior, Ministry of Labour and 
Social Affairs, Ministry of Justice). 
11.2.1 Definition and Objectives of Substitution Treatment 
According to applicable Standards of Substitution Treatment, substitution treatment is an open-ended 
maintenance therapy that postpones the fulfilment of the final goal, i.e. permanent and consistent 
abstinence, until the patients are objectively and subjectively able to undergo abstinence-oriented 
treatment. Until then, substitution treatment aims to maintain and improve the patient’s somatic and 
mental condition. Substitution treatment is the first-choice method for patients who are not able to 
accept therapeutic methods that primarily focus on abstinence from NPSs (Ministerstvo zdravotnictví 
ČR, 2001a). 
11.2.2 Criteria for Admission to Substitution Programmes 
Criteria for admission for substitution programmes are especially defined as: (Ministerstvo 
zdravotnictví ČR, 2001a) 
Indications for methadone treatment:  
• Serious and long-term addiction to high doses of opioid-type substances. 
• Repeated unsuccessful attempts to undergo abstinence-oriented treatment. 
Factors supporting the admission of patients to a programme:  
• Medical records indicating a positive experience with substitution. 
                                                           
57 The programme in VFN in Prague (Apolinář) had been the only substitution programme in the Czech Republic until 2000. 25 
patients (17 males and 8 females) received methadone treatment in Apolinář between July 1997 (when it started to be provided) and 
the end of 1997, 30 patients in 1998 (21 males, 9 females), 88 patients in 1999 (61 males, 27 females) and 118 patients in 2000 (82 
males, 36 females). 
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• Opioid-type addiction of HIV-positive people or those who commit drug-related criminal activities 
when it is not possible to provide abstinence-oriented treatment. 
• Opioid-type addiction of pregnant women when it is not possible to provide considerate 
detoxification and abstinence-oriented treatment. 
Indications for buprenorphine treatment:  
• Opioid addiction when the daily equivalent of the dose does not exceed 60 mg of methadone, and 
when  
• It is not possible to provide abstinence-oriented treatment. 
Factors supporting the admission of patients to a programme: 
• Opioid-type addiction in combination with the abuse of a different substance (cocaine, pervitin). 
11.2.3 Availability 
The proportion of opiate users in substitution treatment in the Czech Republic was insufficient in 2002 
– 463 persons undergoing methadone substitution treatment and the estimated 500 -700 persons 
undergoing Subutex® substitution treatment (see below) form approximately 1,000 persons 
undergoing substitution treatment (approximately 7% of the estimated number of problem opiate 
users, as opposed to the average figure of more than 30% in EU Member States). 
This was especially caused by the poor availability of substitution centres; they are located in 6 large 
towns and therefore they are practically inaccessible to potential patients from small towns or villages. 
The capacity of substitution centres is completely saturated in some places, and there are waiting lists 
(Prague, Ústí nad Labem, Brno); the capacity is rather underused in other places (Olomouc, Ostrava, 
Hradec Králové). The programme in Mělník collaborates with the programmes in Prague and 
therefore it could be a model for the provision of this type of care under the circumstances of regular 
outpatient medical care. 
After Subutex® was registered, treatment with this product started to pick up in outpatient clinics of 
psychiatrists and general practitioners. Data about the scope and quality of this service are not 
available; there is an apparent trend towards expansion. It is possible to estimate from the number of 
batches issued from the distributor’s stocks that 500 – 700 patients were receiving this treatment by 
the end of 2002.58 
Table 11-2: Substitution treatment patients in specialized programmes – by December 31. 2002 
 
11.2.4 Substitution Preparations and 
Organization of Substitution 
Treatment 
Two preparations for substitution 
treatment have been approved in the 
Czech Republic:  
• Methadone (generic substance): a 
solution is made in a pharmacy and 
then it is distributed to individual 
facilities; patients with a long history 
of successful therapy receive doses for home use for several days – for a maximum of one week. 
Methadone is fully covered from a special subsidy of the Ministry of Health.  
                                                           
58 Assuming that it is used in proper treatment and doses; the estimated number does not include drug users who use buprenorphine 
from the black market for ‘wild’ substitution.  
Centres  Number of 
persons  
VFN - Prague 2 54 
FN Ostrava-Poruba 2 
AT Clinic Olomouc 4 
DPS Elysium Brno 52 
Methadone unit Ústí nad Labem 119 
DROP IN o.p.s. Prague 1 (two programmes) 100 
OAT Clinic Hradec Králové 11 
AT Clinic Mělník 11 
Total 353 
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• Buprenorphine (brand-product Subutex®; prescription was not limited in 2002). None of the 
insurance companies in the Czech Republic provides even partial coverage and patients must 
pay for it themselves. The Ministry of Health provides several residential and outpatient facilities 
with subsidies for the purchasing of Subutex®, namely for additional funding of treatment care 
(detoxification) and also for maintenance treatment of selected groups of patients (especially at-
risk groups, socially underprivileged groups, etc.). 
Insurance companies cover the costs of all tasks performed by practitioners and health-service 
personnel in connection with the supply of substitution treatment. However, the actual task of 
“administration of a substitution medicament” is not covered and it is not even defined.  
The National Register of Medically Indicated Substitution Substances has been working in the Czech 
Republic since mid-2000 (Ministerstvo zdravotnictví ČR, 2001b). Only methadone-based substitution 
treatment was obliged to be registered in 2002. 
11.2.5 Psychosocial Counselling 
Psychosocial care is an obligatory part of the lege artis treatment provided (with the exception of 
special cases of short-term hospitalization, etc.) according to the Standard of Substitution Treatment 
(Ministerstvo zdravotnictví ČR, 2001a).  
However, it is problematic to ensure a quality supply of this treatment component in specialized 
programmes in practice, mainly due to the non-existence of a mechanism of financial compensation. 
This field is considered to be one of the significant weaknesses of the current state of affairs, even 
though specialized programmes are trying to ensure this care within the limits of their possibilities.  
The supply of psychosocial care for patients who use Subutex® is not sufficiently described. It is 
generally believed that there is insufficient networking between outpatient practitioners and providers 
of psychosocial care to drug addicts.  
11.2.6 Leakages of Substitution Drugs to Black Market 
There is no available verified knowledge about the occurrence of methadone on the black market in 
2002.  
Field programmes started to report the presence of Subutex® on Prague’s black market in summer 
2002; by the end of 2002, similar reports also appeared in Northern Bohemia and sporadically even in 
other regions of the Czech Republic.  
Some of those who use Subutex® illicitly use it sublingually; however, a part of them dissolve it for 
intravenous use and they “substitute” the injecting use of the markedly more expensive heroin; 
however, general health risks following from intravenous use persist. However, no overdoses or other 
negative consequences specifically connected with buprenorphine use have yet been recorded. The 
potential risks especially involve buprenorphine use in combination with benzodiazepine 
medicaments.  
However, buprenorphine use on the open scene also has positive impacts; they were discussed at 
the 2003 Prague Harm Reduction Conference (Větrovec, 2003). The existence of this cheaper 
competitor of heroin unambiguously brings about a decline in the demand for heroin, a reduction of 
crime (thefts), a better opportunity to make contact with these clients, and a reduction in the provision 
of first aid during heroin overdoses.  
11.2.7 Output Evaluation, Statistics, Research and Education  
No comprehensive evaluation of substitution treatment has yet been carried out in the Czech 
Republic. 
A survey of Prague authors (Kábrt et al.  1999) dealt with the influence of the methadone programme 
on the nutritional condition of opiate users. It found out that methadone substitution treatment led to 
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an improvement of their subjective condition and also to an objectively demonstrable improvement in 
nutrition (weight increase, axillary plica).  
The personnel of VFN Apolinář prepared a simple internal evaluation of treatment results in 1999. It is 
planned that substitution programmes will be extensively evaluated in the Czech Republic within the 
framework of an international WHO survey in 2003; the Czech National Focal Point is coordinating the 
Czech part.  
902 heroin addicts were admitted to substitution treatment between May 2000 and May 2002. In total, 
580 went through this treatment in this time period, 404 of whom were males and 176 females 
(Matoušková, 2002); see Table 11-3 and Table 11-4. 
Table 11-3: Age structure of methadone treatment clients in the Czech Republic from May 2000 to April 2002 (Matoušková, 2002) 
Table 11-4: Average number of attempts for methadone substitution (admissions) per client by his/her age in the period between 
May 2000 to April 2002 (Matoušková, 2002) 
 
11.2.8 Plan for Further Periods  
Government Resolution No. 549/2003 assigned the following targets on the basis of the outputs of the 
Phare Twinning Project: 
• ”To initiate and conduct negotiations about covering at least one substitution preparation and 
appropriate performance of tasks connected with the administration of substitution treatment by 
health insurance companies” by the end of 2003 (Ministry of Health), 
• ”To increase the availability of substitution treatment evenly throughout the whole republic 
according to identified needs and demands” by the end of 2004 (Ministry of Health), 
• “To provide for ongoing professional education to providers of substitution treatment (practitioners 
and nurses)” (Ministry of Health), 
• “To ensure the availability of substitution treatment in prisons, remand prisons, and police cells” by 
June 31, 2004 (Ministry of Justice and Ministry of the Interior, in collaboration with Ministry of 
Health). 
Males Females Age category 
(years) Number % number % 
18 - 24  136 33.7 81 46.0 
25 - 29  135 33.4 62 35.2 
30 - 34  55 13.6 16 9.1 
35 - 39  46 11.4 13 7.4 
40 and more  32 7.9 4 2.3 
Total 404 100.0 176 100.0 
Males Females Age category 
(years)  Number Average number of 
attempts for treatment  
Number Average number of attempts 
for treatment  
18 - 24  136 1.4 81 1.3 
25 - 29  135 1.4 62 1.7 
30 - 34  55 1.6 16 1.4 
35 - 39  46 2.1 13 1.6 
40 and more  32 2.0 4 1.8 
Total 404 1.6 176 1.5 
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11.3 After-care and Re-integration  
11.3.1 Definition of After-care and Re-integration  
In the bio-psycho-social model of addiction, after-care can be defined as a collection of all services 
that take place after the end of a basic treatment programme and that, in summary, help to set up 
conditions for the maintenance of abstinence from drug use or the re-integration of a client after 
treatment (Kalina et al.  2001). Therefore, a client’s abstinence is not the only goal; the prevention of 
relapse to the primary drug or his/her involvement in normal life without considerable problems 
caused by the occasional use of a psychotropic substance are also aimed at (Kuda, 2001). In 
principle, three types of after-care programmes can be distinguished: 
• outpatient after-care programmes, 
• programmes of sheltered accommodation and sheltered housing with psychosocial support, 
• programmes of sheltered workshops and sheltered work with psychosocial support.  
It has not yet been possible to develop these services in a manner that would ensure the requisite 
availability of services or professionalism of the staff. After-care for drug users after completion of their 
sentence and for other specific groups of addicts (e.g. specific programmes for females, mothers with 
children, and ethnic minorities) is totally absent.  
11.3.2 Delivery of Services 
Currently there are 12 facilities in the Czech Republic that specialize in after-care. All of these facilities 
have been established by NGOs and they are mainly funded from the state budget. In addition to 
three main programmes (see above), after-care can also mean requalification or training programmes 
etc. Clients who have completed treatment in a psychiatric hospital, therapeutic community, or 
intensive outpatient treatment, and abstain and return to normal life are the target group for after-care. 
All twelve facilities provide outpatient treatment that mainly consists of individual and group therapy, 
pair and family therapy, counselling and social work, relapse prevention, education, and other 
activities. Approximately 400 clients used the services of these twelve facilities in 2002. 7 facilities 
provide sheltered housing; 183 clients made use of this sheltered housing in 2002. The length of a 
stay in sheltered housing varies from four to twelve months. Seven after-care facilities also provide 
work in sheltered workshops; some even offer a possibility of re-qualification (Národní monitorovací 
středisko pro drogy a drogové závislosti, 2003c). 
Two Prague programmes for mothers with children were specially arranged within the framework of 
after-care; the number of mothers in treatment and after-care has been constantly increasing 
(Národní monitorovací středisko pro drogy a drogové závislosti, 2003c).  
Most facilities cooperate with the Probation and Mediation Service of the Czech Republic, see the 
chapter  on Alternatives to Prison for Drug Dependent Offenders for more information. 
After-care services are, for instance, also provided by several outreach centres that organize so-called 
after-care groups; some therapeutic communities and psychiatric hospitals also provide repeated 
(short-term) treatment stay for clients who have completed treatment. 
In the manner of Alcoholics Anonymous and Narcotics Anonymous, self-helping organizations of (ex) 
drug users started to emerge in the mid-1990s; inside information about their activities is not available.  
11.4 Overview of Treatment Availability in the Czech Republic 
Table 11-5 and Map 11-1 to Map 11-3 provide a summary of data collected about the number of 
respective types of treatment facilities in the Czech Republic, and the capacity and level of use of 
these facilities in 2002 (Generální ředitelství Vězeňské služby ČR, 2003a; Miovský et al.  2003; 
Národní monitorovací středisko pro drogy a drogové závislosti, 2003c; Ústav zdravotnických informací 
a statistiky, 2003a). 
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Table 11-5: Treatment programmes in the Czech Republic in 2002  
Note: * data for 2000. ** all “psychiatric” beds. *** data from 12 (of 16) communities. **** number of hospitalizations  
Map 11-1: Psychiatric hospitals and therapeutic communities in the Czech Republic in 2002 
 
Programme type  Number  Capacity 
(places/beds) 
Occupancy rate 
(number of persons) 
Outpatient psychiatric clinics and AT 
clinics  
342 n.a.  apx 15,600 
Day-care centres  1 12 43 
Detoxification units 19 n.a. n.a. 
Psychiatric hospitals  15 1,194 2,510**** 
Psychiatric departments in hospitals * 32 1 534** n.a. 
Residential departments with 
treatment programmes (special 
education facilities for problem youth) 
2 31 n.a. 
Therapeutic communities  16 197*** 448*** 
After-care programmes 12 n.a. 398 
Detoxification units in prisons 2 n.a. n.a. 
Drug-free zones in prisons 22 1,114 n.a. 
Departments for differentiated 
sentence  
3 188 n.a. 
Department for compulsory treatment 
in prisons  
3 62 n.a. 
Substitution centres  9  n.a. 463 
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Map 11-2: Substitution centres in the Czech Republic in 2002 
 
 
Map 11-3: After-care centres in the Czech Republic in 2002 
 
12 Interventions in the Criminal Justice System 
There were no legislative changes in statutory regulations regarding custody and sentence in 2002. 
However, the amendment to the Code of Criminal Procedure has had a substantial impact on the 
prison system (see the chapter on Legal Framework); this especially involved a new arrangement of 
custody proceedings that brought about a significant decline in the number of persons placed in 
custody and especially the number of persons newly placed in custody in 2002 (by 30%) (see the 
chapter on Drug Offences ).  
The “Prisons” working group was working within the framework of the Phare Twinning Project in 2002; 
it also involved representatives of the General Directorate of the Prison Service, representatives of 
several prisons, and the Association of Non-Governmental Organizations. The main outputs involve:  
• The final report of the Prisons working group; it also includes a list of main recommendations 
(Haas et al.  2003), see below, 
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• The draft of Minimum Standards for Therapeutic Departments in Prisons (Kuda, 2003), 
• The draft of an Educational Curriculum for the Prison Staff of the Czech Republic (Miovský et al., 
2002), 
• A document, ”NGOs in Drug Services in Prisons and Custody Prisons (Nestátní neziskové 
organizace v drogových službách ve věznicích a vazebních věznicích)”; it also includes an 
analysis of the current state of affairs and a blueprint for conditions for collaboration between the 
Prison Service and NGOs. 
The group formulated the following recommendations:  
• to set up an intersectorial working group in the field of prisons and drugs (General Directorate of 
the Prison Service in collaboration with the National Drug Commission); it should become a 
communication platform for the solution of long-term and current tasks, 
• to review the measures of the Prison Service regarding NPSs, with an emphasis on linking up, 
following up, and providing comprehensive care within the prison system and linking up these 
activities with programmes outside the Prison Service, 
• to deepen collaboration with NGOs that deal with the implementation of programmes for drug 
users in prisons, namely in the form of the completion and conclusion of a contract for 
collaboration and in the form of the preparation and implementation of a system of funding of 
these services with the objective of achieving a sustainable form of this collaboration,  
• to facilitate and support the development of research activities implemented both within the 
framework of the Prison Service and through independent studies conducted by research bodies 
outside the Prison Service, 
• to extend and improve the monitoring system in the field of the use of NPSs within the framework 
of the prison system and interconnect this system with other data collection systems coordinated 
by the Czech National Focal Point, 
• to assess the possibilities of, and set up conditions for, the introduction of substitution treatment 
for opiate addicts (namely heroin addicts) in custody or serving a sentence. 
The two last-mentioned recommendations are reflected in a Government Resolution No. 549/2003 
(Sekretariát Rady vlády pro koordinaci protidrogové politiky,  2003), that directed the appropriate 
ministers to fulfil the targets following from the conclusions and recommendations of the Phare 
Twinning Project. On the basis of this decree, the other conclusions and recommendations of the 
“Prisons” working group should be incorporated into the prisons drug policy strategy by June 30, 
2004.  
This involves the implementation of long-term objectives and this is connected with a number of 
changes to the system; many of these changes go far beyond the current relatively conservative 
approach. If these changes are implemented successfully, it is possible to expect fundamental 
changes in the position of prisons in the system of the national drug policy in the field of demand 
reduction.  
12.1 Assistance to Drug Users in Prisons 
The study implemented by the Institute for Criminology and Social Prevention in 2000 (Marešová et 
al.  2000) claims that at least 40% of all persons serving a sentence (not those in custody) report 
lifetime experience with an illicit drug; at the same time, approximately 50% of them have used drugs 
in the long-term. According to this study, 31% of juveniles and 19% of males convicted for the first 
time have used a drug in prison; as far as repeatedly convicted persons are concerned, this involves 
5% of males and 4% of females. It is common that drugs find their way into prisons; 20 – 30% of 
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those incarcerated have access to them; employees and consignments from the outside (packages, 
visitors) are the main routes of penetration of drugs to prisons.  
The results of screening tests for the presence of drugs carried out by the Prison Service on 
admission and during the course of the serving of sentences showed that the share of positive results 
has declined between 2001 and 2002 (see Table 12-1).  
Tests for the presence of drugs on admission were only carried out in two Prague prisons in 2002 (Pankrác, 
Ruzyně). 981 (26.6%) out of 3,689 entrance tests were positive in 2002 (26.6%). Tests on inmates for the 
presence of drugs were carried out in 17 prisons in 2002; i.e. in nearly a half of the total number of 35 prisons in 
the Czech Republic. 1,806 sets of tests were carried out in total (each test being for the presence of 6 basic 
types of drugs); 154 (8.5%) of these tests were positive. However, the number of persons tested is unknown 
because some persons could have been tested several times; at the same time, the directors of individual 
prisons determine the manner of selection of those (repeatedly) tested. 
Amphetamines - 35.5% of all positive findings (33.1% in 2001), then benzodiazepines - 25.9% (46.7% 
in 2001), cannabinoids - 25.1%, and opiates - 10.0%, were the most commonly found substances. In 
addition, there were barbiturates (3.1%) and cocaine (0.3%), (Generální ředitelství Vězeňské služby 
ČR, 2003a; Zábranský et al.  2002). 
Table 12-1: Tests conducted for the presence of drugs among inmates in 2001 and 2002 (Generální ředitelství Vězeňské služby ČR, 
2003a; Zábranský et al.  2002) 
 
Table 12-2 (Generální ředitelství Vězeňské služby ČR, 2003b) presents data about the numbers of 
persons registered as “drug-addicted”59. The proportion of such registered drug users in the whole 
prison population increased from 18.6% in 1998 to 33.9% in 2002. However, it is necessary to 
exercise caution in interpreting these data, due to the unfocused criteria for inclusion in this group. 
Table 12-2: Development in the number of registered drug users from 1996 to 2002 and the proportion of these users in the entire 
prison population (Generální ředitelství Vězeňské služby ČR, 2003b) 
 
The proportion of persons convicted for drug-related criminal offences in the total number of convicted 
persons serving a sentence has been increasing continuously; it increased from 4.4% in 1999 to 4.8% 
in 2002 (Řeháček, 2003). The number of drug-related criminal offences per person serving a 
sentence for drug-related criminal offences increased from 885 in 2001 to 965 in 2002 (see the 
chapter on Drug Offences  for detailed information about criminal offences).  
Tests for infectious diseases (HIV, hepatitis, syphilis) are carried out in all 35 prisons. 674 tests for HIV 
(3 tests (i.e. 0.4%) thereof positive), 1,438 tests for HBV (282 positive tests, i.e. 19.6%), and 1,319 
                                                           
59 The use of the term “drug-addicted” by the Prison Service is inaccurate. According to a statement of the General Directorate of the 
Prison Service, it basically refers to persons who claim to be (regular) drug users, persons who had a record of addiction in their 
health documentation before they entered prison, and persons who were found positive through drug screening. Occasional users 
should not be included in this category.  
2001 2002 Indicator 
Total On 
admission  
During 
sentence  
Total 
Number of tests  4,966 3,689 1,806 5,495 
Positive thereof  1,245 981 154 1,135 
% of positive tests  25.1 26.6 8.5 20.7 
Indicator 1996 1997 1998 1999 2000 2001 2002 
Number of inmates  20,860 21,560 22,067 23,060 21,538 19,320 16,213 
Number of drug users  2,517 3,255 4,115 5,990 5,477 5,524 5,481 
Share in the total number of 
inmates (%) 
12.1 15.1 18.6 26.0 25.4 28.6 33.8 
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tests for HCV (686 positive, i.e. 52.0%) were carried out among incarcerated drug users in 2002 (see 
also the chapter on Drug-Related Infectio). 
It follows from the results of the survey “HCV Seroprevalence among Injecting Drug Users” that 
40.6% of clients of low-threshold programmes have at some time been incarcerated. 40.1% thereof 
injected drugs in prison (3% thereof for the first time in their lives). HCV prevalence among injecting 
users who have been incarcerated reaches 51.9%; this is statistically more relevant than among non-
incarcerated users – see the chapter on Drug-Related Infectio for more information. 
12.1.1 Treatment Programmes for Drug Users in Prison 
The situation in the field of treatment and other specialized programmes intended for drug users in 
prison does not meet the needs in this field (Miovský et al.  2003). It is true that there has been an 
increase in the number and total capacity of such programmes; however, attempts to draw up and 
implement standards of treatment and other services have failed so far. Health care programmes – 
especially psychiatric departments – are not sufficiently accommodated to the specific nature of drug 
addiction treatment. Substitution treatment has not yet been introduced; harm reduction measures are 
totally inadequate. Approximately 30% of prisons collaborate with NGOs; however, this cooperation 
lacks a specific defined framework. 
Detoxification is still being carried out in two prison hospitals (Prague – Pankrác and Brno).  
The number of drug-free zones increased to 22 of 35 Czech prisons; therefore, the total capacity 
increased to 1,444 beds. The main goal of these departments is to prevent the convicts from getting 
into contact with NPSs. With exceptions, the drug-free zone programmes do not provide therapy; this 
approximates their functions to the internationally acknowledged definition. The General Directorate of 
the Prison Service recommends that the facilities where therapy is still provided should be 
transformed into specialized therapeutic departments.  
Institutional compulsory treatment (both voluntary and ordered by the court) is provided in specialized 
departments in the Rýnovice prison, the Opava prison (with a department for females and a 
department for juveniles) and, newly, also in the Znojmo prison. A total capacity of 62 beds was 
available in these departments in 2002. This treatment is based on a community system; at the same 
time, it makes use of group and individual therapy and other treatment procedures.  
Differentiated treatment for convicts “suffering from personality disorders and behavioural disorders 
caused by the use of narcotic and psychotropic substances” was provided in the the Pilsen prison (a 
department for males), the Příbram prison, and the Bělušice prison. A total capacity of 188 beds was 
available in these specialized departments in 2002.  
Substitution treatment of opiate addicts has not yet been introduced in prisons. Government 
Resolution No. 549/2003, approved on the basis of recommendations of the Substitution Treatment 
and the Prisons working groups of the Phare Twinning Project, directs the Minister of Justice to 
guarantee the implementation of substittion treatment in prisons and remand prisons in collaboration 
with the Minister of Health. 
Apart from several exceptions, measures for the minimization of drug-related damage (harm 
reduction) are not implemented in prisons in the Czech Republic; this is true even though injecting use 
is relatively common in prisons (see above). The above-mentioned working group of the Phare 
Twinning Project identified this fact as one of the main problems. Condoms are an obligatory part of 
the assortment of goods offered for sale to accused or convicted persons in prisons and remand 
prisons, together with foods, dry goods, and industrial goods.  
12.1.2 Cooperation with Outside Subjects 
The publication “NNO v drogových službách ve věznicích a vazebních věznicích (NGOs in drug 
services in prisons and custody prisons)” (Miovský et al.  2003) was drawn up within the framework of 
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activities of the Prisons working group of the Phare Twinning Project. It included a description of the 
current level and quality of cooperation between NGOs and the Prison Service regarding the supply of 
services for drug users in prison, examples of the current cooperation between the Prison Service and 
several NGOs, identification of the main problems, and a proposal for a possible solution of these 
issues.  
This publication also contains a proposal for a framework agreement between the Association of Non-
Governmental Organizations and the General Directorate of the Prison Service; it should provide for 
and stabilize basic conditions for mutual cooperation with applicable legal regulations, allow for the 
development of counselling and therapeutic programmes, and solve other issues regarding mutual 
cooperation.  
No complete list of NGOs that offer and provide services for drug users in prisons is yet available. The 
facilities that are the most active in these activities involve the Podané ruce Brno civic association - 
programme ”Drug Services in Prison” (in collaboration with prisons in Brno, Kuřim, and Břeclav), 
SANANIM Prague civic association - programme ”Work with Drug Users in Custody” (Prague prisons 
in Pankrác and Ruzyně), Laxus Hradec Králové civic association (prisons in Hradec Králové and 
Pardubice), and AVE Český Těšín civic association – outreach centre programme (prison Karviná).  
The most frequently provided services involve individual and group counselling and therapy, 
motivation training, family counselling and therapy, mediation of after-care or treatment after release 
from prison, social and legal counselling, and the like. These facilities especially collaborate with 
medical staff and psychologists or special pedagogues of the Prison Service for the purposes of the 
supplying of these services; in addition, they also collaborate with other subjects (Probation and 
Mediation Service or after-care institutions). NGOs are also involved in the education of Prison 
Service staff, Probation and Mediation Service staff, or judges.  
12.2 Alternatives to Prison for Drug Dependent Offenders 
The provision of Section 27 of the Penal Code contains a list of sentences that can be imposed for 
criminal offences committed under Czech law. This involves the following sentences: imprisonment, 
community service, loss of honorary degrees and awards, loss of military rank, prohibition of activities, 
forfeiture of property, statutory penalty, forfeiture, deportation, and prohibition of stay.  
In a broad sense, the term ‘alternative sentences’ is used for sentences that are not connected with 
imprisonment. The so-called diversions from standard criminal proceedings (also called alternative 
manners of criminal proceedings), which also include the suspension of criminal proceedings and 
settlement, must be distinguished from alternative sentences. The common attribute of both of these 
is that when they are used, criminal prosecution does not end in a decision about guilt or punishment 
(the decision is taken by means of a ruling and not by means of a conviction) but rather in a manner 
that prefers other interests of the offender and the interests of society (e.g. the interest in 
compensation of loss and damage) (Sotolář et al.  2002). However, the institute of settlement is not 
used within the framework of primary and secondary drug-related criminality, because one of the 
conditions for this procedure is that the accused makes a financial deposit for public purposes. 
Therefore, this solution is out of the question for problem drug users, especially with regard to their 
financial situation.  
However, not all types of sentences can be imposed separately. The alternative sentences that can 
be imposed separately and are not linked to a sentence of imprisonment involve community service, 
statutory penalties, prohibition of stay, and deportation.  
A suspended sentence, or suspended sentence with supervision, is the most common form of 
punishment in the Czech Republic. It is also possible to regard it as an alternative to an unsuspended 
sentence because it does not mean the immediate isolation of the offender in prison, which is similar 
to other alternative sentences.  
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93,378 persons were prosecuted by Public Prosecutors’ Offices in 2002; 77,210 persons appeared in 
court. The courts convicted 65,098 persons; 9,659 received unsuspended sentences, 34,942 
received suspended sentences, a prohibition of activities was imposed on 94 persons, 3,500 persons 
received a statutory penalty, and 13,424 persons were sentenced to community service (Ministerstvo 
spravedlnosti ČR, 2003). The proportion of alternative sentences in all sentences has been increasing 
(10.1% in 1996, 27.8% in 2002); it is mainly due to the sharp rise in the number of sentences to 
community service imposed.  
Table 12-3 provides a summary of sentences and compulsory treatments imposed on offenders of 
drug-related criminal offences, i.e. criminal offences according to the provision of Section 187 to 188a 
of the Penal Code. The Czech legal system does not consider compulsory treatment as a punishment 
but rather as a protective measure. It is possible to impose compulsory treatment both in addition to 
sentences and in the case of waiver of sentence (see also the chapter on Laws Implementation). 
Table 12-3: Summary of sentences and compulsory treatments imposed on offenders of drug-related criminal offences by courts in 
the Czech Republic in 2001 – 2002 (Ministerstvo spravedlnosti ČR, 2002; Ministerstvo spravedlnosti ČR, 2003) 
 
12.2.1.1 Probation and Mediation Service  
The Probation and Mediation Service was established by Act 257/2000 Coll. and it carries out 
probation and mediation for cases in penal proceedings in a scope defined by the Penal Code and 
the Code of Criminal Procedure. Special departments focusing on work with drug users have been 
established within the framework of the Probation and Mediation Service. Special attention should be 
paid to juveniles or very young people, especially if they are users of narcotic and psychotropic 
substances.  
Probation especially means the organizing and carrying out of the supervision of an accused, 
prosecuted, or convicted person (hereinafter referred to as “the accused”), supervision of sentences 
that are not connected with imprisonment, including imposed obligations and limitations, and 
monitoring of the behaviour of a person sentenced to a period of probation. 
Mediation means out-of-court mediation for the purposes of solving the dispute between the 
aggrieved and the accused parties and activities geared towards the settlement of a conflict and 
Section 187 Section 187a Section 188 Section 188a Total Sentence (compulsory 
treatment)  2001 2002 2001 2002 2001 2002 2001 2002 2001 2002 
abs
. 
365 347  16  18  13  10  10  4  404  379  Unsuspended 
sentence  
% 40.3 34.5 18.6 17.5 20.9 17.2 24.4 8.3 36.9 31.2 
abs
. 
474  540  45  60  40  34  23  31  582  665  Suspended 
sentence  
% 52.4 53.6 52.4 58.3 64.5 58.6 56.1 64.6 53.2 54.7 
abs
. 
41  77  18 17 4  12  5  7  68  113  Community service 
% 4.5 7.6 20.9 16.5 6.5 20.8 12.2 14.6 6.2 9.3 
abs
. 
8  9 2  5  4  1 1  0 15  15 Other sentence  
% 0.9 0.9 2.3 4.9 6.5 1.7 2.4 0 1.4 1.2 
abs
. 
17 34 5 3 1 1 2 6 25 44 Sentence waived  
% 1.9 3.4 5.8 2.8 1.6 1.7 4.9 12.5 2.3 3.6 
Total convicted  abs
. 
905 1,007 86 103 62 58 41 48 1,094 1,216 
abs
. 
43  45 2  5  1  1  0 3 46  54  Compulsory 
treatment thereof  
 % 4.8 4.5 2.3 4.9 1.6 1.7 0 6.3 4.2 4.4 
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carried out in connection with penal proceedings. It is only possible to carry out mediation with the 
express consent of the accused and the aggrieved parties.  
The Probation and Mediation Service recorded 29,291 new cases in 2002. 765 cases thereof 
involved drug-related criminal offences (Probační a mediační služba ČR, 2003). A representative of 
the Probation and Mediation Service is also involved in the work of the Criminal Law Sector Data 
working group of the Czech National Focal Point. This level also involves work on a change in the 
recording of criminal cases by the Probation and Mediation Service; this especially concerns more 
detailed records of drug-related criminal activities (drug type) and the secondary criminality of drug 
users. The reason is that officers of the Probation and Mediation Service interview drug users, 
especially during the preparation of documentation for the court and in connection with the 
supervision of suspended sentences, and they get detailed information about the offenders of these 
crimes. This involves information that is not regarded as relevant from the point of view of criminal 
proceedings, or information that the prosecuted are not willing to tell the law enforcement bodies. 
More detailed recording by the Probation and Mediation Service could then make a significant 
contribution to the collection of important qualitative data about drug addicts who did not come into 
conflict with the law, or at least about some of these persons.  
12.3 Evaluation and Training 
The evaluation of programmes designed for incarcerated drug users and the education of Prison staff 
in this field are relatively new topics in the Czech prison system.  
There are no available comprehensive evaluation studies dealing with the efficiency and effectiveness 
of treatment programmes and interventions in the prison environment.  
12.3.1 Statistics and Research 
The Yearbook of the Prison Service of the Czech Republic, published by the General Directorate of 
the Prison Service, is the main source of statistical data reported within the framework of the prison 
system. The basic structure of the yearbook has remained the same for several years. It provides 
basic statistical data about the status and development in size of the prison population (accused and 
convicted), and its structure by age, gender, nationality, offences, length of imprisonment, number of 
previous convictions, etc.; at the same time, it provides basic data about prison staff and the finances 
of the Prison Service. 
As far as data involving incarcerated drug users are concerned, the Yearbook provides data about:  
• The number of persons convicted for drug-related criminal offences and the number of offences 
committed by them (see the chapter on Drug Offences ),  
• The number of persons registered as drug users by the Health Service of the Prison Service (see 
the chapter on Assistance to Drug Users in Prisons). 
The publication Drogová problematika ve věznicích ČR a některých zahraničních věznicích (Drug 
Issues in Prisons in the Czech Republic and Several Foreign Prisons) (Marešová et al.  2000) is one 
of the first attempts to provide a comprehensive description of the prison drug scene. 
The publication Úspěšnost preventivní práce (Success of Preventive Work) (Večerka and Holas, 
2001) deals with the evaluation of crime and drug use prevention measures in prisons. It especially 
deals with one aspect of evaluation: the evaluation of the satisfaction and acceptability of a 
programme for the target population; other fields of evaluation are not processed in such a 
comprehensive manner or are totally missing.  
The study Specifické aspekty zneužívání drog u žen (Specific Aspects of Drug Abuse Among 
Females) (Trávníčková et.al., 2001) seems to be a promising work in the field of the future 
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development of treatment programme evaluations; it deals with the specifics of drug use among 
females and issues related to criminal activities. 
Inter alia, the PAD research study (Zábranský et al.  2001b) calculated expenditure on persons in 
custody or serving a sentence in any connection with the use of drugs (i.e. not only for primary drug-
related criminal offences but also for so-called secondary drug-related criminality). These amounted to 
approximately CZK 469 million (€ 14.8. million) in 1998.  
A publication describing the state of drug use in prison and related phenomena was developed within 
the framework of the Phare Twinning Project  (Miovský a kol., 2003). 
In the last two years, data about drug users in prison have been acquired from the Department of 
Execution of Custody and Sentence of the General Directorate of the Prison Service; the head of this 
department is a member of the Criminal Law Sector Data working group of the Czech National Focal 
Point. In 2002, this collaboration resulted in the supply of data that especially involved:  
• The number of screening tests conducted for the presence of drugs and the results of these tests 
(the Health Service of the Prison Service conducts this testing),  
• The number and capacity of drug-free zones and specialized departments for drug users,  
• Tests conducted for infectious diseases.  
Unification of the methodology of data collection about drug use between the prisons system and the 
outside systems is one of the main priorities for the future.  
12.3.2 Education of the Prison Service in the Field of Drugs and Drug Addictions   
The Institute of Education of the Prison Service, located in Stráž pod Ralskem, plays a key role in 
Prison Service staff training. The Institute of Education of the Prison Service provides, for instance, 
basic entrance education for all new Prison staff. The institute provides three short courses in the field 
of drug use and related questions. The target group of these courses does not exclusively involve 
staff in programmes designed for drug users; however, it was shown in the course of 2002 (see 
below) that this group is a major target for further education, namely for ongoing education.  
A Needs Analysis in the field of education of the Prison Service was carried out within the framework 
of the Phare Twinning Project; it identified trainer training (i.e. that of persons who will provide 
education within the framework of the Prison Service) as a missing field (Miovský, 2002b). For this 
purpose, a detailed curriculum for an educational course for workers responsible for the education of 
other staff in individual prisons was suggested and drawn up in the course of 2002 (Miovský et al., 
2002). It is expected that this course will be piloted and evaluated in 2003 and 2004, and then it will be 
included in the standard offer of the Institute of Education of the Prison Service.  
13 Quality Assurance  
13.1 New Trends and Developments in 2002 
Guaranteeing the quality of treatment, with the objective of achieving maximum efficiency, has been 
playing an increasingly important role in the treatment of drug users. Quality assessment can be 
divided into user assessment and professional assessment. The existence of criteria and introduction 
of mechanisms that assess the level of service delivery according to these criteria is a prerequisite for 
professional quality assessment (Kalina, 2001). Standards of Service Quality and the consequent 
process of certification of quality are tools for the improvement of quality and efficiency of treatment; in 
addition, they can be used for the monitoring and optimization of treatment costs.  
The “Accreditations” working group of the Phare Twinning Project analyzed the development of 
standards of quality of services in addiction treatment and the process of quality assessment by the 
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Ministry of Health and Ministry of Labour and Social Affairs (see below). The main objective was to 
assess whether it is possible to consolidate the accreditation processes of both ministries.  
The working group also reviewed the standards of quality that meet the registration standards of the 
Ministry of Labour and Social Affairs and the requirements of the Ministry of Health regarding the 
quality of drug services.  
After the reviewed version of the standards had been published, a first course for future members of 
accreditation teams (auditors) was conducted. The training focused especially on three main fields of 
education:  
• general part (quality assurance systems, accreditation, verification process, psychology of audit, 
and execution and evaluation of audit), 
• special part (interpretation and analysis of accreditation standards according to individual service 
modalities, measurement of system performance, quality, and effectiveness), 
• organizational part (accreditation process, organizational guarantee of audit, documentation 
required for an audit, and consequent evaluation). 
A draft of the minimum methodology for local investigation was drawn up for the purposes of the 
guaranteeing of a uniform procedure for the evaluation of service providers; i.e. whether services are 
delivered in compliance with the appropriate standards. It is absolutely essential to maintain an 
interdisciplinary and intersectorial approach and focus on drawing up uniform quality standards 
acceptable for all participating ministries (i.e. Ministry of Health, Ministry of Labour and Social Affairs, 
Ministry of Education, Youth, and Sports), in order to preserve the continuity of the whole process of 
the certification of quality and contingent accreditation. This requirement was also confirmed by the 
outputs of the Phare Twinning Project, which resulted in the adoption of Government Resolution No. 
549/2003. 
13.2 Requirements for Quality of Care 
The 2001 – 2004 National Drug Policy Strategy defines indicators of the evaluation of quality and 
efficiency of services and the success and fulfilment of defined objectives, and it has set up the 
objective of preparing and implementing a system of evaluation of provided care as an open system 
of the accreditation of health care and non-health care programmes that would also be based on the 
fulfilment of defined standards (Sekretariát Meziresortní protidrogové komise, 2000). The Secretariat 
of the National Drug Commission drew up the standards as early as 1995 and they were 
subsequently reviewed several times (Draft 6 was drawn up within the framework of the Phare 
Twinning Project in December 2002). The standards are divided into the general part (service 
accessibility, spectrum of services and principles of service provision, place of provision, rights of 
patients/clients, organizational and financial guarantees, and the education and supervision of 
employees) and the special part (dedicated to individual types of care). It has not yet been possible to 
implement these standards in practice; the implementation of the standards is still in preparation. 
Nevertheless, many facilities already use these standards and subsidy providers (e.g. the National 
Drug Commission) take these standards into consideration when providing financial subsidies to 
individual service providers.  
A comparative analysis of the Standards of Social Services of the Ministry of Labour and Social 
Affairs and the basic perspectives of the Standards of the Ministry of Health was carried out within the 
framework of the activities of the “Accreditations” working group of the Phare Twinning Project - see 
Table 13-1. It is apparent that Draft 6 of the Standards of the Ministry of Health was sufficiently 
comprehensive and that it anchors all of the basic fields.  
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Table 13-1: Comparison of the Basic Aspects of the Standards of Social Services of the Ministry of Labour and Social Affairs and the 
Standards of the Ministry of Health  
 
13.3 Criteria and Instruments – Plan for 2003  
The plan for further procedures in the field of certification of the quality of care for 2003 was 
determined in relation to the recommendations of the Accreditations working group of the Phare 
Twinning Project. This plan is based on:  
• Unification of terminology and performance indicators in all types of drug services,  
• Drawing up a list of relevant performances and definitions of these performances for each type of 
drug service, 
• Drawing up a Minimum Evaluation Set60 (MES) and a simple verification procedure in several 
facilities,  
• Training programme leaders how to work with the MES, 
• Training another group of accreditators (auditors) with consideration of regional aspects, 
• Completion of rules of certification proceedings, including methodology of level investigation, 
evaluation procedure, design of financial and institutional anchorage, etc.  
All of these activities will be carried out in compliance with the Government Resolution No. 549/2003 
and they will respect the requirement for the intersectorial nature of standards and the process of 
certification of quality. The process involves the individual ministries, the Sections of the Association of 
Non-Governmental Organizations, and the Czech Medical Association of J. E. Purkyně – Association 
for Addictive Diseases.  
14 Selected Issues 
Three sected issues chapters are included in each annual report. The EMCDDA, in collaboration with 
focal points in individual countries, defines the topics of these chapters with regard to current needs in 
practice and research. 
                                                           
60 i.e. a self-evaluation questionnaire for individual types of services that captures basic quality parameters for services and 
reporting. 
Aspect monitored Standards of 
Ministry of Health  
Standards of the 
Ministry of Labour 
and Social Affairs  
Quality management  YES YES 
Comprehensive entry assessment of a client  YES YES 
Evaluated and documented process of care  YES YES 
Bio-psycho-social approach  YES NO 
Guaranteeing comprehensiveness of care  YES NO 
Guaranteeing continuity of care  YES YES 
Guaranteeing confidentiality of information  YES YES 
“Minimum safety” requirements  YES Partly 
Client rights  YES YES 
Adequate team structure  YES YES 
Staff education  YES YES 
Efficiency evaluation  YES YES 
Mandatory content and scope of care according to 
type  
YES NO 
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14.1 Evaluation of the National Drug Strategy 
The 2001 – 2004 National Drug Policy Strategy defines goals, aims, objectives and targets, indicators 
of success, and tools for efficiency evaluation for each pillar of the Czech drugs policy (i.e. primary 
prevention, treatment and resocialization, harm reduction, supply reduction, and law enforcement). At 
the same time, it assigned 84 short-term and medium-term tasks to individual relevant ministries and 
local and regional public administrative bodies and defined deadlines for fulfilment (Sekretariát 
Meziresortní protidrogové komise, 2000). The 2001 – 2004 National Drug Policy Strategy has not yet 
been systematically evaluated according to the determined indicators of success and defined 
evaluation tools.  
Even the individual ministries do not carry out any evaluation of their own activities according to the 
generally accepted criteria. This may also be caused by the considerable costs of external 
evaluations. However, checks on the fulfilment of tasks are carried out on a regular basis and are 
similar to the monitoring of the fulfilment of the EU Action Plan.  
14.1.1 Evaluation Report 
It is one of the roles of the National Drug Commission to evaluate drugs policy measures and 
activities and conduct control activities. The Executive Vice-Chairman of the National Drug 
Commission has been directed to prepare an annual Evaluation Report on the Fulfilment of Targets 
Following from the 2001 – 2004 National Drug Policy Strategy. The 2002 Evaluation Report focused 
especially on the evaluation of the fulfilment of short-term targets following from the 2001 – 2004 
National Drug Policy Strategy for institutions/public administration bodies (i.e. 15 targets with a 
deadline by December 31, 2001). The Government acknowledged the Evaluation Report by means of 
the Government Resolution No. 1110/2002 of November 13, 2002.  
The Evaluation Report was submitted to the Government in the following structure:  
• Targets that were not fulfilled on schedule  
The Evaluation Report claimed that 14 out of 15 targets were not fulfilled. The Ministry of Education, 
Youth, and Sports failed to fulfil 6 targets, the Executive Vice-Chairman of the National Drug 
Commission failed to fulfil 4 targets, the Ministry of Health failed to fulfil 2 targets, the Ministry of 
Interior failed to fulfil 1 target, and the Ministry of Labour and Social Affairs failed to fulfil 1 target.  
The failed targets of the Ministry of Education, Youth, and Sports involve the field of primary and 
secondary prevention of drug use among children and young people. The drawing up of Minimum 
Standards of Primary Prevention is probably the most important target. Therefore, the services 
provided within the framework of primary prevention have still remained the least standardized, in 
comparison with services in the field of treatment and resocialization. A draft of minimum standards of 
primary prevention, a draft of a dictionary of primary prevention, and a draft of a manual of good 
practice were prepared within the framework of the Phare Twinning Project. These documents were 
submitted to the Ministry of Education, Youth, and Sports for completion.  
As far as the sphere of competence of the executive vice-chairman of the National Drug Commission 
is concerned, the failure to fulfil the target “to draw up financial standards of individual types of 
addiction treatment in collaboration with the Ministry of Health and the Ministry of Labour and Social 
Affairs” can be regarded as the most substantial issue. The task was only fulfilled partly – an analysis 
of the cost-effectiveness of individual types of services was carried out; however, as the reporting of 
the services delivered has not been unified yet, it cannot serve as a financial standard for a delivered 
service. The financial standards of services represent one of the planned tools for the control of quality 
and efficiency for the provision of subsidies to drug policy programmes.  
As far as the Ministry of Health is concerned, the most important non-fulfilled target was that of 
amending, or, more accurately, replacing Act No. 37/1989 Coll. on Protection against Alcoholism and 
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Other Drug Addictions. The act is not satisfactory in terms of the existing needs (for instance, it does 
not sufficiently determine the relationship between the state and the regions).  
The Ministry of Labour and Social Affairs failed to fulfil the target “to draw up a basic conceptual 
document in collaboration with the Ministry of Health that will define the question of resocialization and 
after-care in drug prevention”.  
The Ministry of the Interior did not meet the target “to draw up a project of reduction of drug supply 
and availability in Prague, including technical, staff and financial guarantees”. It is a key target, as the 
capital is currently the place most affected by the illicit drugs trafficking”.  
The Government defined new deadlines for the fulfilment of the targets mentioned in the period 
between December 31, 2002 and December 31, 2003.  
• Targets that require updating  
Updating of the targets was only carried out when there were serious reasons for it and in a manner 
that will not endanger the fulfilment of the objectives of the 2001 – 2004 National Drug Policy Strategy. 
The Government updated three targets – one at the request of the Ministry of Education, Youth, and 
Sports (clarification of the target “ to create an interconnected system of preventive activities at the 
level of the sphere of competence of the Ministry of Education, Youth, and Sports”), and two at the 
request of the Ministry of the Interior – one formal change of the wording and one change of the 
deadline from December 31, 2001 to “continuously” for the target “to prepare a programme of 
prevention of the use of narcotic and psychotropic substances; i.e. to provide pupils of primary 
schools with sufficient information in the field of drug issues and violence by means of specially 
trained uniformed police officers”. 
• Targets monitored by the European Commission within the framework of the Regular Evaluation 
Report about Accession of Candidate Countries to the European Union”  
A total of 12 targets assigned to appropriate ministries (especially the Ministry of the Interior – National 
Drug Squad and the Ministry of Finance – General Customs Headquarters for the field of drug supply 
reduction, Ministry of Labour and Social Affairs, National Drug Commission, Ministry of Health, 
Ministry of Education, Youth, and Sports, Ministry of Defence for the field of drug demand reduction). 
Non-compliance with the targets that are relevant to the European Union was not found within the 
framework of the Evaluation Report.  
14.1.2 Regional Drug Strategies 
The National Strategy is the basis for the creation and implementation of regional drug strategies (of 
course, it is not a normative basis). Ten regions have adopted a regional strategy so far; a draft has 
been prepared in one region, and three regions have not yet drawn one up. The existence of ten 
comprehensive regional drug policy conceptions based on the 2001 – 2004 National Drug Policy 
Strategy can be regarded positively, considering the relatively short period of time that these regions 
have been in existence (they were established as at January 1, 2001).  
Regional drug coordinators (and representatives of individual ministries) received basic information 
about evaluation rules within the framework of the Phare Twinning Project. The original intention of 
this part of the Phare Twinning Project (i.e. to draw up a set of concrete evaluation tools that are 
appropriate for the evaluation of impacts of implemented drug policy measures and proposals for the 
most appropriate procedures for the implementation of these measures, etc.) has not been fulfilled.  
A pilot project of evaluation of the Central Bohemia region’s drug policy was initiated in 2002 (it is 
funded from the region’s own financial resources); the Czech National Focal Point is the professional 
guarantor of this project. Knowledge acquired from this project (especially concrete evaluation tools 
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and methods appropriate for drug policy strategy evaluation) can be used by other regions or at a 
national level in the future. 
An evaluation project has three levels: the conceptual level (regional strategy), the level of partial 
strategies in the fields of drug supply and demand reduction, and the level of service providers.  
1. Conceptual Level (regional strategy): 
The conceptual level involves analysis of the regional strategy at two basic levels:  
• Content analysis of the concepts at regional level (e.g. a designed coordination system, control 
mechanisms, authority and competence, information flows, subsidy system, stability of regional 
drug policy system, etc.),  
• Content analysis of external consistency with the National Strategy and existing links with drug 
policy at national level (e.g. level of compatibility of the central and the regional system of 
coordination, compliance in authorities and competencies, compatibility of information flows and 
financial flows, etc.).  
2. Level of Partial Strategies in the Field of Drug Supply and Demand Reduction: 
A cost analysis model will be used at this level. It will be completed with a formative evaluation 
component with the objective of proposing ways of improving the quality and effectiveness of partial 
fields of regional drug policy implementation.  
The following activities will be carried out:  
• evaluation of basic epidemiological indicators;  
• analysis of the institutional context and cost-effectiveness of the following fields:  
• primary prevention, early diagnostics and intervention, 
• treatment and social re-integration, 
• tertiary prevention; 
• analysis of the institutional context of strategies that are geared towards drug supply reduction, 
including cost analysis. 
3. Level of Service Providers: 
The pursuit of several partial analyses (especially of several types of needs analyses) at the level of 
individual providers will especially serve as a source of verification of data and contextual 
relationships; this is also a prerequisite for the execution of a formative evaluation.  
14.2 Cannabis problems in context: understanding increased treatment demand  
There were very substantial changes in the use of cannabis drugs in the 1990s. They can be 
described as a process of gradual commercialization in the context of the commercialization of the 
market of other drugs (Miovský and Zábranský, 2002; Miovský and Zábranský, 2003). The main 
attributes of this process involve: a shift from the growing of cannabis for personal use to purchasing 
it, the use of new indoor growing technologies (especially the use of hydroponic technologies with 
artificial lighting), the development of the use of more potent cannabis cultivars (with a higher active 
substance content), and the gradual approximation and intermingling of markets of cannabis drugs 
and markets of more risk-laden substances like pervitin or heroin.  
The opinions of the general public and the professional public regarding the use of cannabis drugs 
and the related risks vary. Discussion in this field takes place in the media rather than in professional 
fora. 
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In the field of research in the Czech Republic, research into cannabinoids is implemented at the non-
human level at the Medical Faculty of Masaryk University in Brno (Nováková and Šulcová, 2002; 
Šulcová et al.  2002). A three-year study (2002 – 2004) implemented by the Department of 
Psychology at the Philosophical Faculty of Palacky University and the Institute of Psychology at the 
Academy of Science of the Czech Republic (GAČR 406/02/1449) is the only original study in the 
history of the Czech Republic that focuses on the psychosocial dimension of cannabis drugs use. 
More information about the study is available at www.curp.cz.  
Data about the use of cannabis drugs, public attitudes to cannabis use, the market or cannabis drugs, 
and offenders of criminal offences in connection with cannabis are included in the appropriate 
chapters. 
Smoking is still the most common pattern of cannabis use. Peroral use of THC, i.e. in food or in oil or 
fat, is relatively less common61.  
No specific treatment programme for cannabis users has been implemented in the Czech Republic; 
the need for such programmes has not yet been verified from the clinical point of view. The processed 
case studies indicate that the primary problem of heavy cannabis users is usually based on another 
disorder (e.g. more serious personality disorders, depressions, development disorders, commonly in 
combination with a very difficult family and social situation) (Miovský, 1998).  
From the point of view of monitoring the volume and the type of treatment sought by cannabis users, 
we encounter problems regarding diagnostics. A large part of the care delivered to drug users has the 
nature of social services. This field is especially covered by NGOs; a clear majority of them do not use 
the international classification of diseases (MKN 10). Low awareness among the professional public 
regarding dual diagnosis-related issues is yet another reason for the careful handling of data about 
first treatment demands. It is possible to assume that a large part of treatment demands involves 
unrecognized (non-diagnosed) clinical primary problems of a different nature.  
No relevant classification of cannabis users has existed or been used in the Czech Republic. One 
attempt to create such a classification has not yet been sufficiently verified on a large sample of users 
(Miovský, 1998); it is currently being verified within the framework of the project GAČR 406/02/1449.  
14.2.1 Cannabis Users in the Treatment Demand Register 
The Prague Hygiene Station carried out an analysis of cannabis-related treatment demands in the 
Register of Treatment Demands in 2002 for the purposes of this chapter (Studničková, 2003). 1,486 
users of cannabis drugs were recorded in the Register of Treatment Demands in 2002; 751 cases 
involved cannabis as the main drug, and one or more other drugs were present in 735 cases.  
71.3% of 751 users who reported cannabis as the only drug were under 19; see Table 14-1. There is 
an approximate 3 : 1 ratio of males and females. 574 cases involved first contact with a therapeutic or 
helping institution.  
Table 14-1: Number of registered cannabis users with cannabis as main drug (Studničková, 2003) 
 
Most cases involved reporting 
from low-threshold programmes; 
therefore, this does not 
necessarily have to involve 
treatment as such but rather a 
first contact in the user’s life. It is 
also necessary to be cautious in 
                                                           
61 Even the Czech Republic has recently witnessed cases of self-medication with cannabis; this especially involved degenerative and 
tumorous diseases. 
Age 
(years)  
Males Females Unknown Total % 
under 15  45 24 0 69 9.2 
15-19  325 135 6 466 62.1 
20-24  118 23 0 141 18.8 
25-39  55 4 1 60 8.0 
40 and more  4 0 0 4 0.5 
Unknown 7 4 0 11 1.5 
Total 554 190 7 751 100.0 
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the interpretation of data regarding cannabis users registered as “patients”, due to the fact that 48% of 
users (of those who reported how long they have been using it) have only been using cannabis for 
less than a year; see Table 14-2. It is highly unlikely that there would be complications that would be 
primarily caused by cannabis drug use and that would lead to the seeking of treatment in these cases.  
Table 14-2: Length of use of cannabis as main drug before contact with a treatment facility by gender (Studničková, 2003) 
Length of marijuana use  Males Females Unknown Total % 
0 years 48 19 2 69 9.2 
1 year 138 68 1 207 27.6 
2 years 72 31 2 105 14.0 
3 years 55 13 0 68 9.1 
4 years 43 6 0 49 6.5 
5 years 27 3 0 30 4.0 
6-10 years  34 2 1 37 4.9 
11 years and more  11 2 0 13 1.7 
Unknown 126 46 1 173 23.0 
 
735 respondents reported that they also use a drug other than cannabis. Pervitin was the most 
common secondary drug (20.9%), followed by alcohol (8.5%), heroin (5%), and solvents (4.3%). A 
third of those whose records contained data about a secondary drug mentioned a substance with 
more serious consequences than cannabis as the secondary drug. It is appropriate to ask which of 
these drugs was the actual reason for seeking contact.  
Table 14-3 gives an overview of the reasons that were given for seeking contact. More than half of 
registered users came into contact with a helping institution otherwise than exclusively through their 
own free will.  
Table 14-3: Motivation for seeking contact by groups of cannabis users (Studničková, 2003) 
 
In June – July 2003, the Czech National Focal Point carried out a survey in those facilities that report 
the highest rates of cannabis users to the Register of Drug Users (Národní monitorovací středisko pro 
drogy a drogové závislosti, 2003b). The objective was to receive detailed information about the health 
and social status of these clients, the reasons why they contacted the facility, and the nature of 
services delivered in these facilities. 
Total 554 190 7 751 100.0 
Motivation for contact  
 
Marijuana 
as the only 
drug  
 
% 
Marijuana with a 
secondary drug  
 
% 
Total – 
marijuana as a 
primary drug  
 
% 
Own  302 40.2 363 49.4 665 44.8 
Family  229 30.5 127 17.3 356 24.0 
Another 
treatment/outreach 
centre  
86 11.5 121 16.5 207 13.9 
General practitioner  29 3.9 25 3.4 54 3.6 
Residential health care 
facility  
22 2.9 25 3.4 47 3.2 
Social Service  38 5.1 17 2.3 55 3.7 
Courts, Police  24 3.2 26 3.5 50 3.4 
Unknown 21 2.8 31 4.2 52 3.5 
Total 751 100.0 735 100.0 1.486 100.0 
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40 providers of services in the whole Czech Republic who reported ten or more cannabis users to the 
Register of Drug Users in 2002 were addressed. Fifteen questionnaires were returned (i.e. a 38% 
return rate). Table 14-4 gives a description of the spectrum of facilities.  
Table 14-4: Types of facilities that responded to the questionnaire survey Marijuana Users – Treatment Demands (Národní 
monitorovací středisko pro drogy a drogové závislosti, 2003b) 
 
Ten K-centres reported that cannabis users mostly 
sought the facility on their own; one K-centrum 
reported parents as a prevailing reason. In the 
remaining four facilities, the most frequently 
mentioned reasons rather involved restrictive 
measures (compulsory treatment, repeated drop-
outs from treatment, etc.). The spectrum of indicated 
difficulties mostly involved educational and social 
difficulties; health difficulties were not so common (Table 14-5). For illustration purposes, the three 
most commonly reported difficulties were selected for each facility in the sequence from the most to 
the least common one. The most commonly reported reason scored three points, and the least 
common one scored one point.  
Table 14-5: Proportion between main reasons for seeking contact with a facility – questionnaire survey Marijuana Users – Treatment 
Demands (Národní monitorovací středisko pro drogy a drogové závislosti, 2003b) 
Note: * Each facility had 6 points available for the nomination of the first three most common reasons for contact (3, 2, 1 point 
respectively). One facility failed to answer this question – therefore, 14 facilities were evaluated (total score of 84 points).  
Most of the responding service providers reported a predominance of problems connected with 
difficulties other than health difficulties resulting from cannabis use. However, the fact that only one of 
the facilities tested uses the MKN 10 diagnostic system represents a certain limitation for 
interpretation. A qualitative description of troubles experienced by users indicates that 10 – 15% of the 
clientele show symptoms of problems that can be causally connected with cannabis use (memory 
defects, concentration, etc.) The problems described for other clients (85 – 90%) do not seem as 
likely to be direct consequences of cannabis use (discipline problems etc.). The type of interventions 
provided to cannabis users correspond with this finding. In 4 out of 15 facilities, the approach mainly 
involves curative methods (especially systematic long-term psychotherapy, or pharmacotherapy in 
justified cases). One facility reports a prevailing classic harm reduction approach because 10 out of 15 
reported clients injected another drug at the same time (see below). In the ten remaining facilities, this 
mostly involved prevailing counselling and sociotherapeutic interventions, often in combination with 
specific leisure-time programmes focusing on young people at risk.  
Four facilities reported cannabis users (with cannabis as the main drug) in more than 50% of cases; 
however, this also involved users who also mentioned parallel use of highly risk-laden drugs (pervitin, 
heroin), often in combination with highly risk-laden modes of use (injecting). For instance, one the 
facilities reported fifteen cannabis users in this manner; at the same time, injecting pervitin or heroin 
was recorded for ten of them. It is reasonable to believe that this is rather a result of non-uniformity of 
definitions for the reporting of clients, or it is a consequence of insufficient informedness on the part of 
professionals (especially in low-threshold and counselling services). The relatively considerable 
type of facility Number of 
questionnaires  
AT clinic  1 
Educational care centre  1 
Diagnostic institution  1 
Preventive/crisis centre  1 
K-centrum 11 
Total 15 
Reason for contact  Sum of points  Total share in all reasons for 
contact (%) 
Problems with parents 33 39.3 
Discipline problems  25 29.8 
Problems with school 
results  
19 22.6 
Mental problems  4 4.8 
Problems with police  3 3.6 
Total 84*  100.0 
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variance and lack of homogeneity of the answers lead to the conclusion that it would be appropriate to 
carry out case evaluations in randomly selected facilities in order to arrive at a relevant evaluation and 
description of the situation. 
In this respect, it seems very suitable to focus more on the field of diagnostics of cannabis drugs-use 
related problems and the preparation of short and specific educational programmes in 2003 and 
2004; the course should be designed for the target group of professionals in social and health-care 
drug services.  
14.3 Comorbidity 
14.3.1 Frequency and Spectrum of Dual Diagnoses – Data from Literature  
The term dual diagnosis (comorbidity) means a clinical picture of two or more diagnoses of one 
patient (Kaplan et al.  1991). As far as drug-related disorders are concerned, this usually involves the 
concurrence of an addiction to a psychoactive substance and another mental disorder. It is likely that 
the issues of dual diagnoses are very extensive in this field; however, the data vary. Some authors 
mention 76% of males and 65% of females (Kaplan et al.  1991). Popov (Popov, 2001) mentions 20 - 
60% of psychiatric complications among alcohol addicts (20 - 40% of males, 40 - 60% of females).  
According to Bayer (Bayer, 2003), a personality disorder is the most common type of comorbidity 
among males, and neurotic and affective disorders are the most common among females. Personality 
disorders dominate when psychotropic substances other than alcohol or anxiolytics are used. 
American authors place asocial personality disorder in first place; according to the existing MKN 10 
applicable in the Czech Republic, this disorder corresponds the most with an antisocial personality 
disorder. Anxiety depression symptoms are relatively common; however, these symptoms usually do 
not have the nature of major depression: they can involve symptoms that take place within a disorder 
of adaptation to an unsatisfactory living situation or also personality disorder (borderline or mixed 
personality disorder). 
Nešpor (Nešpor, 2003) quotes the Director of the American National Institute on Drug Abuse (NIDA), 
who claims that 30 – 60% of drug abusers suffer from a concurrent mental disorder (Leshner, 1999).  
What is the relationship between these two diagnoses? According to Nešpor, a client who has 
previously suffered from another mental disorder may develop addiction to a drug or another addiction 
disease, or a mental disorder manifests itself secondarily in an individual who has previously abused 
drugs or was addicted to them. However, the symptoms of mental disorder and addiction disease 
interact and mutually influence one another (Nešpor, 2003). 
The prevalence of addiction problems among patients suffering from mental disorders is higher than 
in the general population. This involves depressive disorders, personality disorders (more common 
among males), and food intake disorders (more common among females). It is also more common 
among females that social phobia or post-traumatic stress disorders precede the problems with the 
drug. In general, most mental problems increase the risk of problems with drugs and complicate the 
prevention and treatment of these problems.  
Nešpor mentions the following typical combinations that have repeatedly appeared in practice:  
• food intake disorders (anorexia, bulimia) and addiction to alcohol or drugs (this is much more 
frequent among females), 
• depressions and anxiety states and addiction to alcohol or sedatives (more common among 
females), 
• antisocial personality disorder and addiction to alcohol or drugs (substantially more common 
among males); it is typical that violent or other forms of inconsiderate behaviour preceded the 
addiction disease and did not appear as a consequence of it, 
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• narcissistic disorders,  
• pathological gambling – these clients are more endangered by addiction to alcohol and other 
drugs (a combination of pathological gambling and pervitin is extraordinarily dangerous), 
• repeated decompensations of psychotic disorders related to the abuse of alcohol, cannabis, 
pervitin, or hallucinogenic drugs. 
It follows from several surveys monitored by Kalina (2000) that approximately only 30% of patients 
have a single “drug addiction” diagnosis – the occurrence of other disorders shows that a 
considerable part of clients suffer from phobias, depressions, anxiety, psychosexual disorders, and, 
especially, personality disorders (see Table 14-6).  
Table 14-6: The most frequent accessory diagnoses among drug addicts in therapeutic communities in the United States of America  
(Tims et al.  1997)  
 
14.3.2 Dual Diagnoses among 
Hospitalized Patients  
3,164 persons were 
hospitalized in psychiatric 
hospitals and hospital 
psychiatric departments due to 
illicit drugs and solvents in 
2001, according to the data of 
the Institute for Health 
Information and Statistics 
(Ústav zdravotnických 
informací a statistiky, 2003d). A 
dual diagnosis from the field of 
mental disorders was recorded for 226 patients (7.1%) from this sample.  
However, nearly a half of these diagnoses suggested problems with use of a substance other than 
the main drug (116 persons, i.e. 3.6% of the sample and 51.3% of psychic complications). Psychic 
disorders outside the sphere of drugs were reported for 110 persons (i.e. 3.5% of the sample and 
48.7 of psychic complications).  
Table 14-7 provides a summary of dual diagnoses from the field of drugs. The other drugs that cause 
psychic problems mainly involve stimulants, opioids, and alcohol. Non-specified disorders are 
reported very frequently. The low representation of cannabinoids may be surprising and it certainly 
does not correspond with the frequency of cannabis use among the patients in the sample. At the 
same – in comparison with foreign data – problems with alcohol are mentioned far less frequently: 
they involved 39% of clients in the study of Tims et al (Tims et al.  1997), as opposed to 0.5% of 
clients in the sample of the Institute for Health Information and Statistics.  
Diagnostic group Frequency  
(% of clients) 
Organic brain syndromes  3 
Schizophrenic disorders  3 
Obsessive compulsive disorder  6 
Gambling  6 
Anorexia and bulimia  15 
Phobia  28 
Affective disorders (especially depression of various 
degrees)  
29 
Generalized anxiety  34 
Alcohol abuse  39 
Psychosexual dysfunction  40 
Personality dsorders  44 
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Table 14-7: Disorders related to the use of another drug mentioned as second diagnoses – psychiatric hospitals and hospital 
psychiatric departments in the Czech Republic, 2001 (Ústav zdravotnických informací a statistiky, 2003d) 
 
Personality disorders dominate as 
far as other psychic disorders are 
concerned – 34.5% of complications 
from this sphere (see Table 14-8). 
More than a half of them are mixed 
and emotionally unstable/borderline 
personality disorders; an antisocial 
personality disorder, the most 
common disorder reported by American authors (Bayer, 2003), can only be found sporadically in the 
sample of the Institute for Health Information and Statistics. Neurotic and stress-related disorders 
occupy the second position. Affective disorders and food intake disorders are reported less frequently 
than would seem appropriate according to clinical experience; the share of these disorders in 
complications of this type is practically identical to the share of schizophrenia.  
Table 14-8: Other psychic disorders mentioned as secondary diagnosis – psychiatric hospitals and hospital psychiatric departments 
in the Czech Republic in 2001 (Ústav zdravotnických informací a statistiky, 2003d) 
However, it is necessary to say that the 
total share of second diagnoses in the 
sample of the Institute for Health 
Information and Statistics is very low (even 
by orders) in comparison with data found in 
foreign literature. It is nearly twice as low, 
compared to the survey of Tims et al. (Tims 
et al.  1997). We have mentioned the 
comparison of alcohol problems with this 
survey above. As far as disorders other 
than those caused by drugs are concerned, we can, for instance, compare personality disorders – 
1.2% of the sample of the Institute for Health Information and Statistics, versus 44% in the survey of 
Tims et al.; food intake disorders – 0.3% versus 15% - and affective disorders – 0.4% versus 29%. 
With regard to complications from the field of drugs, we can compare problems with alcohol: the 
survey of Tims et al (Tims et al.  1997) records them for 39% of clients; the survey of the Institute for 
Health Information and Statistics reports 0.5%63. Therefore, the picture of dual diagnoses in the health 
statistics of the Czech Republic rather gives a picture of differences in methodology and focus than in 
the actual representation and profile of psychic complications and comorbidities in the clientele 
treated.  
14.3.3 Dual Diagnoses in Other Facilities in the Czech Republic  
Benchmark testing of a sample of 200 clients treated for problems with non-alcoholic drugs was 
carried out in two Czech therapeutic communities and one day-care centre in 2001 – 2002 for the 
purposes of this Annual Report. 
Psychic complications and comorbidities were found among 35.5% of clients, and among nearly 50% 
of day-care clients (in recent years, the facility won the reputation of a facility where it is possible to 
refer such a clientele). The spectrum was again dominated by personality disorders (nearly 40% of 
complications, 14% of clients); depressions, neurotic disorders, and food intake disorders were found 
among 5 -7% of all clients. A summary is included in Table 14-9.  
                                                           
62 Nicotine is completely neglected among the presented drugs.  
63 However, even the domestic drug scene keeps changing and traditional addictions to heroin or pervitin have been replaced with 
polymorphous addictions. It is apparent that it is no longer relevant to distinguish between clientele addicted to licit and illicit drugs in 
terms of treatment and after-care.  
Drug62 Number  Share in%  
Alcohol  18 15.5 
Opioids  25 21.5 
Cannabinoids 8 6.9 
Stimulants  28 24.2 
Other drugs (sedatives and hypnotics. 
hallucinogens, solvents)  
13 11.2 
Not specified  24 20.7 
Total 116 100.0 
Diagnostic group  Number  Share (%)  
Schizophrenia  12 10.9 
Affective disorders  13 11.8 
Neurotic and stress disorders  23 20.9 
Food intake disorders  10 9.1 
Personality disorders  38 34.5 
Mental retardation  3 2.7 
Children’s behaviour disorders 11 10.0 
Total 110 100.0 
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Even though it was just a benchmark survey, the results are closer to the data found in foreign 
literature and they provide a certain picture of the representation and profile of psychic complications 
and comorbidities in the clientele treated.  
Table 14-9: Psychic complications and comorbidities of clients treated in SANANIM facilities  in 2001 - 2002 (Kalina. 2003) 
 
14.3.4 Significance of Dual Diagnoses for Treatment  
Dual diagnoses bring about the following problems:  
• The accessory disorder very often complicates the participation of a client in treatment in an 
addiction treatment facility, it decreases his/her ability to benefit from it or even stay in the 
treatment at all.  
• The complications following from the accessory disorder often trigger relapse. 
• It not possible to treat the accessory disorder in common psychiatric/psychotherapeutic services 
when the client uses drugs because: (a) the addiction issues overshadow and distort the clinical 
picture and dynamics, (b) the participation of an addict in treatment regime, systematic 
psychotherapy, or pharmacotherapy is very problematic, (c) it is not possible to administer most 
psychopharmalogical medicaments reliably, meaningfully, effectively, and safely when drugs are 
used at the same time.  
• The staff of facilities for the treatment of addictive diseases are often not equipped with the 
requisite knowledge and skills to handle these issues.  
An addiction problem is usually more urgent and it requires cooperation during psychotherapy or 
pharmacotherapy of a given disorder. However, it is apparent that a client with a dual diagnosis has to 
be treated for both the addiction and the other mental problem. Such treatment is far more effective 
than treatment of the addiction or the mental problem only. Nešpor (Nešpor, 2003) describes the 
following distinct types of treatment: subsequent (it usually starts in an addiction treatment facility and 
then in a different facility for mental treatment), concurrent (in an addiction treatment facility and in a 
different psychiatric facility at the same time) or integrated treatment (in one facility and by one 
therapeutic team that is able to treat both of the problems). It is apparent that integrated treatment 
represents the best of the possibilities mentioned. However, not many facilities in the Czech Republic 
can provide integrated treatment.  
Integrated treatment of dual diagnoses requires many innovations in treatment procedures. First of all, 
we must mention the classification of therapy as a legitimate part of a treatment programme. Popov 
Diagnostic group  Number  Share of 
complications 
(%) 
Occurrence 
of 
complications 
in the sample 
(%) 
Affective disorders (depressive syndrome)  14 19.7 7.0 
Neurotic disorders  12 16.9 6.0 
Food intake disorders  10 14.0 5.0 
Personality disorders  28 39.4 14.0 
Paranoid syndrome  7 9.8 3.5 
Total of psychic complications and comorbidity  71 100.0 35.5 
Total in the sample of clients  200  100.0 
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(Popov, 2001; Popov, 2003) points that that the effort to “principally” avoid any pharmacotherapy for 
drug-addicted patients is unjustified and counterproductive for dual diagnoses.64 
It is necessary to provide for higher individualization of psychosocial approaches and to pay much 
more attention to issues other than the addiction ones. At the same time it is appropriate to be more 
sensitive and supportive. Confrontation-oriented approaches are usually explicitly contraindicated for 
most clients with a dual diagnosis (they did not even prove successful among clients with an addiction 
disorder only).65 Basic rules of cooperation must be defined, even though it is necessary to be more 
tolerant in the approach to clients with a dual diagnosis. Work with family members and partners, 
family therapy, and family counselling are considered necessary.  
Nešpor also mentions that treatment of a patient with a dual diagnosis makes specific demands on 
the team and on interdisciplinary cooperation. This does not only involve theoretical preparation of the 
teams but also increased flexibility, increased frustration tolerance, and good communication and 
cooperation of practitioners, psychologists, and social and other workers.  
14.3.5 Conclusion – Perspectives and Needs  
Foreign data, clinical experience, and the results of the benchmark survey indicate that facilities 
providing help to addicts must take into account the existence of a high share of patients with dual 
diagnoses. At least one in three clients would also need treatment other than that offered to him in a 
standard programme for addicts, or at least requires specific attention to his specific troubles.  
The development in developed countries shows that solving this complex package of problems can 
and must start among facilities and their staff by means of the training and education of the staff and 
consequent changes in treatment approaches.  
Treatment programmes in the Czech Republic have started to change. A benchmark survey has 
shown that up to 10% of clients in the monitored therapeutic communities use medicaments 
prescribed by the psychiatrist for at least some time (20% of clients in the day care centre). This is not 
the case in all facilities; however, this was something unimaginable several years ago. At the same 
time, the share of workers who completed psychotherapeutic training is increasing, and individual 
approaches and focusing on the general psychological and family problems of the clients are 
becoming more common. This makes it possible even for clients who used to drop out of treatment or 
were not accepted to it at all to benefit from the treatment.  
It is necessary to proceed with these innovations. A look at the dual diagnosis issues also shows 
another demand: the level of our knowledge is insufficient and it is necessary to conduct structured 
research and introduce measures in the field of diagnostics and data collection66. 
                                                           
64 See (Bayer, 2003), (Nešpor, 2000; Nešpor, 2003) and (Popov, 2001; Popov, 2003) for an overview of issues associated with 
pharmacotherapy in dual diagnoses. Inter alia, the authors point out the risk of the development of combined addiction (e.g. 
alcohol/benzodiazepines, heroin/benzodiazepines).  
65 It must be mentioned that these approaches are used far less than in the countries with a tradition of therapeutic communities of 
the so-called hierarchical type (Synanon line); e.g. in Poland.  
66 The insufficient level of knowledge also involves another type of dual diagnosis – the concurrence of addiction to tobacco 
(nicotine) and other mental disorders. This chronically neglected or, more accurately, unreported problem is not becoming subject to 
professional interest; however, an attempt to map this field exceeds the limits of this chapter.  
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Selected Czech Web Pages about Drug Issues  
An extensive list of (not only) Czech web pages dealing with drugs is available at http://www.drogy-
info.cz/link/category/1/. The following list includes selected official pages of key institutions in the field 
of prevention, treatment and monitoring of drug use.  
Adiktologie – Addictology – a professional 
journal for prevention, treatment and research of 
addictions: http://www.adiktologie.cz/  
A.N.O. – Association of Non-Governmental 
Organizations: http://www.asociace.org/  
Antidoping Committee of the Czech Republic: 
http://www.antidoping.cz/  
Customs Administration of the Czech Republic: 
http://www.cs.mfcr.cz/  
Centre of Epidemiology and Microbiology of the 
National Health Institute: 
http://www.szu.cz/cem/hpcem.htm  
Public Opinion Poll Center – Institute of 
sociology of the Academy of Science of the 
Czech Republic: 
http://www.cvvm.cas.cz/index.php3?rubrika=O&
oblast=B  
Czech Streetwork Association: 
http://sttreetwork.ecn.cz/  
Czech Medical Association: http://www.cls.cz/  
Czech Medical Association – search in journals): 
http://www.clsjep.cz/hledani.asp  
Czech Neuropsychopharmalogical Society: 
http://www.cnps.cz/  
Czech Statistical Office: http://www.czso.cz/  
Drug Information Server (SANANIM): 
http://www.sananim.cz/  
DROP-IN: http://www.dropin.cz/  
EXTC – prevention of synthetic drug abuse: 
http://www.extc.cz/  
Prague Hygiene Station: 
http://www.hygPraha.cz/  
Information Centre of the UNO in Prague: 
http://www.unicprague.cz/  
Institute for Criminology and Social Prevention: 
http://portal.justice.cz/justice/iksp.nsf/Stranky/Uv
od  
Institute of Criminology: 
http://www.mvcr.cz/policie/ku/index.html  
Methadone substitution: 
http://www.methadone.cz/  
Ministry of Justice – Czech courts: 
http://portal.justice.cz/  
Ministry of Labour and Social Affairs: 
http://www.mpsv.cz/  
Ministry of Education, Youth, and Sports: 
http://www.msmt.cz/  
Ministry of Interior: http://www.mvcr.cz/  
Ministry of Health: http://www.mzcr.cz/  
Czech National Focal Point: http://www.drogy-
info.cz/, http://www.focalpoint.cz/  
National Program of Combating AIDS in the 
Czech Republic: http://www.aids-hiv.cz/  
National Police Drug Squad: 
http://www.mvcr.cz/policie/npdc.html  
Newton IT – press monitor regarding drugs: 
http://imm.newtonit.cz/drogy.newton.cz.asp  
Podané ruce: http://www.podaneruce.cz/  
House of Commons of the Parliament of the 
Czech Republic – Subcommittee for Drugs and 
Addiction issues: 
http://snemovna.cz/sqw/fsnem.sqw?id=669  
Probation and Mediation Service: 
http://portal.justice.cz/justice/pms.nsf/Stranky/Uv
od  
Prev-Centrum: http://www.prevcentrum.cz  
Prague Psychiatric Centre: 
http://www.pcp.lf3.cuni.cz/pcpout/  
National Drug Commission: 
http://wtd.vlada.cz/vrk/vrk.htm  
Forensic Medicine in the Czech Republic: 
http://www.nemcb.cz/soudni/  
National Health Institute: http://www.szu.cz/  
Institute of Pharmacology of the 3rd Medical 
Faculty of Charles University in Prague – 
neuropsychopharmacology and prevention of 
drug addictions: http://www.lf3.cuni.cz/drogy/  
Institute for Health Information and Statistics: 
http://www.uzis.cz/  
Prison Service of the Czech Republic: 
http://www.vscr.cz/  
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Abbreviations  
AT – alcohol – toxicomania (drug addiction)  
CASRI – Scientific and Research Centre of 
Physical Education and Sport Prague 
CR - Czech Republic 
CZK – Czech crown(s) 
DDRSTP – project Pompidou Group Drug 
Demand Reduction Staff Training Programme  
EMCDDA – European Monitoring Centre for 
Drugs and Drug Addiction  
ESPAD - Evropská školní studie o alkoholu a 
jiných drogách (European School Survey 
Project on Alcohol and Other Drugs) 
EU – European Union  
GENACIS – study Gender and Alcohol 
Comparative International Study  
HBSC – study Health and Health Behaviour in 
School-Aged Children 
HBV – hepatitis B virus infection 
HCV – hepatitis C virus infection 
HIV - Human Immunodeficiency Virus  
HR – harm reduction 
IgM – M immunoglobulin(s)  
IDU – injecting drug user(s)  
KC – outreach centre  
KPE – dental health index (caries, fillings, 
extractions)  
MAD – school survey “Youth and Drugs” 
MES - Minimum Evaluation Set  
MKN 10 – Revision 10 of the International 
Classification of Diseases  
NEAD – school survey “Non-Alcoholic Drugs”  
NGOs - Non-Governmental Organizations 
NMS - Czech National Focal Point (Národní 
monitorovací středisko pro drogy a drogové 
závislosti)  
NPC – National Drug Squad (Národní 
protidrogová centrála služby kriminální policie 
a vyšetřování Policie ČR) 
NPS – narcotic and psychotropic substance 
PAD – Impact Analysis Project of New Drugs 
Legislation in the Czech Republic (Projekt 
analýzy dopadů nové drogové legislativy)   
WHO  - World Health Organization 
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